Medizinische Universität Graz - Research portal

Navigation/Search

• Researchers.
  • Curriculum.
  • Publications.
  • Projects.
  • Patent applications/Patents.
  • Presentations.
  • Advised theses.
• Institutions.
• Projects.
• Publications.
• Partners.
• Sponsors.
• Equipment.
• Knowhow.
• Fields of Research.

Mader Julia |

** = Publications listed in SCI/SSCI/Pubmed

2025

Full paper/article (Journal)

** Agarwal, S; Mader, JK; Arevalo, G; Avula, S; Chavez, E; Sloan, LA; Galindo, RJ Diabetes and Glucose Management in People on Hemodialysis.
Diabetes Spectr. 2025; 38(1): 7-18. Doi: 10.2337/dsi24-0015 [OPEN ACCESS]
PubMed FullText FullText_MUG

 

** Barnard-Kelly, K; Marrero, D; de, Wit, M; Pouwer, F; Khunti, K; Hermans, N; Pierce, JS; Laffel, L; Holt, RIG; Battelino, T; Naranjo, D; Fosbury, J; Fisher, L; Polonsky, W; Weissberg-Benchell, J; Hood, KK; Schnell, O; Messer, LH; Danne, T; Nimri, R; Skovlund, S; Mader, JK; Sherr, JL; Schatz, D; O'Neill, S; Doble, E; Town, M; Lange, K; de, Beaufort, C; Gonder-Frederick, L; Jaser, SS; Liberman, A; Klonoff, D; Elsayed, NA; Bannuru, RR; Ajjan, R; Parkin, C; Snoek, FJ Towards standardization of person-reported outcomes (PROs) in pediatric diabetes research: A consensus report.
Diabet Med. 2025; 42(3):e15484 Doi: 10.1111/dme.15484
Web of Science PubMed FullText FullText_MUG

 

** Fan, KS; Manoli, A; Baumann, PM; Shojaee-Moradie, F; Jeivad, F; Koehler, G; Cigler, M; Umpleby, AM; Russell-Jones, D; Mader, JK, , EASA, Diabetes, Consortium Comparison of continuous glucose monitoring with self-monitoring of blood glucose in type 1 diabetes in the changing atmospheric pressures in aviation: a hypobaric flight simulation.
Diabetologia. 2025; Doi: 10.1007/s00125-025-06364-z [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Fan, KS; Paterson, M; Shojaee-Moradie, F; Manoli, A; Edwards, V; Lee, V; Hutchison, E; Gifford, RM; Parsons, IT; Koehler, G; Mathieu, C; Mader, JK; King, BR; Russell-Jones, D Performance of Fluid Infusion Systems in the Changing Atmospheric Pressures Encountered in Aviation
AEROSP MED HUM PERF. 2025; 96(1): Doi: 10.3357/AMHP.6477.2025
Web of Science PubMed FullText FullText_MUG

 

** Fan, KS; Shojaee-Moradie, F; Manoli, A; Baumann, PM; Koehler, G; Edwards, V; Lee, V; Mathieu, C; Mader, JK; Russell-Jones, D, , EASA, Diabetes, Consortium The Feasibility of an Experimental Hypobaric Simulation to Evaluate the Safety of Closed-Loop Insulin Delivery Systems in Flight-Related Atmospheric Pressure Changes.
Diabetes Technol Ther. 2025; 27(2):128-133 Doi: 10.1089/dia.2024.0380
Web of Science PubMed FullText FullText_MUG

 

** Garden, GL; Fan, KS; Paterson, M; Shojaee-Moradie, F; Borg, Inguanez, M; Manoli, A; Edwards, V; Lee, V; Frier, BM; Hutchison, EJ; Maher, D; Mathieu, C; Mitchell, SJ; Heller, SR; Roberts, GA; Shaw, KM; Koehler, G; Mader, JK; King, BR; Russell-Jones, DL, , EASA, Diabetes, Consortium Effects of atmospheric pressure change during flight on insulin pump delivery and glycaemic control of pilots with insulin-treated diabetes: an in vitro simulation and a retrospective observational real-world study.
Diabetologia. 2025; 68(1):52-68 Doi: 10.1007/s00125-024-06295-1 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Golomb, RC; Tittel, SR; Welters, A; Karges, W; Meyhöfer, S; Hummel, M; Mader, JK; Kämmer, JC; Schloot, NC; Holl, RW Increased cardiovascular risk in people with LADA in comparison to type 1 diabetes and type 2 diabetes: Findings from the DPV registry in Germany and Austria.
Diabetes Obes Metab. 2025; 27(2):563-573 Doi: 10.1111/dom.16048 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Gölz, S; Mader, JK; Bilz, S; Kenzler, J; Danne, T Safety and Effectiveness of Glargine 300 U/ml After Switching from Basal Insulins in Patients with Type 1 Diabetes: COMET-T Study.
Diabetes Ther. 2025; 16(1):121-134 Doi: 10.1007/s13300-024-01670-y [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Hochfellner, D; Poettler, T; Schoerghuber, M; Lukic, E; Yates, A; Keeling, I; Zimpfer, D; Aberer, F; Berti, F; Lucarelli, F; Valgimigli, F; Mader, J Accuracy and Safety of a Novel Intravenous Continuous Glucose Monitoring System in Patients Admitted to a Cardiothoracic ICU: A Pilot Trial.
J Diabetes Sci Technol. 2025; 19322968251342598 Doi: 10.1177/19322968251342598
PubMed FullText FullText_MUG

 

** Hoffmann, L; Kohls, M; Arnolds, S; Achenbach, P; Bergholdt, R; Bonifacio, E; Bosi, E; Gündert, M; Hoefelschweiger, BK; Hummel, S; Jarosz-Chobot, P; Kordonouri, O; Lampasona, V; Narendran, P; Overbergh, L; Pociot, F; Raposo, JF; Šumník, Z; Szypowska, A; Vercauteren, J; Winkler, C; Mathieu, C; Ziegler, AG, , EDENT1FI, consortium EDENT1FI Master Protocol for screening of presymptomatic early-stage type 1 diabetes in children and adolescents.
BMJ Open. 2025; 15(1): e088522 Doi: 10.1136/bmjopen-2024-088522 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Hossmann, S; Tan, S; Mader, JK; Klonoff, DC; Adams, D; Ballhausen, H; Bally, L; Balmer, ML; Braunack-Mayer, V; Bonhoure, A; Burren, D; Boughton, CK; Cengiz, D; Eberle, C; Fabris, C; Friedman, M; Fröhlich-Reiterer, E; Gunn, T; Gusyatiner, O; Hastings, T; Huwiler, VV; Khan-Gallo, S; Levy, CJ; Moser, O; O'Kane, AA; Keighron, C; Oliver, N; Prioleau, T; Thybo, T; Yardley, J; Zueger, T; Faber-Heinemann, G; Heinemann, L; Rothenbühler, M One Size Does Not Fit All: The Need for Sex-Specific Precision Medicine in Diabetes Technology.
J Diabetes Sci Technol. 2025; 19322968251340673 Doi: 10.1177/19322968251340673
PubMed FullText FullText_MUG

 

** Olsen, MT; Liarakos, AL; Wilmot, EG; Dhatariya, K; Thabit, H; Sánchez-García, D; Nørgaard, K; Pedersen-Bjergaard, U; Hansen, KB; Vangoitsenhoven, R; Mathieu, C; Kristensen, PL; Mader, JK Implementation strategies for inpatient continuous glucose monitoring-based diabetes management: a systematic review.
J Clin Endocrinol Metab. 2025; Doi: 10.1210/clinem/dgaf074
Web of Science PubMed FullText FullText_MUG

 

** Saboo, B; Garg, S; Bergenstal, RM; Battelino, T; Ceriello, A; Choudhary, P; De, Bock, M; Elbarbary, N; Forlenza, G; Gomez, AM; Corrales, BG; Mader, J; O'Neal, D; Schwarz, P, , Call-to-Action, Coalition A Call-to-Action to Eliminate Barriers to Accessing Automated Insulin Delivery Systems for People with Type 1 Diabetes.
Diabetes Technol Ther. 2025; 27(3):147-151 Doi: 10.1089/dia.2025.0028
Web of Science PubMed FullText FullText_MUG

 

** Sourij, H; Azhar, K; Aziz, F; Kojzar, H; Sourij, C; Fasching, P; Clodi, M; Ludvik, B; Mader, JK; Resl, M; Rega-Kaun, G; Ress, C; Stechemesser, L; Stingl, H; Tripolt, NJ; Wascher, T; Kaser, S Interplay of health-related quality of life and comorbidities in people with type 2 diabetes mellitus treated in primary care settings in Austria: a countrywide cross-sectional study.
BMJ Open. 2025; 15(4):e092951 Doi: 10.1136/bmjopen-2024-092951 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Sourij, H; Azhar, K; Aziz, F; Kojzar, H; Sourij, C; Fasching, P; Clodi, M; Ludvik, B; Mader, JK; Resl, M; Rega-Kaun, G; Ress, C; Stechemesser, L; Stingl, H; Tripolt, NJ; Wascher, T; Kaser, S Metabolic risk factor targets in relation to clinical characteristics and comorbidities among individuals with type 2 diabetes treated in primary care - The countrywide cross-sectional AUSTRO-PROFIT study.
Diabetes Obes Metab. 2025; 27(1): 111-122. Doi: 10.1111/dom.15988 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Spartano, NL; Prescott, B; Walker, ME; Shi, E; Venkatesan, G; Fei, D; Lin, H; Murabito, JM; Ahn, D; Battelino, T; Edelman, SV; Fleming, GA; Freckmann, G; Galindo, RJ; Joubert, M; Lansang, MC; Mader, JK; Mankovsky, B; Mathioudakis, NN; Mohan, V; Peters, AL; Shah, VN; Spanakis, EK; Waki, K; Wright, EE; Zilbermint, M; Wolpert, HA; Steenkamp, DW Expert Clinical Interpretation of Continuous Glucose Monitor Reports From Individuals Without Diabetes.
J Diabetes Sci Technol. 2025; 19322968251315171 Doi: 10.1177/19322968251315171 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Short report/Letter

** Baechle, C; Rosenbauer, J; Stahl-Pehe, A; Seufert, J; Mader, JK; Wagner, C; Wosch, FJ; Erath, D; Holl, RW; Lanzinger, S, , in, cooperation, with, the, DPV‐Science, initiative, supported, by, the, German, Center, for, Diabetes, Research, (DZD) Effectiveness of add-on therapy with SGLT2 inhibitors or GLP-1 receptor agonists in adults with type 1 diabetes: A prospective DPV registry study.
Diabetes Obes Metab. 2025; 27(3):1591-1596 Doi: 10.1111/dom.16149
Web of Science PubMed FullText FullText_MUG

 

** Fan, KS; Manoli, A; Shojaee-Moradie, F; Hutchison, E; Strollo, F; Koehler, G; Mader, JK; Russell-Jones, D, , EASA, Diabetes, Consortium The practical operation and consequences of glucose measurement by pilots with diabetes.
Diabet Med. 2025; 42(3):e15472 Doi: 10.1111/dme.15472 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Mader, JK; Huffman, B; Sharon, R; Bucklar, G; Roetschke, J Glucagon-like Peptide-1-Based Therapies Do Not Interfere With Blood Glucose Monitoring Systems.
J Diabetes Sci Technol. 2025; 19(1):272-273 Doi: 10.1177/19322968241293810 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Review

** Klonoff, DC; Berard, L; Franco, DR; Gentile, S; Gomez, OV; Hussein, Z; Jain, AB; Kalra, S; Anhalt, H; Mader, JK; Miller, E; O'Meara, MA; Robins, M; Strollo, F; Watada, H; Heinemann, L Advance Insulin Injection Technique and Education With FITTER Forward Expert Recommendations.
Mayo Clin Proc. 2025; 100(4): 682-699. Doi: 10.1016/j.mayocp.2025.01.004
Web of Science PubMed FullText FullText_MUG

 

** Mader, JK; Fornengo, R; Hassoun, A; Heinemann, L; Kulzer, B; Monica, M; Nguyen, T; Sieber, J; Renard, E; Reznik, Y; Ryś, P; Stożek-Tutro, A; Wilmot, EG Existing Knowledge Gaps in Risk Factors and Consequences of Lipohypertrophy in People Using Continuous Subcutaneous Insulin Infusion Therapy: A Systematic Review and Meta-analysis.
J Diabetes Sci Technol. 2025; 19322968251319806 Doi: 10.1177/19322968251319806 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Mader, JK; Fornengo, R; Hassoun, A; Heinemann, L; Kulzer, B; Monica, M; Nguyen, T; Sieber, J; Renard, E; Reznik, Y; Ryś, P; Stożek-Tutro, A; Wilmot, EG Risk factors for Lipohypertrophy in People With Insulin-Treated Diabetes: A Systematic Meta-Analysis.
J Diabetes Sci Technol. 2025; 19322968251325569 Doi: 10.1177/19322968251325569 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Moser, O; Zaharieva, DP; Adolfsson, P; Battelino, T; Bracken, RM; Buckingham, BA; Danne, T; Davis, EA; Dovč, K; Forlenza, GP; Gillard, P; Hofer, SE; Hovorka, R; Jacobs, PG; Mader, JK; Mathieu, C; Nørgaard, K; Oliver, NS; O'Neal, DN; Pemberton, J; Rabasa-Lhoret, R; Sherr, JL; Sourij, H; Tauschmann, M; Yardley, JE; Riddell, MC The use of automated insulin delivery around physical activity and exercise in type 1 diabetes: a position statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD).
Diabetologia. 2025; 68(2):255-280 Doi: 10.1007/s00125-024-06308-z [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Saeed, ZI; Akturk, HK; Aleppo, G; Kruger, D; Levy, CJ; Mader, JK; Sherr, JL; Shah, VN Insulin Titration Recommendations When Using Glucagon-Like Peptide 1 Receptor Agonist Therapy in Adults With Type 1 Diabetes.
Clin Diabetes. 2025; 43(1): 131-138. Doi: 10.2337/cd24-0067 [OPEN ACCESS]
PubMed FullText FullText_MUG

 

** Schoemaker, M; Martensson, A; Mader, JK; Nørgaard, K; Freckmann, G; Benhamou, PY; Diem, P; Heinemann, L Combining Glucose Monitoring and Insulin Infusion in an Integrated Device: A Narrative Review of Challenges and Proposed Solutions.
J Diabetes Sci Technol. 2023; 19322968231203237 Doi: 10.1177/19322968231203237 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Shah, VN; Peters, AL; Umpierrez, GE; Sherr, JL; Akturk, HK; Aleppo, G; Bally, L; Cengiz, E; Cinar, A; Dungan, K; Fabris, C; Jacobs, PG; Lal, RA; Mader, JK; Masharani, U; Prahalad, P; Schmidt, S; Zijlstra, E; Ho, CN; Ayers, AT; Tian, T; Aaron, RE; Klonoff, DC Consensus Report on Glucagon-Like Peptide-1 Receptor Agonists as Adjunctive Treatment for Individuals With Type 1 Diabetes Using an Automated Insulin Delivery System.
J Diabetes Sci Technol. 2025; 19(1):191-216 Doi: 10.1177/19322968241291512 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2024

Full paper/article (Journal)

** Barnard-Kelly, K; Thienel, F; Mader, JK; Oliver, N; Franek, E; Vesper, I; Dagenbach, N; Vogt, G; Etter, T; Künsting, T A Three-Arm Randomized Controlled Study Comparing Patient-Reported Outcomes in People With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion or Multiple Daily Injections.
J Diabetes Sci Technol. 2024; 19322968241234055 Doi: 10.1177/19322968241234055 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Bergenstal, RM; Ásbjörnsdóttir, B; Watt, SK; Lingvay, I; Mader, JK; Nishida, T; Rosenstock, J Continuous glucose monitoring-based metrics and the duration of hypoglycaemia events with once-weekly insulin icodec versus once-daily insulin glargine U100 in insulin-naive type 2 diabetes: an exploratory analysis of ONWARDS 1.
Lancet Diabetes Endocrinol. 2024; 12(11):799-810 Doi: 10.1016/S2213-8587(24)00220-1
Web of Science PubMed FullText FullText_MUG

 

** Danne, TPA; Joubert, M; Hartvig, NV; Kaas, A; Knudsen, NN; Mader, JK Association Between Treatment Adherence and Continuous Glucose Monitoring Outcomes in People With Diabetes Using Smart Insulin Pens in a Real-World Setting.
Diabetes Care. 2024; 47(6):995-1003 Doi: 10.2337/dc23-2176 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Divilly, P; Martine-Edith, G; Zaremba, N; Søholm, U; Mahmoudi, Z; Cigler, M; Ali, N; Abbink, EJ; Brøsen, J; de, Galan, B; Pedersen-Bjergaard, U; Vaag, AA; McCrimmon, RJ; Renard, E; Heller, S; Evans, M; Mader, JK; Amiel, SA; Pouwer, F; Choudhary, P, , Hypo-RESOLVE, Consortium Relationship Between Sensor-Detected Hypoglycemia and Patient-Reported Hypoglycemia in People With Type 1 and Insulin-Treated Type 2 Diabetes: The Hypo-METRICS Study.
Diabetes Care. 2024; 47(10):1769-1777 Doi: 10.2337/dc23-2332 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Fattah, M; Boughton, CK; Ware, J; Allen, JM; Hartnell, S; Willinska, ME; Thankamony, A; de, Beaufort, C; Campbell, FM; Fröhlich-Reiterer, E; Hofer, SE; Kapellen, TM; Rami-Merhar, B; Ghatak, A; Randell, TL; Besser, REJ; Elleri, D; Trevelyan, N; Denvir, Md, L; Davis, N; Bally, L; Thabit, H; Leelarathna, L; Evans, ML; Mader, JK; Hovorka, R Evaluating the Impact of Applying Personal Glucose Targets in a Closed-Loop System for People With Type 1 Diabetes.
J Diabetes Sci Technol. 2024; 18(3):695-700 Doi: 10.1177/19322968221145184 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Haliloglu, B; Boughton, CK; Lakshman, R; Ware, J; Nwokolo, M; Thabit, H; Mader, JK; Bally, L; Leelarathna, L; Wilinska, ME; Allen, JM; Hartnell, S; Evans, ML; Hovorka, R Postprandial Glucose Excursions with Ultra-Rapid Insulin Analogs in Hybrid Closed-Loop Therapy for Adults with Type 1 Diabetes.
Diabetes Technol Ther. 2024; 26(7):449-456 Doi: 10.1089/dia.2023.0509
Web of Science PubMed FullText FullText_MUG

 

** Kietaibl, AT; Aziz, F; Wurm, E; Tomka, C; Fröhlich-Reiterer, E; Moser, O; Pieber, TR; Fasching, P; Mader, JK; Sourij, H; Aberer, F Improved Glycemic Control during a One-Week Adventure Camp in Adolescents with Type 1 Diabetes-The DIACAMP Study.
Biosensors (Basel). 2024; 14(9): Doi: 10.3390/bios14090451 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Kietaibl, AT; Schütz-Fuhrmann, I; Bozkurt, L; Frühwald, L; Rami-Merhar, B; Fröhlich-Reiterer, E; Hofer, SE; Tauschmann, M; Resl, M; Hörtenhuber, T; Stechemesser, L; Winhofer, Y; Riedl, M; Zlamal-Fortunat, S; Eichner, M; Stingl, H; Schelkshorn, C; Weitgasser, R; Rega-Kaun, G; Köhler, G; Mader, JK [Position paper: Open-source technology in the treatment of people living with diabetes mellitus-an Austrian perspective : Technology Committee of the Austrian Diabetes Association].
Wien Klin Wochenschr. 2024; 136(Suppl 9): 467-477. Doi: 10.1007/s00508-024-02400-x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Klonoff, DC; Freckmann, G; Pleus, S; Kovatchev, BP; Kerr, D; Tse, CC; Li, C; Agus, MSD; Dungan, K; Voglová, Hagerf, B; Krouwer, JS; Lee, WA; Misra, S; Rhee, SY; Sabharwal, A; Seley, JJ; Shah, VN; Tran, NK; Waki, K; Worth, C; Tian, T; Aaron, RE; Rutledge, K; Ho, CN; Ayers, AT; Adler, A; Ahn, DT; Aktürk, HK; Al-Sofiani, ME; Bailey, TS; Baker, M; Bally, L; Bannuru, RR; Bauer, EM; Bee, YM; Blanchette, JE; Cengiz, E; Chase, JG; Y, Chen, K; Cherñavvsky, D; Clements, M; Cote, GL; Dhatariya, KK; Drincic, A; Ejskjaer, N; Espinoza, J; Fabris, C; Fleming, GA; Gabbay, MAL; Galindo, RJ; Gómez-Medina, AM; Heinemann, L; Hermanns, N; Hoang, T; Hussain, S; Jacobs, PG; Jendle, J; Joshi, SR; Koliwad, SK; Lal, RA; Leiter, LA; Lind, M; Mader, JK; Maran, A; Masharani, U; Mathioudakis, N; McShane, M; Mehta, C; Moon, SJ; Nichols, JH; O'Neal, DN; Pasquel, FJ; Peters, AL; Pfützner, A; Pop-Busui, R; Ranjitkar, P; Rhee, CM; Sacks, DB; Schmidt, S; Schwaighofer, SM; Sheng, B; Simonson, GD; Sode, K; Spanakis, EK; Spartano, NL; Umpierrez, GE; Vareth, M; Vesper, HW; Wang, J; Wright, E; Wu, AHB; Yeshiwas, S; Zilbermint, M; Kohn, MA The Diabetes Technology Society Error Grid and Trend Accuracy Matrix for Glucose Monitors.
J Diabetes Sci Technol. 2024; 18(6):1346-1361 Doi: 10.1177/19322968241275701 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Kopanz, J; Lagerwaard, B; Beran, M; Veldwijk, J; Mader, JK; Pöttler, T; Tews, D; Grobbee, DE; Zuidgeest, MGP, , Trials@Home, consortium What motivates people with type 2 diabetes mellitus to participate in clinical trials from home?
Clin Transl Sci. 2024; 17(11): e70070 Doi: 10.1111/cts.70070 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Kopanz, J; Lichtenegger, K; Schwarz, C; Wimmer, M; Kamolz, LP; Pieber, T; Sendlhofer, G; Mader, J; Hoffmann, M Risks in the analogue and digitally-supported medication process and potential solutions to increase patient safety in the hospital: A mixed methods study.
PLoS One. 2024; 19(2): e0297491 Doi: 10.1371/journal.pone.0297491 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Lanzinger, S; Laubner, K; Warncke, K; Mader, JK; Kummer, S; Boettcher, C; Biester, T; Galler, A; Klose, D; Holl, RW Clinical characteristics, treatment, and treatment switch after molecular-genetic classification in individuals with maturity-onset diabetes of the young: Insights from the multicenter real-world DPV registry.
J Diabetes. 2024; 16(11): e70028 Doi: 10.1111/1753-0407.70028 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Mader, JK; Baumstark, A; Tüting, J; Sokol, G; Schuebel, R; Tong, Y; Roetschke, J; Slingerland, RJ Monitoring of the Analytical Performance of Four Different Blood Glucose Monitoring Systems: A Post-market Performance Follow-Up Study.
Diabetes Ther. 2024; 15(12):2525-2535 Doi: 10.1007/s13300-024-01665-9 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Mader, JK; Waldenmaier, D; Mueller-Hoffmann, W; Mueller, K; Angstmann, M; Vogt, G; Rieger, CC; Eichenlaub, M; Forst, T; Freckmann, G Performance of a Novel Continuous Glucose Monitoring Device in People With Diabetes.
J Diabetes Sci Technol. 2024; 18(5):1044-1051 Doi: 10.1177/19322968241267774 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Martine-Edith, G; Divilly, P; Zaremba, N; Søholm, U; Broadley, M; Baumann, PM; Mahmoudi, Z; Gomes, M; Ali, N; Abbink, EJ; de, Galan, B; Brøsen, J; Pedersen-Bjergaard, U; Vaag, AA; McCrimmon, RJ; Renard, E; Heller, S; Evans, M; Cigler, M; Mader, JK; Speight, J; Pouwer, F; Amiel, SA; Choudhary, P; Hypo-Resolve, FT A Comparison of the Rates of Clock-Based Nocturnal Hypoglycemia and Hypoglycemia While Asleep Among People Living with Diabetes: Findings from the Hypo-METRICS Study.
Diabetes Technol Ther. 2024; 26(7):433-441 Doi: 10.1089/dia.2023.0522
Web of Science PubMed FullText FullText_MUG

 

** Martine-Edith, G; Zaremba, N; Divilly, P; Søholm, U; Broadley, M; Baumann, PM; Mahmoudi, Z; Gomes, M; Ali, N; Abbink, EJ; de, Galan, B; Brøsen, J; Pedersen-Bjergaard, U; Vaag, AA; McCrimmon, RJ; Renard, E; Heller, S; Evans, M; Cigler, M; Mader, JK; Amiel, SA; Speight, J; Pouwer, F; Choudhary, P Associations Between Hypoglycemia Awareness Status and Symptoms of Hypoglycemia Among Adults with Type 1 or Insulin-Treated Type 2 Diabetes Using the Hypo-METRICS Smartphone Application.
Diabetes Technol Ther. 2024; 26(8):566-574 Doi: 10.1089/dia.2023.0596
Web of Science PubMed FullText FullText_MUG

 

** Royston, C; Boughton, C; Nwokolo, M; Lakshman, R; Hartnell, S; Wilinska, ME; Ware, J; Allen, JM; Thabit, H; Mader, JK; Bally, L; Leelarathna, L; Evans, ML; Hovorka, R Impact of Ultra-Rapid Insulin on Boost and Ease-Off in the Cambridge Hybrid Closed-Loop System for Individuals With Type 1 Diabetes.
J Diabetes Sci Technol. 2024; 19322968241289963 Doi: 10.1177/19322968241289963 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Schütz, A; Rami-Merhar, B; Schütz-Fuhrmann, I; Blauensteiner, N; Baumann, P; Pöttler, T; Mader, JK Retrospective Comparison of Commercially Available Automated Insulin Delivery With Open-Source Automated Insulin Delivery Systems in Type 1 Diabetes.
J Diabetes Sci Technol. 2024; 19322968241230106 Doi: 10.1177/19322968241230106 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Secco, K; Baumann, PM; Pöttler, T; Aberer, F; Cigler, M; Elsayed, H; Harer, CM; Weitgasser, R; Schütz-Fuhrmann, I; Mader, JK Glycemic Control Assessed by Intermittently Scanned Glucose Monitoring in Type 1 Diabetes during the COVID-19 Pandemic in Austria.
Sensors (Basel). 2024; 24(14): Doi: 10.3390/s24144514 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Søholm, U; Broadley, M; Zaremba, N; Divilly, P; Baumann, PM; Mahmoudi, Z; Martine-Edith, G; Mader, JK; Cigler, M; Brøsen, JMB; Vaag, A; Heller, S; Pedersen-Bjergaard, U; McCrimmon, RJ; Renard, E; Evans, M; de, Galan, B; Abbink, E; Amiel, SA; Hendrieckx, C; Speight, J; Choudhary, P; Pouwer, F, , Hypo-RESOLVE, consortium The impact of hypoglycaemia on daily functioning among adults with diabetes: a prospective observational study using the Hypo-METRICS app.
Diabetologia. 2024; 67(10):2160-2174 Doi: 10.1007/s00125-024-06233-1 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Ware, J; Wilinska, ME; Ruan, Y; Allen, JM; Boughton, CK; Hartnell, S; Bally, L; de, Beaufort, C; Besser, REJ; Campbell, FM; Draxlbauer, K; Elleri, D; Evans, ML; Fröhlich-Reiterer, E; Ghatak, A; Hofer, SE; Kapellen, TM; Leelarathna, L; Mader, JK; Mubita, WM; Narendran, P; Poettler, T; Rami-Merhar, B; Tauschmann, M; Randell, T; Thabit, H; Thankamony, A; Trevelyan, N; Hovorka, R Safety of User-Initiated Intensification of Insulin Delivery Using Cambridge Hybrid Closed-Loop Algorithm.
J Diabetes Sci Technol. 2024; 18(4):882-888 Doi: 10.1177/19322968221141924 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Zaremba, N; Martine-Edith, G; Divilly, P; Søholm, U; Broadley, M; Ali, N; Abbink, EJ; de, Galan, B; Cigler, M; Mader, JK; Brosen, J; Pedersen-Bjergaard, U; Vaag, A; Evans, M; Renard, E; McCrimmon, RJ; Heller, S; Speight, J; Pouwer, F; Amiel, SA; Choudhary, P, , Hypo‐RESOLVE, Consortium Associations of clinical, psychological, and sociodemographic characteristics and ecological momentary assessment completion in the 10-week Hypo-METRICS study: Hypoglycaemia MEasurements ThResholds and ImpaCtS.
Diabet Med. 2024; 41(8):e15345 Doi: 10.1111/dme.15345
Web of Science PubMed FullText FullText_MUG

 

Short report/Letter

** Aberer, F; Haberl, HC; Elsayed, H; Pöttler, T; Hochfellner, DA; Mader, JK Accuracy of the professional flash glucose monitoring system FreeStyle Libre Pro in hospitalized individuals with type 2 diabetes mellitus receiving standardized basal-bolus insulin therapy.
Diabetes Obes Metab. 2024; 26(9):4111-4115 Doi: 10.1111/dom.15719
Web of Science PubMed FullText FullText_MUG

 

** Thabit, H; Boughton, C; Mubita, W; Rubio, J; Allen, S; Heugh, R; Mader, JK; Narendran, P; Evans, M; Leelarathna, L; Wilinska, ME; Fullwood, C; Garratt, C; Hovorka, R; Rutter, MK Impact of hybrid closed-loop insulin delivery on cardiac rhythm in older adults with type 1 diabetes: A post hoc analysis of trial data.
Diabetes Obes Metab. 2024; 26(3):1105-1109 Doi: 10.1111/dom.15366 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Review

** Barnard-Kelly, K; Marrero, D; de, Wit, M; Pouwer, F; Khunti, K; Hermans, N; Pierce, JS; Laffel, L; Holt, RIG; Battelino, T; Naranjo, D; Fosbury, J; Fisher, L; Polonsky, W; Weissberg-Benchell, J; Hood, KK; Schnell, O; Messer, LH; Danne, T; Nimri, R; Skovlund, SE; Mader, JK; Sherr, JL; Schatz, D; O'Neill, S; Doble, E; Town, M; Lange, K; de, Beaufort, C; Gonder-Frederick, L; Jaser, SS; Liberman, A; Klonoff, D; ElSayed, NA; Bannuru, RR; Parkin, CG; Snoek, F Towards the standardisation of adult person-reported outcome domains in diabetes research: A Consensus Statement development panel.
Diabet Med. 2024; 41(8):e15332 Doi: 10.1111/dme.15332
Web of Science PubMed FullText FullText_MUG

 

** Eichenlaub, M; Pleus, S; Rothenbühler, M; Bailey, TS; Bally, L; Brazg, R; Bruttomesso, D; Diem, P; Eriksson, Boija, E; Fokkert, M; Haug, C; Hinzmann, R; Jendle, J; Klonoff, DC; Mader, JK; Makris, K; Moser, O; Nichols, JH; Nørgaard, K; Pemberton, J; Selvin, E; Spanou, L; Thomas, A; Tran, NK; Witthauer, L; Slingerland, RJ; Freckmann, G Comparator Data Characteristics and Testing Procedures for the Clinical Performance Evaluation of Continuous Glucose Monitoring Systems.
Diabetes Technol Ther. 2024; 26(4):263-275 Doi: 10.1089/dia.2023.0465 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Jendle, J; Adolfsson, P; Choudhary, P; Dovc, K; Fleming, A; Klonoff, DC; Mader, JK; Oliver, N; Sherr, JL; Šoupal, J; Heinemann, L A narrative commentary about interoperability in medical devices and data used in diabetes therapy from an academic EU/UK/US perspective.
Diabetologia. 2024; 67(2):236-245 Doi: 10.1007/s00125-023-06049-5 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Mader, JK; Fornengo, R; Hassoun, A; Heinemann, L; Kulzer, B; Monica, M; Nguyen, T; Sieber, J; Renard, E; Reznik, Y; Ryś, P; Stożek-Tutro, A; Wilmot, EG Relationship Between Lipohypertrophy, Glycemic Control, and Insulin Dosing: A Systematic Meta-Analysis.
Diabetes Technol Ther. 2024; 26(5):351-362 Doi: 10.1089/dia.2023.0491 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Editorial

** Ayers, AT; Ho, CN; Wong, JC; Kerr, D; Mader, JK; Klonoff, DC The Benefits of Using Continuous Glucose Monitoring to Diagnose Type 1 Diabetes.
J Diabetes Sci Technol. 2024; 19322968241288923 Doi: 10.1177/19322968241288923 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Brosen, JMB; Divilly, P; Martine-Edith, G; Zaremba, N; Ali, N; Evans, M; McCrimmon, R; Heller, S; de Galan, B; Mader, J; Renard, E; Vaag, AA; Choudhary, P; Bjergaard, UP Hypoglycaemia measured by continuous glucose monitoring in people with insulin-treated type 2 diabetes and chronic kidney disease: post hoc analysis from the HypoMETRICS study
DIABETOLOGIA. Abstracts. 2024; 67: S390-S391.-60th Annual Meeting of the EASD; SEP 9-13, 2024; Madrid, SPAIN. [Oral Communication]
Web of Science

 

** De Ridder, F; Dovc, K; Potocnik, N; Oberosler, M; Kheir, S; Windhaber, J; Mader, JK; Battelino, T; De Block, C Cardiopulmonary and aerobic exercise tests assessing multiple biomarkers and hormones in type 1 diabetes under different circumstances: the act-one study
DIABETOLOGIA. Abstracts. 2024; 67: S513-S513.-60th Annual Meeting of the EASD; SEP 9-13, 2024; Madrid, SPAIN. [Oral Communication]
Web of Science

 

** Divilly, P; Martine-Edith, G; Mahmoudi, Z; Zaremba, N; Soholm, U; Broadley, M; de Galan, B; Pedersen-Bjergaard, U; McCrimmon, RJ; Renard, E; Heller, S; Evans, M; Mader, JK; Seibold, A; Speight, J; Amiel, SA; Choudhary, P Symptomatic hypoglycaemia in insulin treated Type 2 Diabetes assessed by real time person reported hypoglycaemia and continuous glucose monitoring based on awareness status: the Hypo-METRICS study
IRISH J MED SCI. Abstracts. 2024; 193: S127-S127.-46th Annual Meeting of the Irish Endocrine Society; NOV 11-12, 2022; Dublin, IRELAND. [Oral Communication]
Web of Science

 

** Fan, K; Paterson, M; Manoli, A; Shojaee-Moradie, F; Edwards, V; Lee, V; Hutchison, E; Koehler, G; Mathieu, C; Mader, J; King, B; Russell-Jones, D Simulated commercial flights and the effects of atmospheric pressure changes on insulin pump delivery
DIABETOLOGIA. Abstracts. 2024; 67: S400-S400.-60th Annual Meeting of the EASD; SEP 9-13, 2024; Madrid, SPAIN. [Oral Communication]
Web of Science

 

** Kulzer, B; Ehrmann, D; Heinemann, L; Faber-Heinemann, G; Roos, T; Resl, M; Mader, J; Diem, P; Truempy, C; Brandt, D; Hermanns, N Can AID systems reduce diabetes-related stress?
DIABETOLOGIA. Abstracts. 2024; 67: S419-S419.-60th Annual Meeting of the EASD; SEP 9-13, 2024; Madrid, SPAIN. [Poster]
Web of Science

 

** Mader, JK; Hartvig, NV; Kaas, A; Knudsen, NN; Winhofer, Y Improvement in time in range after smart insulin pen initiation in Austria
DIABETOLOGIA. Abstracts. 2024; 67: S131-S131.-60th Annual Meeting of the EASD; SEP 9-13, 2024; Madrid, SPAIN. [Oral Communication]
Web of Science

 

Guideline

** Moser, O; Zaharieva, D; Adolfsson, P; Battelino, T; Bracken, RM; Buckingham, BA; Danne, T; Davis, EA; Dovc, K; Forlenza, GP; Gillard, P; Hofer, SE; Hovorka, R; Jacobs, PJ; Mader, JK; Mathieu, C; Nørgaard, K; Oliver, NS; O'Neal, DN; Pemberton, J; Rabasa-Lhoret, R; Sherr, JL; Sourij, H; Tauschmann, M; Yardley, JE; Riddell, MC The Use of Automated Insulin Delivery around Physical Activity and Exercise in Type 1 Diabetes: A Position Statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD).
Horm Res Paediatr. 2024; 1-28 Doi: 10.1159/000542287
Web of Science PubMed FullText FullText_MUG

 

2023

Full paper/article (Journal)

** Alwan, H; Ware, J; Boughton, CK; Wilinska, ME; Allen, JM; Lakshman, R; Nwokolo, M; Hartnell, S; Bally, L; de, Beaufort, C; Besser, REJ; Campbell, FM; Davis, N; Denvir, L; Evans, ML; Fröhlich-Reiterer, E; Ghatak, A; Hofer, SE; Kapellen, TM; Leelarathna, L; Mader, JK; Narendran, P; Rami-Mehrar, B; Tauschmann, M; Thabit, H; Thankamony, A; Hovorka, R Time Spent in Hypoglycemia According to Age and Time of Day: Observations During Closed-Loop Insulin Delivery.
Diabetes Technol Ther. 2023; 25(7):485-491 Doi: 10.1089/dia.2023.0061
Web of Science PubMed FullText FullText_MUG

 

** Clodi, M; Abrahamian, H; Brath, H; Schernthaner, G; Brix, J; Ludvik, B; Drexel, H; Saely, CH; Fasching, P; Rega-Kaun, G; Föger, B; Francesconi, C; Fröhlich-Reiterer, E; Kautzky-Willer, A; Harreiter, J; Luger, A; Resl, M; Riedl, M; Winhofer, Y; Hofer, SE; Hoppichler, F; Huber, J; Kaser, S; Ress, C; Lechleitner, M; Aberer, F; Mader, JK; Sourij, H; Toplak, H; Paulweber, B; Stechemesser, L; Pieber, T; Prager, R; Stingl, H; Stulnig, T; Rami-Merhar, B; Drexel, H; Roden, M; Schelkshorn, C; Wascher, TC; Weitgasser, R; Zlamal-Fortunat, S [Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2023)].
Wien Klin Wochenschr. 2023; 135(Suppl 1): 32-44. Doi: 10.1007/s00508-023-02186-4 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Garden, GL; Shojaee-Moradie, F; Hutchison, EJ; Frier, BM; Shaw, KM; Heller, SR; Koehler, G; Mader, JK; Maher, D; Roberts, GA; Russell-Jones, DL Continuous Glucose Monitoring by Insulin-Treated Pilots Flying Commercial Aircraft Within the ARA.MED.330 Diabetes Protocol: A Preliminary Feasibility Study.
Diabetes Technol Ther. 2023; 25(8):543-548 Doi: 10.1089/dia.2023.0069
Web of Science PubMed FullText FullText_MUG

 

** Klonoff, DC; Wang, J; Rodbard, D; Kohn, MA; Li, C; Liepmann, D; Kerr, D; Ahn, D; Peters, AL; Umpierrez, GE; Seley, JJ; Xu, NY; Nguyen, KT; Simonson, G; Agus, MSD; Al-Sofiani, ME; Armaiz-Pena, G; Bailey, TS; Basu, A; Battelino, T; Bekele, SY; Benhamou, PY; Bequette, BW; Blevins, T; Breton, MD; Castle, JR; Chase, JG; Chen, KY; Choudhary, P; Clements, MA; Close, KL; Cook, CB; Danne, T; Doyle, FJ; Drincic, A; Dungan, KM; Edelman, SV; Ejskjaer, N; Espinoza, JC; Fleming, GA; Forlenza, GP; Freckmann, G; Galindo, RJ; Gomez, AM; Gutow, HA; Heinemann, L; Hirsch, IB; Hoang, TD; Hovorka, R; Jendle, JH; Ji, L; Joshi, SR; Joubert, M; Koliwad, SK; Lal, RA; Lansang, MC; Lee, WA; Leelarathna, L; Leiter, LA; Lind, M; Litchman, ML; Mader, JK; Mahoney, KM; Mankovsky, B; Masharani, U; Mathioudakis, NN; Mayorov, A; Messler, J; Miller, JD; Mohan, V; Nichols, JH; Nørgaard, K; O'Neal, DN; Pasquel, FJ; Philis-Tsimikas, A; Pieber, T; Phillip, M; Polonsky, WH; Pop-Busui, R; Rayman, G; Rhee, EJ; Russell, SJ; Shah, VN; Sherr, JL; Sode, K; Spanakis, EK; Wake, DJ; Waki, K; Wallia, A; Weinberg, ME; Wolpert, H; Wright, EE; Zilbermint, M; Kovatchev, B A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings.
J Diabetes Sci Technol. 2023; 17(5):1226-1242 Doi: 10.1177/19322968221085273 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Mader, JK; Brix, JM; Aberer, F; Vonbank, A; Resl, M; Hochfellner, DA; Ress, C; Pieber, TR; Stechemesser, L; Sourij, H [Hospital diabetes management (Update 2023)].
Wien Klin Wochenschr. 2023; 135(Suppl 1): 242-255. Doi: 10.1007/s00508-023-02177-5 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Pfleger, S; Meçani, R; Semlitsch, B; Krall, A; Sendlhofer, G; Mader, JK; Wedrich, A Perioperative Insulin Regimens in Patients With Insulin-Treated Type 2 Diabetes Mellitus Hospitalized for a Short Time for Minor Eye Surgery.
J Diabetes Sci Technol. 2023; 17(3):679-682 Doi: 10.1177/19322968231168904 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Schneider-Utaka, AK; Hanes, S; Boughton, CK; Hartnell, S; Thabit, H; Mubita, WM; Draxlbauer, K; Poettler, T; Hayes, J; Wilinska, ME; Mader, JK; Narendran, P; Leelarathna, L; Evans, ML; Hovorka, R; Hood, KK Patient-reported outcomes for older adults on CamAPS FX closed loop system.
Diabet Med. 2023; 40(9):e15126 Doi: 10.1111/dme.15126
Web of Science PubMed FullText FullText_MUG

 

** Schütz-Fuhrmann, I; Rami-Merhar, B; Fröhlich-Reiterer, E; Hofer, SE; Tauschmann, M; Mader, JK; Resl, M; Kautzky-Willer, A; Winhofer-Stöckl, Y; Laimer, M; Zlamal-Fortunat, S; Weitgasser, R [Insulin pump therapy and continuous glucose monitoring].
Wien Klin Wochenschr. 2023; 135(Suppl 1): 53-61. Doi: 10.1007/s00508-023-02165-9 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Søholm, U; Broadley, M; Zaremba, N; Divilly, P; Nefs, G; Carlton, J; Mader, JK; Baumann, PM; Gomes, M; Martine-Edith, G; Pollard, DJ; Rath, D; Heller, S; Pedersen-Bjergaard, U; McCrimmon, RJ; Renard, E; Evans, M; de, Galan, B; Forkmann, T; Amiel, SA; Hendrieckx, C; Speight, J; Choudhary, P; Pouwer, F, , Hypo-RESOLVE, consortium Psychometric properties of an innovative smartphone application to investigate the daily impact of hypoglycemia in people with type 1 or type 2 diabetes: The Hypo-METRICS app.
PLoS One. 2023; 18(3): e0283148 Doi: 10.1371/journal.pone.0283148 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Søholm, U; Zaremba, N; Broadley, M; Axelsen, JL; Divilly, P; Martine-Edith, G; Amiel, SA; Mader, JK; Pedersen-Bjergaard, U; McCrimmon, RJ; Renard, E; Evans, M; de, Galan, B; Heller, S; Hendrieckx, C; Choudhary, P; Speight, J; Pouwer, F, , Hypo-RESOLVE, consortium Assessing the Content Validity, Acceptability, and Feasibility of the Hypo-METRICS App: Survey and Interview Study.
JMIR Diabetes. 2023; 8: e42100 Doi: 10.2196/42100 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Short report/Letter

** Kastner, JR; Poettler, T; Kopanz, J; Hochfellner, DA; Romey, M; Baumann, PM; Muchmore, D; Strasma, PJ; Mader, JK Current insulin infusion set failure criteria may be too stringent for real-life settings and may skew infusion set failure outcomes in extended-wear infusion set studies.
Diabetes Obes Metab. 2023; 25(4):1106-1111 Doi: 10.1111/dom.14935
Web of Science PubMed FullText FullText_MUG

 

** Thabit, H; Boughton, C; Mubita, W; Rubio, J; Mader, JK; Narendran, P; Evans, M; Leelarathna, L; Wilinska, ME; Fullwood, C; Gregory, AM; Hovorka, R; Rutter, MK Impact of the CamAPS FX hybrid closed-loop insulin delivery system on sleep traits in older adults with type 1 diabetes.
Diabetes Obes Metab. 2023; 25(3):889-893 Doi: 10.1111/dom.14914 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Review

** Heinemann, L; Nguyen, T; Bailey, TS; Hassoun, A; Kulzer, B; Oliveria, T; Reznik, Y; de, Valk, HW; Mader, JK Needle Technology for Insulin Administration: A Century of Innovation.
J Diabetes Sci Technol. 2023; 17(2): 449-457. Doi: 10.1177/19322968211059564 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Adolfsson, P; Hartvig, NV; Kaas, A; Knudsen, NN; Mader, JK Improvement in time in range after smart pen initiation in routine clinical practice
DIABETOLOGIA. 2023; 66(SUPPL 1):S81-S82.-59th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); OCT 02-06, 2023; Hamburg, GERMANY. [Oral Communication]
Web of Science

 

** Adolfsson, P; Hartvig, NV; Kaas, A; Knudsen, NN; Mader, JK Improvement in time in range after smart pen initiation in routine clinical practice
WIEN KLIN WOCHENSCHR. 2023; 135: S768-S768. [Poster]
Web of Science

 

** Alwan, H; Ware, J; Wilinska, M; Boughton, C; Allen, J; Lakshman, R; Nwokolo, M; Hartnell, S; Bally, L; De Beaufort, C; Besser, R; Campbell, F; Evans, M; Frohlich-Reiterer, E; Ghatak, A; Hofer, S; Kapellen, T; Leelarathna, L; Mader, J; Narendran, P; Rami-Mehrar, B; Thabit, H; Thankamony, A; Denvir, L; Davis, N; Hovorka, R TIME SPENT IN HYPOGLYCAEMIA ACCORDING TO AGE AND TIME OF DAY: OBSERVATIONS DURING CLOSED-LOOP INSULIN DELIVERY
DIABETES TECHNOL THE. 2023; 25: A134-A134. [Poster]
Web of Science

 

** Auzannneau, M; Schwettmann, L; Mader, J; Jung, R; Altmeier, M; Kopp, F; Zeyfang, A; Holl, RW SOCIOECONOMIC DISPARITIES IN ACCESS TO CGM FOR ADULTS WITH DIABETES. RESULTS FROM THE GERMAN DPV REGISTRY
DIABETES TECHNOL THE. 2023; 25: A57-A57. [Poster]
Web of Science

 

** Baumann, P; Cigler, M; Kuznetsov, D; Rosilio, M; Hochfellner, D; Ibberson, M; Amiel, S; Heller, S; Gall, MA; De Galan, B; Pieber, T; Choudhary, P; Mader, J ASSOCIATION OF SENSOR-DETECTED HYPOGLYCAEMIC EPISODES (SDHE) WITH HYPOGLYCAEMIA FROM SMBG IN 15 CLINICAL TRIALS WITH SHORT-DURATION CGM. PRELIMINARY RESULTS FROM THE HYPO-RESOLVE DATABASE
DIABETES TECHNOL THE. Abstracts. 2023; 25(S2):A157-A157.-ATTD 2023 Conference; FEB 22-25, 2023; Berlin, GERMANY. [Poster]
Web of Science

 

** Baumann, PM; Cigler, M; Hochfellner, D; Kuznetsov, D; Rosilio, M; Ibberson, M; Amiel, SA; Heller, S; Gall, MA; de Galan, B; Choudhary, P; Mader, JK How well does sensor-detected hypoglycaemia (SDH) from short-duration CGM reflect person-reported hypoglycaemia (PRH)?
WIEN KLIN WOCHENSCHR. Abstracts. 2023; 135(Suppl7):S753-S753.-51. Jahrestagung der ÖDG; NOV 16-18, 2023; Salzburg, AUSTRIA. [Poster]
Web of Science

 

** Baumann, PM; Cigler, M; Kuznetsov, D; Rosilio, M; Hochfellner, D; Ibberson, M; Amiel, SA; Heller, S; Gall, MA; de Galan, B; Pieber, TR; Choudhary, P; Mader, JK How well does sensor-detected hypoglycaemia from short-duration CGM reflect person-reported hypoglycaemia?
DIABETOLOGIA. 2023; 66(SUPPL 1):S407-S408.-59th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); OCT 02-06, 2023; Hamburg, GERMANY. [Oral Communication]
Web of Science

 

** Bergenstal, R; Watt, SK; Matos, ALSA; Lingvay, I; Mader, JK; Nishida, T; Rosenstock, J CGM outcomes and hypoglycemia duration with once-weekly insulin icodec versus oncedaily insulin glargine U100 in insulin-naive T2D: ONWARDS 1 exploratory analysis
WIEN KLIN WOCHENSCHR. 2023; 135: S767-S768. [Poster]
Web of Science

 

** Bergenstal, R; Watt, SK; Matos, ASA; Lingvay, I; Mader, JK; Nishida, T; Rosenstock, J CGM outcomes and hypoglycaemia duration with once-weekly insulin icodec versus once-daily insulin glargine u100 in insulin-naive type 2 diabetes: ONWARDS 1 exploratory analysis
DIABETOLOGIA. 2023; 66(SUPPL 1):S397-S397.-59th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); OCT 02-06, 2023; Hamburg, GERMANY. [Oral Communication]
Web of Science

 

** Cigler, M; Soholm, U; Abbink, E; Ali, N; Baumann, P; Pouwer, F; Broadley, M; Place, J; Farret, A; Renard, E; Evans, M; Chapman, D; Kennet, J; Brosen, JMB; Pedersen-Bjergaard, U; Mc Crimmon, R; Heller, S; Caunt, S; Speight, J; Divilly, P; Choudhary, P; Mader, JK The Hypo-METRICS App - a quantitative assessment of user experience
WIEN KLIN WOCHENSCHR. Abstracts. 2023; 135(Suppl7):S756-S757.-51. Jahrestagung der ÖDG; NOV 16-18, 2023; Salzburg, AUSTRIA. [Poster]
Web of Science

 

** Danne, T; Hartivig, NV; Kaas, A; Knudsen, NN; Mader, JK Association between treatment adherence and continuous glucose monitoring outcomes in people with diabetes using smart insulin pens in a real-world setting
DIABETOLOGIA. 2023; 66(SUPPL 1):S434-S435.-59th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); OCT 02-06, 2023; Hamburg, GERMANY. [Oral Communication]
Web of Science

 

** Divilly, P; Mahmoudi, Z; Martine-Edith, G; Zaremba, N; de Galan, B; Pedersen-Bjergaard, U; McCrimmon, R; Renard, E; Heller, S; Evans, M; Mader, J; Speight, J; Amiel, S; Pouwer, F; Choudhary, P Factors associated with symptomatic hypoglycaemia are different from those for CGM hypoglycaemia in people living with type 1 diabetes: the Hypo-METRICS study
DIABETOLOGIA. 2023; 66(SUPPL 1):S407-S407.-59th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); OCT 02-06, 2023; Hamburg, GERMANY. [Oral Communication]
Web of Science

 

** Divilly, P; Mahmoudi, Z; Martine-Edith, G; Zaremba, N; Soholm, U; Broadley, M; De Galan, B; Pedersen-Bjergaard, U; Mccrimmon, R; Renard, E; Heller, S; Evans, M; Mader, J; Seibold, A; Speight, J; Amiel, S; Choudhary, P ASSOCIATION BETWEEN PERSON-REPORTED HYPOGLYCAEMIA AND TIME BELOW RANGE: THE HYPO-METRICS STUDY
DIABETES TECHNOL THE. 2023; 25: A59-A59. [Oral Communication]
Web of Science

 

** Kaser, S; Sourij, H; Clodi, M; Aziz, F; Fasching, P; Fritsch, M; Kojzar, H; Ludvik, B; Mader, J; Resl, M; Rega-Kaun, G; Ress, C; Sourij, C; Stechemesser, L; Stingl, H; Tripolt, N; Wascher, T Characteristics of people with type 2 diabetes in Austrian primary care - data from the AUSTRO-PROFIT study
WIEN KLIN WOCHENSCHR. Abstracts. 2023; 135(Suppl7):S781-S782.-51. Jahrestagung der ÖDG; NOV 16-18, 2023; Salzburg, AUSTRIA. [Oral Communication]
Web of Science

 

** Kingsnorth, A; Divilly, P; Mahmoudi, Z; Martine-Edith, G; Zaremba, N; Soholm, U; De Galan, B; Pedersen-Bjergaard, U; Mccrimmon, R; Renard, E; Heller, S; Evans, M; Mader, J; Amiel, S; Pouwer, F; Choudhary, P EVALUATING THE IMPACT OF DAILY STEP COUNT ON GLUCOSE INDICES ACROSS 10 WEEKS OF MONITORING: THE HYPO-METRICS STUDY
DIABETES TECHNOL THE. 2023; 25: A149-A149. [Oral Communication]
Web of Science

 

** Kingsnorth, AP; Martine-Edith, G; Divilly, P; Pedersen-Bjergaard, U; McCrimmon, RJ; de Galan, B; Heller, S; Evans, M; Mader, J; Choudhary, P Exploring associations of step data with time in range and hypoglycaemia in people living with type 1 diabetes: The hypo-METRICS study
DIABETIC MED. 2023; 40: [Oral Communication]
Web of Science

 

** Mader, J MONITORING OF DIABETIC FOOT DISEASE
DIABETES TECHNOL THE. 2023; 25: A34-A34. [Oral Communication]
Web of Science

 

** Mader, JK; Fornengo, R; Hassoun, A; Heinemann, L; Kulzer, B; Monica, M; Nguyen, T; Sieber, J; Renard, E; Reznik, Y; Rys, P; Stozek-Tutro, A; Wilmot, EG Relationship between lipohypertrophy, glycemic control, and insulin dosing: a systematic meta-analysis
WIEN KLIN WOCHENSCHR. 2023; 135: S769-S769. [Poster]
Web of Science

 

** Martine-Edith, G; Divilly, P; Zaremba, N; Soholm, U; Broadley, M; Baumann, P; de Galan, B; McCrimmon, RJ; Evans, M; Mader, JK; Amiel, SA; Speight, J; Pouwer, F; Choudhary, P Quantifying intensity of hypoglycaemia symptoms by diabetes type and hypoglycaemia awareness status: results from the Hypo-METRICS study
DIABETOLOGIA. 2023; 66(SUPPL 1):S409-S410.-59th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); OCT 02-06, 2023; Hamburg, GERMANY. [Oral Communication]
Web of Science

 

** Scheikl, K; Pöttler, T; Harer, CM; Schmitt, LM; Mecani, R; Mader, JK; Treiber, G Significant increase in diabetic ketoacidosis in adults with diabetes mellitus
WIEN KLIN WOCHENSCHR. 2023; 135: S779-S779. [Poster]
Web of Science

 

** Soholm, U; Broadley, M; Zaremba, N; Divilly, P; Martine-Edith, G; Nefs, G; Mahmoudi, Z; Gomes, M; Mader, J; Cigler, M; Renard, E; Abbink, E; Baumann, PM; Heller, S; De Galan, B; Pedersen-Bjergaard, U; Evans, M; Pollard, D; Mccrimmon, R; Amiel, S; Hendrieckx, C; Speight, J; Choudhary, P; Pouwer, F IMPACT OF NOCTURNAL SYMPTOMATIC AND ASYMPTOMATIC PERSON-REPORTED HYPOGLYCAEMIA ON MORNING FUNCTIONING AMONG ADULTS WITH INSULIN-TREATED DIABETES: THE HYPO-METRICS STUDY
DIABETES TECHNOL THE. 2023; 25: A266-A267. [Oral Communication]
Web of Science

 

** Sourij, H; Clodi, M; Aziz, F; Fasching, P; Fritsch, M; Kojzar, H; Ludvik, B; Mader, J; Resl, M; Rega-Kaun, G; Ress, C; Sourij, C; Stechemesser, L; Stingl, H; Wascher, T; Kaser, S Prevalence of undiagnosed glucose metabolism disorders during preventive examinations - data from the AUSTRO-PROFIT study
WIEN KLIN WOCHENSCHR. Abstracts. 2023; 135(Suppl7):S782-S782.-51. Jahrestagung der ÖDG; NOV 16-18, 2023; Salzburg, AUSTRIA. [Poster]
Web of Science

 

** Tauschmann, M; Rabensteiner, B; Blauensteiner, N; Baumann, P; Rami-Merhar, B; Mader, J USE OF AID SYSTEMS VERSUS STANDARD SENSOR-AUGMENTED THERAPY DURING A 14-DAY DIABETES SUMMER CAMP: AN OBSERVATIONAL STUDY
DIABETES TECHNOL THE. 2023; 25: A141-A141. [Poster]
Web of Science

 

Comment

** Hochfellner, DA; Simic, A; Taucher, MT; Sailer, LS; Kopanz, J; Pöttler, T; Mader, JK Reply to Freckmann et al. Comment on "Hochfellner et al. Accuracy Assessment of the GlucoMen^® Day CGM System in Individuals with Type 1 Diabetes: A Pilot Study. Biosensors 2022, 12, 106".
Biosensors (Basel). 2023; 13(7): 710 Doi: 10.3390/bios13070710 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2022

Full paper/article (Journal)

** Boughton, CK; Hartnell, S; Thabit, H; Mubita, WM; Draxlbauer, K; Poettler, T; Wilinska, ME; Hood, KK; Mader, JK; Narendran, P; Leelarathna, L; Evans, ML; Hovorka, R Hybrid closed-loop glucose control compared with sensor augmented pump therapy in older adults with type 1 diabetes: an open-label multicentre, multinational, randomised, crossover study
LANCET HEALTH LONGEV. 2022; 3(3): E135-E142. Doi: 10.1016/S2666-7568(22)00005-8 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Camerlingo, N; Vettoretti, M; Sparacino, G; Facchinetti, A; Mader, JK; Choudhary, P; Del, Favero, S, , Hypo-RESOLVE, Consortium Choosing the duration of continuous glucose monitoring for reliable assessment of time in range: A new analytical approach to overcome the limitations of correlation-based methods.
Diabet Med. 2022; 39(5):e14758 Doi: 10.1111/dme.14758
Web of Science PubMed FullText FullText_MUG

 

** de, Beaufort, C; Schierloh, U; Thankamony, A; Ware, J; Wilinska, ME; Fröhlich-Reiterer, E; Kapellen, TM; Rami-Merhar, B; Hofer, SE; Campbell, FM; Yong, J; Bocchino, LE; Sibayan, J; Lawton, J; Roze, S; Fritsch, M; Thiele, A; Allen, JM; Boughton, C; Mader, JK; Kollman, C; Hovorka, R; Pit-Ten Cate, IM; KidsAP Consortium Cambridge Hybrid Closed-Loop System in Very Young Children With Type 1 Diabetes Reduces Caregivers' Fear of Hypoglycemia and Improves Their Well-Being.
Diabetes Care. 2022; 45(12):3050-3 Doi: 10.2337/dc22-0693 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Divilly, P; Zaremba, N; Mahmoudi, Z; Søholm, U; Pollard, DJ; Broadley, M; Abbink, EJ; de, Galan, B; Pedersen-Bjergaard, U; Renard, E; Evans, M; Speight, J; Brennan, A; McCrimmon, RJ; Müllenborn, M; Heller, S; Seibold, A; Mader, JK; Amiel, SA; Pouwer, F; Choudhary, P, , Hypo-RESOLVE, Consortium Hypo-METRICS: Hypoglycaemia-MEasurement, ThResholds and ImpaCtS-A multi-country clinical study to define the optimal threshold and duration of sensor-detected hypoglycaemia that impact the experience of hypoglycaemia, quality of life and health economic outcomes: The study protocol.
Diabet Med. 2022; 39(9):e14892 Doi: 10.1111/dme.14892 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Harer, C; Mader, JK Time in range (TIR) vs. glycated hemoglobin type A(1c) (HbA(1c)): a patient-centered approach Continuous glucose monitoring metrics in daily practice
DIABETOLOGIE. 2022; Doi: 10.1007/s11428-022-00963-9
Web of Science FullText FullText_MUG

 

** Hochfellner, DA; Simic, A; Taucher, MT; Sailer, LS; Kopanz, J; Pöttler, T; Mader, JK Accuracy Assessment of the GlucoMen^® Day CGM System in Individuals with Type 1 Diabetes: A Pilot Study.
Biosensors (Basel). 2022; 12(2): Doi: 10.3390/bios12020106 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Kopanz, J; Mader, JK; Donsa, K; Libiseller, A; Aberer, F; Pandis, M; Reinisch-Gratzer, J; Ambrosch, G; Lackner, B; Truskaller, T; Sinner, FM; Pieber, TR; Lichtenegger, KM Digital algorithm-guided insulin therapy in home healthcare for elderly persons with type 2 diabetes: A proof-of-concept study.
Frontiers in clinical diabetes and healthcare. 2022; 3: Doi: 10.3389/fcdhc.2022.986672 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Mader, JK; Aberer, F; Drechsler, KS; Pöttler, T; Lichtenegger, KM; Köle, W; Sendlhofer, G Medication errors in type 2 diabetes from patients' perspective.
PLoS One. 2022; 17(4): e0267570 Doi: 10.1371/journal.pone.0267570 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Moser, O; Sternad, C; Eckstein, ML; Szadkowska, A; Michalak, A; Mader, JK; Ziko, H; Elsayed, H; Aberer, F; Sola-Gazagnes, A; Larger, E; Fadini, GP; Bonora, BM; Bruttomesso, D; Boscari, F; Freckmann, G; Pleus, S; Christiansen, SC; Sourij, H Performance of intermittently scanned continuous glucose monitoring systems in people with type 1 diabetes: A pooled analysis.
Diabetes Obes Metab. 2022; 24(3):522-529 Doi: 10.1111/dom.14609
Web of Science PubMed FullText FullText_MUG

 

** Nagl, K; Bozic, I; Berger, G; Tauschmann, M; Blauensteiner, N; Weimann, K; Mader, JK; Rami-Merhar, B Time in Range in Children with Type 1 Diabetes before and during a Diabetes Camp-A Ceiling Effect?
Children (Basel). 2022; 9(12): Doi: 10.3390/children9121951 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Sourij, C; Tripolt, NJ; Aziz, F; Aberer, F; Forstner, P; Obermayer, AM; Kojzar, H; Kleinhappl, B; Pferschy, PN; Mader, JK; Cvirn, G; Goswami, N; Wachsmuth, N; Eckstein, ML; Müller, A; Abbas, F; Lenz, J; Steinberger, M; Knoll, L; Krause, R; Stradner, M; Schlenke, P; Sareban, N; Prietl, B; Kaser, S; Moser, O; Steinmetz, I; Sourij, H, , COVAC-DM, study, group Humoral immune response to COVID-19 vaccination in diabetes is age-dependent but independent of type of diabetes and glycaemic control: The prospective COVAC-DM cohort study.
Diabetes Obes Metab. 2022; 24(5):849-858 Doi: 10.1111/dom.14643 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Ware, J; Allen, JM; Boughton, CK; Wilinska, ME; Hartnell, S; Thankamony, A; de, Beaufort, C; Schierloh, U; Fröhlich-Reiterer, E; Mader, JK; Kapellen, TM; Rami-Merhar, B; Tauschmann, M; Nagl, K; Hofer, SE; Campbell, FM; Yong, J; Hood, KK; Lawton, J; Roze, S; Sibayan, J; Bocchino, LE; Kollman, C; Hovorka, R, , KidsAP, Consortium Randomized Trial of Closed-Loop Control in Very Young Children with Type 1 Diabetes.
N Engl J Med. 2022; 386(3): 209-219. Doi: 10.1056/NEJMoa2111673
Web of Science PubMed FullText FullText_MUG

 

Short report/Letter

** Aberer, F; Moser, O; Aziz, F; Sourij, C; Ziko, H; Lenz, J; Abbas, F; Obermayer, AM; Kojzar, H; Pferschy, PN; Müller, A; Unteregger, C; Leitner, M; Banfic, T; Eckstein, ML; Wachsmuth, N; Kaser, S; Mader, JK; Tripolt, NJ; Sourij, H Impact of COVID-19 Vaccination on Glycemia in Individuals With Type 1 and Type 2 Diabetes: Substudy of the COVAC-DM Study.
Diabetes Care. 2022; 45(2): e24-e26. Doi: 10.2337/dc21-1563
Web of Science PubMed FullText FullText_MUG

 

** Schütz, AK; Schütz-Fuhrmann, I; Stadler, M; Staudinger, H; Mader, JK Management of Type 1 Diabetes Mellitus Using Open-Source Automated Insulin Delivery During Pregnancy: A Case Series.
Diabetes Technol Ther. 2022; 24(3):227-230 Doi: 10.1089/dia.2021.0260
Web of Science PubMed FullText FullText_MUG

 

Review

** Mader, JK; Gölz, S; Bilz, S; Bramlage, P; Danne, T Controlling glycemic variability in people living with type 1 diabetes receiving insulin glargine 300 U/mL (Gla-300).
BMJ Open Diabetes Res Care. 2022; 10(4): Doi: 10.1136/bmjdrc-2022-002898 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Baumann, P; Cigler, M; Kuznetsov, D; Rosilio, M; Hochfellner, D; Ibberson, M; Amiel, S; Heller, S; Gall, MA; De Galan, B; Pieber, T; Choudhary, P; Mader, JK SENSOR-DETECTED HYPOGLYCAEMIA IN SHORT-DURATION CGM DATA FROM MULTIPLE CLINICAL TRIALS IN DIABETES. PRELIMINARY RESULTS FROM THE HYPO-RESOLVE DATABASE.
DIABETES TECHNOL THE. Abstracts from ATTD 2022. 2022; 24(S1):A31-A32.-15th International Conference on Advanced Technologies and Treatments for Diabetes; APR 27-30, 2022; Barcelona, SPAIN. [Poster]
Web of Science

 

** Baumann, P; Hochfellner, DA; Cigler, M; Roubik, L; Pottler, T; Mader, JK Gender differences in within-day glycaemic variations in people with T1D. Insights from long-duration CGM data from a diabetes registry
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):231-232. [Poster]
Web of Science

 

** Baumann, PM; Hochfellner, DA; Cigler, M; Roubik, L; Pottler, T; Mader, JK Patterns of sensor-detected hypoglycaemia in long-duration CGM data from a diabetes registry
DIABETOLOGIA. 2022; 65(SUPPL 1):S323-S323. [Oral Communication]
Web of Science

 

** Boughton, C; Hartnell, S; Thabit, H; Mubita, W; Draxlbauer, K; Poettler, T; Wilinska, M; Hood, K; Mader, J; Narendran, P; Leelarathna, L; Evans, M; Hovorka, R HYBRID CLOSED-LOOP GLUCOSE CONTROL COMPARED WITH SENSOR AUGMENTED PUMP THERAPY IN OLDER ADULTS WITH TYPE 1 DIABETES: A MULTICENTRE, MULTINATIONAL, RANDOMISED, CROSSOVER STUDY
DIABETES TECHNOL THE. Abstracts from ATTD 2022. 2022; 24(S1):A54-A55.-15th International Conference on Advanced Technologies and Treatments for Diabetes; APR 27-30, 2022; Barcelona, SPAIN. [Oral Communication]
Web of Science

 

** Cigler, M; Baumann, P; Elsayed, H; Hochfellner, D; Pottler, T; Secco, K; Simic, A; Trajanoski, S; Groselj-Strele, A; Mader, J Improved HbA1c is associated with better glycemic control in continuous glucose monitoring systems, but glycemic control is not influenced by treatment type or CGM duration
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):234-234. [Poster]
Web of Science

 

** Divilly, P; Martine-Edith, G; Mahmoudi, Z; Zaremba, N; Soeholm, U; De Galan, B; Pedersen-Bjergaard, U; Mccrimmon, R; Renard, E; Heller, S; Evans, M; Mader, J; Seibold, A; Amiel, S; Choudhary, P RATES OF SENSOR DETECTED HYPOGLYCAEMIA AND PATIENT REPORTED HYPOGLYCAEMIA; PRELIMINARY DATA FROM THE HYPO-METRICS TRIAL
DIABETES TECHNOL THE. Abstracts from ATTD 2022. 2022; 24(S1):A44-A45.-15th International Conference on Advanced Technologies and Treatments for Diabetes; APR 27-30, 2022; Barcelona, SPAIN. [Oral Communication]
Web of Science

 

** Harer, C; Hochfellner, D; Aberer, F; Mader, JK; Treiber, G Immune checkpoint inhibitor therapy-induced type 1 diabetes mellitus or precipitation of pre-symptomatic (stage 1) type 1 diabetes mellitus?
WIEN KLIN WOCHENSCHR. Abstracts der 50. Jahrestagung der Österreichischen Diabetes Gesellschaft. 2022; 134(SUPPL 4):242-242.-50. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 17-19, 2022; Salzburg, AUSTRIA. [Poster]
Web of Science

 

** Hochfellner, D; Baumann, P; Beck, P; Mader, J ALGORITHM-DRIVEN BASAL-BOLUS THERAPY IN HOSPITALIZED PATIENTS WITH TYPE 2 DIABETES: IMPLICATIONS FOR DISCHARGE THERAPY
DIABETES TECHNOL THE. Abstracts from ATTD 2022. 2022; 24(S1):A28-A28.-15th International Conference on Advanced Technologies and Treatments for Diabetes; APR 27-30, 2022; Barcelona, SPAIN. [Oral Communication]
Web of Science

 

** Hochfellner, DA; Baumann, P; Reinhard, A; Pottler, T; Roubik, L; Kogler, S; Cigler, M; Treiber, G; Mader, J Switching from isCCGM without alarms to isCCGM with alarms: what is the benefit?
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):244-244.-ÖDG Jahrestagung 2022; NOV 17-19; Salzburg, AUSTRIA. [Poster]
Web of Science

 

** Hochfellner, DA; Baumann, PM; Reinhard, AK; Mader, JK Introduction of isCGM with glucose alarms to regular isCGM users under real-life conditions: What is the benefit?
DIABETOLOGIA. 2022; 65(SUPPL 1):S350-S350.-EASD 2022; SEP 19-23, 2022; Stockholm, SWEDEN. [Oral Communication]
Web of Science

 

** Kastner, J; Poettler, T; Kopanz, J; Hochfellner, D; Siegl, R; Romey, M; Muchmore, D; Strasma, P; Mader, J CURRENT INSULIN INFUSION SET CRITERIA DO NOT REPRESENT REAL-LIFE SETTING AND MAY SKEW INFUSION SET FAILURE OUTCOMES IN EXTENDED-WEAR INFUSION SET STUDIES
DIABETES TECHNOL THE. Abstracts from ATTD 2022. 2022; 24(S1):A212-A212.-15th International Conference on Advanced Technologies and Treatments for Diabetes; APR 27-30, 2022; Barcelona, SPAIN. [Poster]
Web of Science

 

** Lichtenegger, K; Scholle, L; Kopanz, J; Libiseller, A; Reinisch-Gratzer, J; Ambrosch, G; Donsa, K; Sinner, F; Pieber, T; Klampfl-Kenny, M; Mader, J Diabetes prevalence and quality of diabetes management before, during and after the implementation of digital decision support for mobile care and support
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):248-248. [Poster]
Web of Science

 

** Mader, J; Siegl, R; Reinhard, A; Kopanz, J; Simic, A; Hartmann, M; Banerjee, S; Kamecke, U; Rebrin, K PERFORMANCE EVALUATION OF SUBCUTANEOUS GLUCOSE MONITORING IN CLINICAL DEVELOPMENT-OPTICAL MEASUREMENT PROFUSA LUMEE GLUCOSE PLATFORM
DIABETES TECHNOL THE. Abstracts from ATTD 2022. 2022; 24(S1):A147-A148.-15th International Conference on Advanced Technologies and Treatments for Diabetes; APR 27-30, 2022; Barcelona, SPAIN. [Poster]
Web of Science

 

** Mader, J; Tuca, A; Scholle, L; Pottler, T; Aberer, F; Reinhard, A; Herler, Y; Kopanz, J; Gamsey, S; Kamecke, U; Rebrin, K The Lumee hydrogel optical glucose sensor in clinical evaluation for assessment of data processing in people with insulin-treated diabetes
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):249-250. [Oral Communication]
Web of Science

 

** Martine-Edith, G; Divilly, P; Zaremba, N; Soeholm, U; Broadley, M; De Galan, B; Pedersen-Bjergaard, U; Mccrimmon, R; Renard, E; Heller, S; Evans, M; Mader, J; Speight, J; Seibold, A; Amiel, S; Pouwer, F; Choudhary, P NOVEL VISUAL TOOL TO ASSESS THE PREVALENCE OF HYPOGLYCAEMIA SYMPTOMS IN TYPE 1 DIABETES
DIABETES TECHNOL THE. Abstracts from ATTD 2022. 2022; 24: A71-A72.-15th International Conference on Advanced Technologies and Treatments for Diabetes; APR 27-30, 2022; Barcelona, SPAIN. [Oral Communication]
Web of Science

 

** Pottler, T; Kastner, J; Kopanz, J; Hochfellner, D; Romey, M; Muchmore, D; Strasma, P; Mader, J Current insulin infusion set criteria do not represent real-life setting and may skew infusion set failure outcomes in extended wear infusion set studies
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):255-255. [Oral Communication]
Web of Science

 

** Schutz, A; Schutz-Fuhrmann, I; Jaschik, M; Treiber, G; Mader, J OPEN-SOURCE AUTOMATED INSULIN DELIVERY WITH INSULIN LISPRO COMPARED TO ULTRA-RAPID INSULIN IN A MAN WITH TYPE 1 DIABETES MELLITUS: A CASE REPORT
DIABETES TECHNOL THE. Abstracts from ATTD 2022. 2022; 24(S1):A103-A104.-15th International Conference on Advanced Technologies and Treatments for Diabetes; APR 27-30, 2022; Barcelona, SPAIN. [Poster]
Web of Science

 

** Soeholm, U; Broadley, M; Divilly, P; Zaremba, N; Nefs, G; Carlton, J; Mader, J; Baumann, P; Gomes, M; Martine-Edith, G; Rath, D; Heller, S; Pedersen-Bjergaard, U; Mccrimmon, R; Renard, E; Evans, M; De Galan, B; Forkmann, T; Amiel, S; Hendrieckx, C; Speight, J; Choudhary, P; Pouwer, F PSYCHOMETRIC PROPERTIES OF HYPO-METRICS: A SMARTPHONE APPLICATION TO INVESTIGATE THE DAILY IMPACT OF HYPOGLYCAEMIA
DIABETES TECHNOL THE. 2022; 24: A216-A217. [Oral Communication]
Web of Science

 

2021

Full paper/article (Journal)

** Aberer, F; Hochfellner, DA; Mader, JK Application of Telemedicine in Diabetes Care: The Time is Now.
Diabetes Ther. 2021; 12(3):629-639 Doi: 10.1007/s13300-020-00996-7 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Boughton, CK; Hartnell, S; Thabit, H; Poettler, T; Herzig, D; Wilinska, ME; Ashcroft, NL; Sibayan, J; Cohen, N; Calhoun, P; Bally, L; Mader, JK; Evans, M; Leelarathna, L; Hovorka, R Hybrid closed-loop glucose control with faster insulin aspart compared with standard insulin aspart in adults with type 1 diabetes: A double-blind, multicentre, multinational, randomized, crossover study.
Diabetes Obes Metab. 2021; 23(6):1389-1396 Doi: 10.1111/dom.14355 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Camerlingo, N; Vettoretti, M; Sparacino, G; Facchinetti, A; Mader, JK; Choudhary, P; Del, Favero, S, , on behalf of the Hypo-RESOLVE, Consortium Design of clinical trials to assess diabetes treatment: Minimum duration of continuous glucose monitoring data to estimate time-in-ranges with the desired precision.
Diabetes Obes Metab. 2021; Doi: 10.1111/dom.14483 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** de, Beaufort, C; Pit-Ten, Cate, IM; Schierloh, U; Cohen, N; Boughton, CK; Tauschmann, M; Allen, JM; Nagl, K; Fritsch, M; Yong, J; Metcalfe, E; Schaeffer, D; Fichelle, M; Thiele, AG; Abt, D; Faninger, K; Mader, JK; Slegtenhorst, S; Ashcroft, N; Wilinska, ME; Sibayan, J; Kollman, C; Hofer, SE; Fröhlich-Reiterer, E; Kapellen, TM; Acerini, CL; Campbell, F; Rami-Merhar, B; Hovorka, R Psychological Well-Being of Parents of Very Young Children With Type 1 Diabetes - Baseline Assessment.
Front Endocrinol (Lausanne). 2021; 12: 721028 Doi: 10.3389/fendo.2021.721028 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Dena, M; Svensson, AM; Olofsson, KE; Young, L; Carlson, A; Miller, K; Grimsmann, J; Welp, R; Mader, JK; Maahs, DM; Holl, RW; Lind, M Renal Complications and Duration of Diabetes: An International Comparison in Persons with Type 1 Diabetes.
Diabetes Ther. 2021; 12(12):3093-3105 Doi: 10.1007/s13300-021-01169-w [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Diouri, O; Cigler, M; Vettoretti, M; Mader, JK; Choudhary, P; Renard, E, , HYPO-RESOLVE, Consortium Hypoglycaemia detection and prediction techniques: A systematic review on the latest developments.
Diabetes Metab Res Rev. 2021; e3449 Doi: 10.1002/dmrr.3449 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Fischer, LT; Hochfellner, DA; Knoll, L; Pöttler, T; Mader, JK; Aberer, F Real-world data on metabolic effects of PCSK9 inhibitors in a tertiary care center in patients with and without diabetes mellitus.
Cardiovasc Diabetol. 2021; 20(1): 89-89. Doi: 10.1186/s12933-021-01283-w [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Fuchs, J; Allen, JM; Boughton, CK; Wilinska, ME; Thankamony, A; de Beaufort, C; Campbell, F; Yong, J; Froehlich-Reiterer, E; Mader, JK; Hofer, SE; Kapellen, TM; Rami-Merhar, B; Tauschmann, M; Hood, K; Kimbell, B; Lawton, J; Roze, S; Sibayan, J; Cohen, N; Hovorka, R; KidsAP Consortium Assessing the efficacy, safety and utility of closed-loop insulin delivery compared with sensor-augmented pump therapy in very young children with type 1 diabetes (KidsAP02 study): an open-label, multicentre, multinational, randomised cross-over study protocol.
BMJ Open. 2021; 11(2): e042790-e042790. Doi: 10.1136/bmjopen-2020-042790 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Hochfellner, DA; Rainer, R; Ziko, H; Aberer, F; Simic, A; Lichtenegger, KM; Beck, P; Donsa, K; Pieber, TR; Fruhwald, FM; Rosenkranz, AR; Kamolz, LP; Baumann, PM; Mader, JK; Plank, J Efficient and safe glycaemic control with basal-bolus insulin therapy during fasting periods in hospitalized patients with type 2 diabetes using decision support technology: A post hoc analysis.
Diabetes Obes Metab. 2021; 23(9):2161-2169 Doi: 10.1111/dom.14458
Web of Science PubMed FullText FullText_MUG

 

** Kopanz, J; Lichtenegger, KM; Koenig, C; Libiseller, A; Mader, JK; Donsa, K; Truskaller, T; Bauer, N; Hahn, B; Sendlhofer, G; Beck, P; Höll, B; Sinner, F; Feichtner, F; Pieber, TR Electronic Diabetes Management System Replaces Paper Insulin Chart: Improved Quality in Diabetes Inpatient Care Processes Due to Digitalization.
J Diabetes Sci Technol. 2021; 15(2):222-230 Doi: 10.1177/1932296820957043 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Lichtenegger, KM; Aberer, F; Tuca, AC; Donsa, K; Höll, B; Schaupp, L; Plank, J; Beck, P; Fruhwald, FM; Kamolz, LP; Pieber, TR; Mader, JK, ;on behalf of the Hypo-RESOLVE, Consortium;AiDAPT, AP@home04, CLOuD, DAN05, DAN06, and, KidsAP, consortia;HYPO-RESOLVE, Consortium;KidsAP, Consortium Safe and Sufficient Glycemic Control by Using a Digital Clinical Decision Support System for Patients With Type 2 Diabetes in a Routine Setting on General Hospital Wards.
J Diabetes Sci Technol. 2021; 15(2):231-235 Doi: 10.1177/1932296820955243 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Nagl, K; Berger, G; Aberer, F; Ziko, H; Weimann, K; Bozic, I; Rami-Merhar, B; Mader, JK, ;on behalf of the Hypo-RESOLVE, Consortium;AiDAPT, AP@home04, CLOuD, DAN05, DAN06, and, KidsAP, consortia;HYPO-RESOLVE, Consortium;KidsAP, Consortium Performance of three different continuous glucose monitoring systems in children with type 1 diabetes during a diabetes summer camp.
Pediatr Diabetes. 2021; 22(2):271-278 Doi: 10.1111/pedi.13160 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Prinz, N; Schwandt, A; Borgert, B; Hartmann, B; Kempe, HP; Mader, JK; Merger, S; Weber-Lauffer, R; Wosch, FJ; Holl, RW Not All Type-2-Diabetes Patients Increase Body Mass Index After Initiating Insulin: Results of Latent Class Analysis from the DPV Registry.
Diabetes Technol Ther. 2021; 23(12):799-806 Doi: 10.1089/dia.2021.0144
Web of Science PubMed FullText FullText_MUG

 

** Simic, A; Schøndorff, PK; Stumpe, T; Heschel, M; Regittnig, W; Pöttler, T; Ninaus, D; Augustin, T; Groselj-Strele, A; Pieber, TR; Mader, JK, ;on behalf of the Hypo-RESOLVE, Consortium;AiDAPT, AP@home04, CLOuD, DAN05, DAN06, and, KidsAP, consortia;HYPO-RESOLVE, Consortium;KidsAP, Consortium Survival assessment of the extended-wear insulin infusion set featuring lantern technology in adults with type 1 diabetes by the glucose clamp technique.
Diabetes Obes Metab. 2021; 23(6):1402-1408 Doi: 10.1111/dom.14337 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Welters, A; Tittel, SR; Laubner, K; Laimer, M; Tschöpe, D; Mader, JK; Merger, S; Milek, S; Kummer, S; Holl, RW Long-term trends of BMI and cardiometabolic risk factors among adults with type 1 diabetes: An observational study from the German/Austrian DPV registry.
Diabetes Res Clin Pract. 2021; 178:108973 Doi: 10.1016/j.diabres.2021.108973
Web of Science PubMed FullText FullText_MUG

 

Short report/Letter

** Chen, NS; Boughton, CK; Hartnell, S; Fuchs, J; Allen, JM; Willinska, ME; Thankamony, A; de, Beaufort, C; Campbell, FM; Fröhlich-Reiterer, E; Hofer, SE; Kapellen, TM; Rami-Merhar, B; Ghatak, A; Randell, TL; Besser, REJ; Elleri, D; Trevelyan, N; Denvir, L; Davis, N; Gurnell, E; Lindsay, R; Morris, D; Scott, EM; Bally, L; Thabit, H; Leelarathna, L; Evans, ML; Murphy, HR; Mader, JK; Hovorka, R, , AiDAPT, AP@home04, CLOuD, DAN05, DAN06, and, KidsAP, consortia User Engagement With the CamAPS FX Hybrid Closed-Loop App According to Age and User Characteristics.
Diabetes Care. 2021; Doi: 10.2337/dc20-2762 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Review

** Aberer, F; Hochfellner, DA; Sourij, H; Mader, JK A Practical Guide for the Management of Steroid Induced Hyperglycaemia in the Hospital.
J Clin Med. 2021; 10(10): Doi: 10.3390/jcm10102154 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Case Report

** van, den, Boom, L; Stuecher, T; Mader, JK Safe use of a once-a-week glucagon-like peptide-1 receptor agonist in a 16-year-old girl with type 2 diabetes when approved therapy options fail.
Clin Case Rep. 2021; 9(9):e04811 Doi: 10.1002/ccr3.4811 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** van, den, Boom, L; Ziko, H; Mader, JK, ;on behalf of the Hypo-RESOLVE, Consortium;AiDAPT, AP@home04, CLOuD, DAN05, DAN06, and, KidsAP, consortia;HYPO-RESOLVE, Consortium;KidsAP, Consortium Safely finishing a half marathon by an adult with type 1 diabetes using a commercially available hybrid closed-loop system.
J Diabetes Investig. 2021; 12(3):450-453 Doi: 10.1111/jdi.13356 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Aberer, F; Moser, O; Sourij, C; Aziz, F; Ziko, H; Muller, A; Obermayer, AM; Kojzar, H; Pferschy, PN; Leitner, M; Lenz, J; Abbas, F; Banfic, T; Eckstein, ML; Wachsmuth, N; Tripolt, N; Kaser, S; Mader, JK; Sourij, H The immediate Impact of the COVID-19 Vaccination on the Time in Range and the Bolus Insulin Dose in People with Type 1 Diabetes - Subgroup Analysis of a multicenter Study
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):222-222. [Oral Communication]
Web of Science

 

** Aleppo, G; DeSalvo, DJ; Mader, JK; Lauand, F; Huyett, LM; Jantz, J; Chang, A; Vienneau, T; Ly, TT Glycemic improvement in 13,389 adults with type 1 diabetes (T1D) using the Omnipod (R) over the first 90 days of use
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):232-232. [Oral Communication]
Web of Science

 

** Barnard-Kelly, K; Franek, E; Vesper, I; Etter, T; Thienel, F; Mader, J PATIENT REPORTED PREFERENCES FROM THE PRO SOLO: NOVEL PATCH PUMP CLINICAL TRIAL
DIABETES TECHNOL THE. 2021; 23: A49-A50. [Oral Communication]
Web of Science

 

** Barnard-Kelly, K; Oliver, N; Thienel, F; Franek, E; Kuensting, T; Dagenbach, N; Etter, T; Mader, JK Biomedical and patient reported outcomes from the PRO solo multi-national, multi-centre clinical trial.
DIABETOLOGIA. 2021; 64(SUPPL 1):294-295. [Oral Communication]
Web of Science

 

** Baumann, PM; Cigler, M; Ziko, H; Kuznetsov, D; Rosilio, M; Hochfellner, DA; Ibberson, M; Amiel, SA; Heller, S; Gall, MA; de Galan, B; Choudhary, P; Mader, J Between- and within-subject variability of hypoglycaemia detected by short-duration CGM in multiple clinical trials in diabetes: variance decomposition of hypoglycaemic events in repeated CGM runs,
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):233-233. [Poster]
Web of Science

 

** Boughton, C; Hartnell, S; Thabit, H; Poettler, T; Herzig, D; Wilinska, M; Ashcroft, N; Sibayan, J; Cohen, N; Calhoun, P; Bally, L; Mader, J; Evans, M; Leelarathna, L REDUCTION OF HYPOGLYCAEMIA USING HYBRID CLOSED-LOOP WITH FASTER-INSULIN ASPART COMPARED WITH STANDARD-INSULIN ASPART IN ADULTS WITH TYPE 1 DIABETES: A DOUBLE-BLIND, MULTINATIONAL, RANDOMISED, CROSSOVER STUDY
DIABETES TECHNOL THE. 2021; 23: A72-A73. [Oral Communication]
Web of Science

 

** Bytyqi, K; Baumann, PM; Hochfellner, D; Aberer, F; Simic, A; Treiber, G; Pottler, T; Holl, B; Fahrleitner-Pammer, A; Beck, P; Mader, J Feasibility to use a continuous glucose monitoring system to manage diabetes during hospitalisation
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):211-212.-49. Jahrestagung ÖDG; NOV 18-20; Salzburg, AUSTRIA. [Poster]
Web of Science

 

** Chen, N; Boughton, C; Hartnell, S; Fuchs, J; Allen, J; Wilinska, M; Thankamony, A; De Beaufort, C; Campbell, F; Frohlich-Reiterer, E; Hofer, S; Rami-Merhar, B; Ghatak, A; Randell, T; Besser, R; Elleri, D; Denvir, L; Trevelyan, N; Davis, N; Gurnell, E; Lindsay, R; Morris, D; Scott, E; Bally, L; Thabit, H; Leelarathna, L; Evans, M; Murphy, H; Mader, J; Hovorka, R DIFFERENCES IN USER ENGAGEMENT WITH THE CAMAPS FX HYBRID CLOSED-LOOP APP ACCORDING TO AGE AND USER CHARACTERISTICS
DIABETES TECHNOL THE. 2021; 23: A62-A63. [Poster]
Web of Science

 

** Cigler, M; Elsayed, H; Ziko, H; Hochfellner, D; Kopanz, J; Pottler, T; Secco, K; Simic, A; Trajanoski, S; Groselj-Strele, A; Mader, JK Shorter Diabetes Duration and Residual Beta Cell Function are associated with better glycemic Control as measured by continuous Glucose Monitoring in People with Type 1 Diabetes
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):212-212. [Oral Communication]
Web of Science

 

** Groselj-Strele, A; Elsayed, H; Cigler, M; Ziko, H; Hochfellner, DA; Kopanz, J; Pottler, T; Secco, K; Simic, A; Trajanoski, S; Mader, JK Influence of Seasons on glycemic Control as measured with CGM Metrics in People with Type 1 Diabetes
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):219-219. [Oral Communication]
Web of Science

 

** Hochfellner, DA; Baumann, PM; Aberer, F; Simic, A; Bytyqi, L; Pottler, T; Holl, B; Fahrleitner-Pammer, A; Pieber, TR; Beck, P; Mader, J Basal-bolus Insulin Therapy through an electronic Decision Support System for stationary glycemic Control with Insulin degludec
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):209-209. [Poster]
Web of Science

 

** Kopanz, J; Mader, JK; Tuca, AC; Scholle, L; Hartmann, M; Roosen, MJ; Reinhard, AK; Herler, Y; Gamsey, S; Kamecke, U; Rebrin, K The Lumee hydrogel optical glucose sensor in clinical evaluation for safety and performance in people with insulin-treated diabetes
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):218-219. [Oral Communication]
Web of Science

 

** Kopanz, J; Scholle, L; Reinisch-Gratzer, J; Ambrosch, GC; Libiseller, A; Aberer, F; Pandis, M; Donsa, K; Truskaller, T; Pieber, T; Mader, J; Lichtenegger, K IMPROVED GLYCEMIC CONTROL AND PREVENTION OF ACUTE HOSPITAL ADMISSIONS BY USING A DIGITAL WORKFLOW AND DECISION SUPPORT SYSTEM IN HOME HEALTH CARE
DIABETES TECHNOL THE. 2021; 23: A103-A103. [Poster]
Web of Science

 

** Mader, J; Simic, A; Roosen, M; Hartmann, M; Scholle, L; Siegl, R; Vardanyan, S; Pottler, T; Menzie, W; Gamsey, S; Rebrin, K; Kamecke, U GLUCOSE TRACKING WITH OPTICAL MEASUREMENT IN CLINICAL EVALUATION-PROFUSA LUMEE GLUCOSE PLATFORM
DIABETES TECHNOL THE. 2021; 23: A37-A38. [Oral Communication]
Web of Science

 

** Mader, JK; Lingvay, I; Beck, BR; Koefoe, MM; Pettus, J; Wagner, L; Mathieu, C CGM Parameters for once a week Administration of Insulin icodec versus daily Administration of Insulin glargine U100 in insulin-naive Female Patients with Type 2 Diabetes
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):200-201. [Oral Communication]
Web of Science

 

** Moser, O; Sternad, C; Eckstein, ML; Aberer, F; Muller, A; Ziko, H; Mader, JK; Sourij, H Analysis of the Measurement Accuracy of the FreeStyle Libre 1 isCGM System based on the Rate of Change in Glucose - A multicenter, retrospective pooled Cohort Study
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):229-230. [Oral Communication]
Web of Science

 

** Nagl, K; Bozic, I; Rami-Merhar, B; Weimann, K; Berger, G; Mader, J TIME-IN-RANGE WITHOUT AUTOMATED INSULIN DELIVERY SYSTEMS IN CHILDREN WITH TYPE 1 DIABETES BEFORE AND DURING A DIABETES SUMMER CAMP - A GLASS CEILING?
DIABETES TECHNOL THE. 2021; 23: A186-A186. [Poster]
Web of Science

 

** Pottler, T; Etter, T; Kaestel, H; Schutz-Fuhrmann, I; Stechemesser, L; Dagenbach, N; Ebenbichler, C; Vonbank, A; Weitgasser, R; Mader, J Comparison of Treatment Satisfaction with Pen-based Therapy versus the Accu-Chek (R) Solo and mylifeTM OmniPod (R) Insulin Pumps among pump-naive People with Type 1 Diabetes in Austria
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):225-226. [Oral Communication]
Web of Science

 

** Schutz, A; Schutz-Fuhrmann, I; Eichner, M; Stulnig, T; Mader, J Case Series about four pregnant Women with pre-existing Type 1 Diabetes mellitus using Do-it-Yourself-Artificial Pancreas Systems
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):195-195. [Poster]
Web of Science

 

** Schutz, A; Schutz-Fuhrmann, I; Jaschik, MP; Treiber, GM; Mader, J Case Report: Comparison of Glucose Control using Insulin Lispro versus UltraRapid Insulin Lispro in a Man with Type 1 Diabetes mellitus under Android-based Artificial Pancreas System Therapy
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):201-201. [Poster]
Web of Science

 

** Schutz, A; Schutz-Fuhrmann, I; Mader, J CASE SERIES OF FOUR WOMEN WITH TYPE 1 DIABETES MELLITUS USING DO-IT-YOURSELF ARTIFICIAL PANCREAS SYSTEMS DURING PREGNANCY
DIABETES TECHNOL THE. 2021; 23: A77-A77. [Poster]
Web of Science

 

** Secco, K; Ziko, H; Pottler, T; Hochfellner, D; Weitgasser, R; Schutz-Fuhrmann, I; Mader, JK Glycemic control in type 1 diabetes during COVID-19 pandemic
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):220-220. [Keynote lecture]
Web of Science

 

** Simic, A; Taucher, M; Hochfellner, D; Dietrich, M; Porttler, T; Aberer, F; Mader, J ACCURACY ASSESSMENT OF THE NEW GLUCOMEN (R) DAY CGM SYSTEM IN INDIVIDUALS WITH TYPE 1 DIABETES
DIABETES TECHNOL THE. 2021; 23: A117-A117. [Poster]
Web of Science

 

** Simic, A; Taucher, M; Hochfellner, D; Pottler, T; Aberer, F; Mader, J Glucomen Day (R) CGM system accuracy assessment in individuals with type 1 diabetes
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):200-200. [Poster]
Web of Science

 

** Tauschmann, M; Fuchs, J; Nagl, K; Cvach, S; Mader, JK; Fritsch, M; Jasser-Nitsche, H; Faninger, K; Binder, E; Steichen, E; Abt, D; Allen, JM; Boughton, CK; Wilinska, ME; Sibayan, J; Thankamony, A; de Beaufort, C; Campbell, FM; Kapellen, TM; Frohlich-Reiterer, E; Hofer, SE; Rami-Merhar, B; Hovorka, R Cambridge Hybrid Closed-Loop in Young Children and Preschoolers with Type 1 Diabetes: A randomized, multi-national 4-Month Study
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):203-203. [Oral Communication]
Web of Science

 

** Treiber, G; Novak, E; Hantschel, E; Mader, J CHALLENGES WITH DIY LOOP IN PREGNANCY WITH TYPE 1 DIABETES
DIABETES TECHNOL THE. 2021; 23: A182-A183. [Poster]
Web of Science

 

** Tripolt, N; Sourij, C; Aberer, F; Kojzar, H; Obermayer, A; Pferschy, P; Aziz, F; Muller, A; Abbas, F; Lenz, J; Mader, J; Pesto, L; Banfic, T; Leitner, M; Steinberger, M; Knoll, L; Goswami, N; Moser, O; Eckstein, M; Wachsmuth, N; Cvirn, G; Stradner, M; Schlenke, P; Kaser, S; Steinmetz, I; Sourij, H Immune Response to COVID-19 Vaccination for Patients with Diabetes mellitus - The Covac-DM Austria Study
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):228-228. [Oral Communication]
Web of Science

 

Comment

** Moser, O; Riddell, MC; Eckstein, ML; Adolfsson, P; Rabasa-Lhoret, R; van den Boom, L; Gillard, P; Nørgaard, K; Oliver, NS; Zaharieva, DP; Battelino, T; de Beaufort, C; Bergenstal, RM; Buckingham, B; Cengiz, E; Deeb, A; Heise, T; Heller, S; Kowalski, AJ; Leelarathna, L; Mathieu, C; Stettler, C; Tauschmann, M; Thabit, H; Wilmot, EG; Sourij, H; Smart, CE; Jacobs, PG; Bracken, RM; Mader, JK Glucose management for exercise using continuous glucose monitoring: should sex and prandial state be additional considerations? Reply to Yardley JE and Sigal RJ [letter].
Diabetologia. 2021; 64(4):935-938 Doi: 10.1007/s00125-020-05374-3 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2020

Full paper/article (Journal)

** Aberer, F; Theiler-Schwetz, V; Ziko, H; Hausegger, B; Wiederstein-Grasser, I; Hochfellner, DA; Eller, P; Tomberger, G; Ellmerer, M; Mader, JK; Bubalo, V Accuracy and stability of an arterial sensor for glucose monitoring in a porcine model using glucose clamp technique.
Sci Rep. 2020; 10(1): 6604-6604. Doi: 10.1038/s41598-020-63659-4 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Camerlingo, N; Vettoretti, M; Facchinetti, A; Sparacino, G; Mader, JK; Choudhary, P; Del Favero, S An analytical approach to determine the optimal duration of continuous glucose monitoring data required to reliably estimate time in hypoglycemia.
Sci Rep. 2020; 10(1): 18180-18180. Doi: 10.1038/s41598-020-75079-5 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Eckert, AJ; Mader, JK; Altmeier, M; Mühldorfer, S; Gillessen, A; Dallmeier, D; Shah, VN; Heyer, C; Hartmann, B; Holl, RW Fracture risk in patients with type 2 diabetes aged ≥50 years related to HbA1c, acute complications, BMI and SGLT2i-use in the DPV registry.
J Diabetes Complications. 2020; 107664-107664. Doi: 10.1016/j.jdiacomp.2020.107664 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Frohlich-Reiterer, E; Tauschmann, M; Rami-Merhar, B; Mader, JK; Fritsch, M; Steichen-Gersdorf, E; Hofer, SE KidsAP: An Artificial Pancreas for Infants with Type 1 Diabetes.
PADIATR PADOL. 2020; Doi: 10.1007/s00608-020-00787-0 [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Leelarathna, L; Thabit, H; Wilinska, ME; Bally, L; Mader, JK; Pieber, TR; Benesch, C; Arnolds, S; Johnson, T; Heinemann, L; Hermanns, N; Evans, ML; Hovorka, R Evaluating Glucose Control With a Novel Composite Continuous Glucose Monitoring Index.
J Diabetes Sci Technol. 2019; 144(1):1932296819838525-1932296819838525 Doi: 10.1177/1932296819838525 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Libiseller, A; Kopanz, J; Lichtenegger, KM; Mader, JK; Truskaller, T; Lackner, B; Aberer, F; Pandis, M; Reinisch-Gratzer, J; Ambrosch, GC; Sinner, F; Pieber, TR; Donsa, K Study protocol for assessing the user acceptance, safety and efficacy of a tablet-based workflow and decision support system with incorporated basal insulin algorithm for glycaemic management in participants with type 2 diabetes receiving home health care: A single-centre, open-label, uncontrolled proof-of-concept study.
Contemp Clin Trials Commun. 2020; 19(10):100620-100620 Doi: 10.1016/j.conctc.2020.100620 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Moser, O; Mueller, A; Eckstein, ML; Ziko, H; Aberer, F; Treiber, G; Unteregger, C; Kojzar, H; Mader, JK; Sourij, C; Pferschy, P; Obermayer, A; Tripolt, N; Sourij, H Improved glycaemic variability and basal insulin dose reduction during a running competition in recreationally active adults with type 1 diabetes-A single-centre, prospective, controlled observational study.
PLoS One. 2020; 15(9): e0239091-e0239091. Doi: 10.1371/journal.pone.0239091 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Moser, O; Ziko, H; Elsayed, H; Hochfellner, DA; Pöttler, T; Mueller, A; Eckstein, ML; Sourij, H; Mader, JK, , Hypo-RESOLVE, Consortium People with type 1 diabetes and impaired awareness of hypoglycaemia have a delayed reaction to performing a glucose scan during hypoglycaemia: a prospective observational study.
Diabet Med. 2020; 37(12):2153-2159 Doi: 10.1111/dme.14362 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Short report/Letter

** Leelarathna, L; Thabit, H; Willinska, ME; Bally, L; Mader, JK; Arnolds, S; Benesch, C; Pieber, TR; Shah, VN; Carlson, AL; Bergenstal, RM; Evans, ML; Hovorka, R; AP@home04 and APCam11 consortia Duration of Hybrid Closed-Loop Insulin Therapy to Achieve Representative Glycemic Outcomes in Adults With Type 1 Diabetes.
Diabetes Care. 2020; 43(3):e38-e39-e38-e39 Doi: 10.2337/dc19-2041 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Schütz-Fuhrmann, I; Schütz, AK; Eichner, M; Mader, JK Two Subsequent Pregnancies in a Woman With Type 1 Diabetes: Artificial Pancreas Was a Gamechanger.
J Diabetes Sci Technol. 2020; 1932296820906219-1932296820906219. Doi: 10.1177/1932296820906219
Web of Science PubMed FullText FullText_MUG

 

Correspondence

** Mader, JK Personal Experiences With Coronavirus Disease 2019 and Diabetes: The Time for Telemedicine is Now.
J Diabetes Sci Technol. 2020; 14(4): 752-753. Doi: 10.1177/1932296820930289 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Aberer, F; Hochfellner, D; Ziko, H; Sagmeister, MH; Cigler, M; Simic, A; Pottler, T; Sendlhofer, G; Beck, P; Mader, JK Efficiency and Safety of an electronic Decision Support System for Insulin Therapy in hospitalized Female Patients with Type 2 Diabetes.
WIEN KLIN WOCHENSCHR. 2020; 132: S334-S334. [Poster]
Web of Science

 

** Bozic, I; Nagl, K; Rami-Merhar, B; Mader, JK; Weimann, K; Berger, G Time-in-Range for 31 Children before and during a Diabetes Camp.
WIEN KLIN WOCHENSCHR. 2020; 132: S359-S359. [Poster]
Web of Science

 

** Camerlingo, N; Vettoretti, M; Facchinetti, A; Mader, JK; Choudhary, P; Sparacino, G; Del Favero, S Determining the minimum duration of CGM monitoring to accurately estimate time below range.
DIABETOLOGIA. 2020; 63(SUPPL 1):S361-S362.-56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 21-25, 2020; ELECTR NETWORK. [Oral Communication]
Web of Science

 

** Cigler, M; Ziko, H; Elsayed, H; Hochfellner, D; Pottler, T; Muller, A; Eckstein, ML; Knoll, L; Sourij, H; Mader, JK; Moser, O People with type 1 diabetes and impaired awareness of hypoglycaemia have a delayed reaction to perform a glucose scan during hypoglycaemia: a prospective observational study.
DIABETOLOGIA. 2020; 63(SUPPL 1):S359-S359.-56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 21-25, 2020; virtuell. [Poster]
Web of Science

 

** Eckert, A; Mader, J; Altmeier, M; Gillessen, A; Dallmeier, D; Shah, V; Heyer, C; Hartmann, B; Holl, R Bone fractures in individuals with type 2 diabetes aged >= 50 years in the DPV registry: effect of glycaemic control and treatment.
DIABETOLOGIA. 2020; 63(SUPPL 1):S461-S461.-56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 21-25, 2020; ELECTR NETWORK. [Poster]
Web of Science

 

** Eckert, A; Mader, J; Altmeier, M; Muhldorfer, S; Gillessen, A; Dallmeier, D; Shah, V; Heyer, C; Hartmann, B; Holl, RW Bone fractures in patients with type 2 diabetes aged >= 50 years in the DPV registry: effect of glycaemic control and treatment.
INTERNIST. Abstracts zum 126. Kongress der Deutschen Gesellschaft für Innere Medizin e.V.. 2020; 61(SUPPL 1):S5-S5.-126. Kongress der Deutschen Gesellschaft für Innere Medizin e.V.; APR 25-28, 2020; Wiesbaden, GERMANY. [Onlinepräsentation]
Web of Science

 

** Eckstein, M; Ziko, H; Moser, O; Elsayed, H; Cigler, M; Hochfellner, D; Pottler, T; Mueller, A; Sourij, H; Mader, J DISCREPANCY OF GLYCAEMIC RANGES IN REGARD TO CGM METRICS FOR CLINICAL CARE VERSUS GUIDANCE FOR GLYCAEMIC TARGETS WITHIN THE RECENT CONSENSUS ON TIR.
DIABETES TECHNOL THE. 2020; 22: A106-A106. [Poster]
Web of Science

 

** Fischer, LT; Aberer, F; Hochfellner, D; Knoll, L; Pottler, T; Mader, JK Prescribing Indications and metabolic Effects of PCSK9-Inhibitors in a tertiary Center - A retrospective Study.
WIEN KLIN WOCHENSCHR. 2020; 132: S349-S349.-ÖDG ; [Poster]
Web of Science

 

** Fritsch, M; Frohlich-Reiterer, E; Wutzl, V; Holbing, E; Aigner, D; Mader, JK Treatment induced neuropathy (TIND) - eine seltene Komplikation bei einem Jugendlichen mit Typ 1 Diabetes.
WIEN KLIN WOCHENSCHR. 2020; 132: S361-S362. [Poster]
Web of Science

 

** Haberl, HC; Pottler, T; Hochfellner, D; Aberer, F; Ziko, H; Simic, A; Bytyqi, L; Baumann, P; Samonigg, J; Beck, P; Fahrleitner-Pammer, A; Mader, JK Evaluation of the Sensor Performance of a blinded, professional continuous Glucose Measurement System in hospitalized Female Patients with Type 2 Diabetes.
WIEN KLIN WOCHENSCHR. 2020; 132: S360-S360.-Jahrestagung der österreichischen Diabetesgesellschaft ; [Poster]
Web of Science

 

** Haberl, HC; Pottler, T; Hochfellner, DA; Aberer, F; Ziko, H; Bytyqi, L; Baumann, P; Samonigg, J; Beck, P; Fahrleitner-Pammer, A; Mader, JK Assessment of sensor performance of a blinded professional continuous glucose monitoring system in hospitalised patients with type 2 diabetes.
DIABETOLOGIA. 2020; 63(SUPPL 1):S348-S349.-56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 21-25, 2020; ELECTR NETWORK. [Poster]
Web of Science

 

** Hochfellner, D; Rainer, R; Aberer, F; Lichtenegger, K; Beck, P; Fruhwald, F; Rosenkranz, A; Kamolz, LP; Mader, JK; Plank, J Safe Basal-Bolus-Insulin Therapy during Fasting Episodes in hospitalized People with Type 2 Diabetes through Decision Support Technology.
WIEN KLIN WOCHENSCHR. 2020; 132: S339-S340. [Oral Communication]
Web of Science

 

** Hochfellner, D; Schondorff, P; Stumpe, T; Heschel, M; Pottler, T; Elsayed, H; Simic, A; Bytyqi, K; Augustin, T; Lueger, A; Mader, J COMPARISON OF INFUSION SET SURVIVAL OF THE NEWLY DEVELOPED ARTIFICIALLY CLOGGED LANTERN CATHETER VS. STANDARD INFUSION SET IN TYPE 1 DIABETES UNDER REAL-LIFE CONDITIONS.
DIABETES TECHNOL THE. The Official Journal of ATTD: Advanced Technologies & Treatments for Diabetes Conference. 2020; 22: A240-A241.-Advanced Technologies & Treatments for Diabetes Conference; FEB 19-20, 2020; Madrid, SPAIN. [Poster]
Web of Science

 

** Hochfellner, D; Ziko, H; Elsayed, H; Cigler, M; Knoll, L; Pottler, T; Treiber, G; Simic, A; Aberer, F; Mader, J Scan-Behavior in People with Type-1-Diabetes and Flash-Glucose-Monitoring in a Real-World-Setting.
WIEN KLIN WOCHENSCHR. Abstracts 51.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin. 2020; 132(SUPPL 2):76-76.-51.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 24-26, 2020; Salzburg, AUSTRIA. [Onlinepräsentation]
Web of Science

 

** Hochfellner, DA; Rainer, R; Aberer, F; Lichtenegger, KM; Beck, P; Fruhwald, F; Rosenkranz, AR; Kamolz, LP; Mader, JK; Plank, J Effective and safe basal-bolus insulin therapy during fasting episodes in hospitalised patients with type 2 diabetes using decision support technology.
DIABETOLOGIA. 2020; 63(SUPPL 1):S377-S378.-56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 21-25, 2020; ELECTR NETWORK. [Poster]
Web of Science

 

** Hochfellner, DA; Ziko, H; Sagmeister, MH; Elsayed, H; Cigler, M; Poettler, T; Aberer, F; Sendlhofer, G; Beck, P; Mader, JK Electronic Decision Support for Insulin Therapy Is Safe and Efficient in Inpatients with Type 2 Diabetes.
DIABETES. 2020; 69(S 1):-80th Scientific Sessions American Diabetes Association (ADA); JUN 12-16,2020; Chicago, IL, USA;. Doi: 10.2337/db20-24-OR [Oral Communication]
Web of Science FullText FullText_MUG

 

** Kopanz, J; Libiseller, A; Lichtenegger, K; Donsa, K; Truskaller, T; Lackner, B; Aberer, F; Pandis, M; Reinisch-Gratzer, J; Ambrosch, G; Sinner, F; Pieber, T; Mader, J A DIGITAL WORKFLOW AND DECISION SUPPORT SYSTEM TO PREVENT DIABETES-RELATED ACUTE HOSPITAL ADMISSIONS AND INPATIENT STAYS (THE GLUCOTAB@MOBILECARE STUDY).
DIABETES TECHNOL THE. The Official Journal of ATTD: Advanced Technologies & Treatments for Diabetes Conference. 2020; 22: A110-A110.-Advanced Technologies & Treatments for Diabetes Conference; FEB 19-20, 2020; Madrid, SPAIN. [Poster]
Web of Science

 

** Kopanz, J; Libiseller, A; Lichtenegger, K; Donsa, K; Truskaller, T; Lackner, B; Aberer, F; Pandis, M; Reinisch-Gratzer, J; Ambrosch, G; Sinner, F; Pieber, T; Mader, J EFFECTIVE, SAFE AND USER-ACCEPTED BASAL-INSULIN THERAPY IN ELDERLY PATIENTS WITH TYPE 2 DIABETES RECEIVING DIGITALY ASSISTED DOMICILIARY NURSING CARE - THE GLUCOTAB@MOBILECARE STUDY.
DIABETES TECHNOL THE. The Official Journal of ATTD: Advanced Technologies & Treatments for Diabetes Conference. 2020; 22: A109-A110.-Advanced Technologies & Treatments for Diabetes Conference; FEB 19-20, 2020; Madrid, SPAIN. [Poster]
Web of Science

 

** Lichtenegger, K; Kopanz, J; Libiseller, A; Mader, J; Donsa, K; Truskaller, T; Bauer, N; Hahn, B; Sendlhofer, G; Beck, P; Feichtner, F; Sinner, F; Pieber, T IMPLEMENTATION OF A DIGITAL WORKFLOW AND DECISION SUPPORT SYSTEM CONFIRMS EFFICACY AND USER-SATISFACTION OF ROUTINE DIABETES CARE IN INPATIENTS WITH TYPE 2 DIABETES.
DIABETES TECHNOL THE. The Official Journal of ATTD: Advanced Technologies & Treatments for Diabetes Conference. 2020; 22: A111-A111.-Advanced Technologies & Treatments for Diabetes Conference; FEB 19-20, 2020; Madrid, SPAIN. [Poster]
Web of Science

 

** Mader, JK; Oliver, N; Vesper, I; Kunsting, T; Barnard-Kelly, K First results from PRO Solo: patient reported outcomes from a clinical trial comparing a new patch pump with MDI and an established patch pump.
DIABETOLOGIA. 2020; 63(SUPPL 1):S341-S342.-56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 21-25, 2020; ELECTR NETWORK. [Poster]
Web of Science

 

** Moser, O; Riddell, MC; Eckstein, ML; Adolfsson, P; Rabasa-Lhoret, R; van den Boom, L; Gillard, P; Norgaard, K; Oliver, NS; Zaharieva, DP; Battelino, T; De Beaufort, C; Bergenstal, RM; Buckingham, B; Cengiz, E; Deeb, A; Heise, T; Heller, S; Kowalski, AJ; Leelarathna, L; Mathieu, C; Stettler, C; Tauschmann, M; Thabit, H; Wilmot, EG; Sourij, H; Smart, CE; Jacobs, PG; Bracken, RM; Mader, JK Glucose Management during physical Activity/Sport by Using continuous Glucose Meters (CGM/isCGM) in Type 1 Diabetes - EASD/ISPAD Position Statement, supported by ADA and JDRF.
WIEN KLIN WOCHENSCHR. 2020; 132: S340-S341. [Onlinepräsentation]
Web of Science

 

** Moser, O; Ziko, H; Eckstein, M; Elsayed, H; Cigler, M; Hochfellner, D; Poettler, T; Mueller, A; Sourij, H; Mader, J TIME IN RANGE (TIR) ACHIEVEMENT IN REGARD TO CLINICAL TARGETS IN PEOPLE WITH TYPE 1 DIABETES (PWT1D): A REAL WORLD SETTING.
DIABETES TECHNOL THE. The Official Journal of ATTD: Advanced Technologies & Treatments for Diabetes Conference. 2020; 22: A231-A231.-Advanced Technologies & Treatments for Diabetes Conference; FEB 19-20, 2020; Madrid, SPAIN. [Poster]
Web of Science

 

** Moser, O; Ziko, H; Elsayed, H; Hochfellner, D; Pottler, T; Muller, A; Eckstein, M; Sourij, H; Mader, JK The FreeStyle Libre 1 isCGM System as the first objective Measuring Instrument for the Diagnosis of Hypoglycemia Unawareness in People with Type 1 Diabetes - A prospective Observational Study.
WIEN KLIN WOCHENSCHR. 2020; 132: S343-S344. [Poster]
Web of Science

 

** Moser, O; Ziko, H; Elsayed, H; Hochfellner, DA; Poettler, T; Mueller, A; Eckstein, ML; Knoll, L; Sourij, H; Mader, JK People with Type 1 Diabetes and Impaired Awareness of Hypoglycemia Have a Delayed Reaction to Perform a Glucose Scan during Hypoglycemia: A Prospective Observational Study.
DIABETES. 2020; 69: -80th Scientific Sessions of the American-Diabetes-Association (ADA); JUN 12-16, 2020; ELECTR NETWORK. Doi: 10.2337/db20-157-OR [Onlinepräsentation]
Web of Science FullText FullText_MUG

 

** Muller, A; Moser, O; Eckstein, ML; Ziko, H; Aberer, F; Treiber, G; Unteregger, C; Kojzar, H; Mader, JK; Sourij, C; Pferschy, P; Obermayer, A; Tripolt, N; Sourij, H Halving the Basal Insulin Dose before a Running Event in physically active Adults with Type 1 Diabetes minimizes the Risk of Hypoglycaemia - A prospective, clinical, controlled, Observational Study.
WIEN KLIN WOCHENSCHR. 2020; 132: S364-S364. [Onlinepräsentation]
Web of Science

 

** Nagl, K; Berger, G; Aberer, F; Mader, J; Rami-Merhar, B PERFORMANCE OF CONTINUOUS GLUCOSE MONITORING SYSTEMS IN CHILDREN WITH TYPE 1 DIABETES DURING A DIABETES SUMMER CAMP.
DIABETES TECHNOL THE. The Official Journal of ATTD: Advanced Technologies & Treatments for Diabetes Conference. 2020; 22: A140-A140.-Advanced Technologies & Treatments for Diabetes Conference; FEB 19-20, 2020; Madrid, SPAIN. [Poster]
Web of Science

 

** Scholle, L; Kopanz, J; Reinisch-Gratzer, J; Ambrosch, GC; Libiseller, A; Aberer, F; Pandis, M; Donsa, K; Truskaller, T; Pieber, TR; Mader, JK; Lichtenegger, KM Can a digital Workflow System and Decision Support System for mobile Care improve Blood Glucose Control and prevent acute Hospital Admissions?
WIEN KLIN WOCHENSCHR. 2020; 132: S343-S343.-Jahrestagung der österreichischen Diabetesgesellschaft ; [Poster]
Web of Science

 

** Semlitsch, B; Omoregbee, S; Sendlhofer, G; Mader, JK; Wedrich, A Perioperative Insulin Management for the Prevention of postoperative Metabolic Disorders.
WIEN KLIN WOCHENSCHR. 2020; 132: S333-S334. [Poster]
Web of Science

 

** Simic, A; Ziko, H; Pottler, T; Hochfellner, D; Samonigg, J; Cigler, M; Beck, P; Aberer, F; Mader, JK A retrospective assessment of blinded continuous glucose monitor accuracy during inpatient management of adults with type 2 diabetes.
WIEN KLIN WOCHENSCHR. 2020; 132: S363-S363. [Poster]
Web of Science

 

** Treiber, G; Verheyen, N; Verheyen, S; Mader, JK; Sourij, H "Atypical" Diabetes - There´s more than Type 1 and Type 2-A Case Report.
WIEN KLIN WOCHENSCHR. Abstracts 51. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin. 2020; 132(SUPPL 2):69-69.-51.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 24-26, 2020; Salzburg, AUSTRIA.
Web of Science FullText

 

** van den Boom, L; Ziko, H; Mader, JK Safely finishing a half marathon by an adult with type 1 diabetes being on a commercially-available hybrid closed-loop system.
WIEN KLIN WOCHENSCHR. 2020; 132: S336-S336. [Poster]
Web of Science

 

Comment

** Eckstein, ML; Knoll, L; Pöttler, T; Hochfellner, DA; Müller, A; Sourij, H; Moser, O; Mader, JK Interpreting the recent consensus on time in range for interstitial glucose right - Or wrong?
Diabetes Res Clin Pract. 2020; 162:108106 Doi: 10.1016/j.diabres.2020.108106
Web of Science PubMed FullText FullText_MUG

 

Guideline

** Moser, O; Riddell, MC; Eckstein, ML; Adolfsson, P; Rabasa-Lhoret, R; van, den, Boom, L; Gillard, P; Nørgaard, K; Oliver, NS; Zaharieva, DP; Battelino, T; de, Beaufort, C; Bergenstal, RM; Buckingham, B; Cengiz, E; Deeb, A; Heise, T; Heller, S; Kowalski, AJ; Leelarathna, L; Mathieu, C; Stettler, C; Tauschmann, M; Thabit, H; Wilmot, EG; Sourij, H; Smart, CE; Jacobs, PG; Bracken, RM; Mader, JK Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA).
Diabetologia. 2020; 63(12):2501-2520 Doi: 10.1007/s00125-020-05263-9 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Moser, O; Riddell, MC; Eckstein, ML; Adolfsson, P; Rabasa-Lhoret, R; van den Boom, L; Gillard, P; Nørgaard, K; Oliver, NS; Zaharieva, DP; Battelino, T; de Beaufort, C; Bergenstal, RM; Buckingham, B; Cengiz, E; Deeb, A; Heise, T; Heller, S; Kowalski, AJ; Leelarathna, L; Mathieu, C; Stettler, C; Tauschmann, M; Thabit, H; Wilmot, EG; Sourij, H; Smart, CE; Jacobs, PG; Bracken, RM; Mader, JK Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA).
Pediatr Diabetes. 2020; 21(8):1375-1393 Doi: 10.1111/pedi.13105 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2019

Full paper/article (Journal)

** Aberer, F; Lichtenegger, KM; Smajic, E; Donsa, K; Malle, O; Samonigg, J; Höll, B; Beck, P; Pieber, TR; Plank, J; Mader, JK GlucoTab-guided insulin therapy using insulin glargine U300 enables glycaemic control with low risk of hypoglycaemia in hospitalized patients with type 2 diabetes.
Diabetes Obes Metab. 2019; 21(3):584-591 Doi: 10.1111/dom.13559 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Aberer, F; Mader, JK; Holzgruber, J; Trummer, C; Schwetz, V; Pandis, M; Pferschy, PN; Greinix, H; Tripolt, NJ; Pieber, TR; Zebisch, A; Sill, H; Wölfler, A; Sourij, H Feasibility and safety of using an automated decision support system for insulin therapy in the treatment of steroid-induced hyperglycemia in patients with acute graft-versus-host disease: A randomized trial.
J Diabetes Investig. 2019; 10(2):339-342 Doi: 10.1111/jdi.12919 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Mader, JK; Brix, J; Aberer, F; Vonbank, A; Resl, M; Pieber, TR; Stechemesser, L; Sourij, H [Hospital diabetes management (Update 2019)].
Wien Klin Wochenschr. 2019; 131(Suppl 1): 200-211. Doi: 10.1007/s00508-019-1447-z [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Mader, JK; Haas, W; Aberer, F; Boulgaropoulos, B; Baumann, P; Pandis, M; Horvath, K; Aziz, F; Köhler, G; Pieber, TR; Plank, J; Sourij, H Patients with healed diabetic foot ulcer represent a cohort at highest risk for future fatal events.
Sci Rep. 2019; 9(1):10325-10325 Doi: 10.1038/s41598-019-46961-8 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Mader, JK; Motschnig, M; Theiler-Schwetz, V; Eibel-Reisz, K; Reisinger, AC; Lackner, B; Augustin, T; Eller, P; Mirth, C Feasibility of Blood Glucose Management Using Intra-Arterial Glucose Monitoring in Combination with an Automated Insulin Titration Algorithm in Critically Ill Patients.
Diabetes Technol Ther. 2019; 21(10):581-588 Doi: 10.1089/dia.2019.0082
Web of Science PubMed FullText FullText_MUG

 

** Moser, O; Pandis, M; Aberer, F; Kojzar, H; Hochfellner, D; Elsayed, H; Motschnig, M; Augustin, T; Kreuzer, P; Pieber, TR; Sourij, H; Mader, JK A head-to-head comparison of personal and professional continuous glucose monitoring systems in people with type 1 diabetes: Hypoglycaemia remains the weak spot.
Diabetes Obes Metab. 2019; 21(4):1043-1048 Doi: 10.1111/dom.13598 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Musolino, G; Dovc, K; Boughton, CK; Tauschmann, M; Allen, JM; Nagl, K; Fritsch, M; Yong, J; Metcalfe, E; Schaeffer, D; Fichelle, M; Schierloh, U; Thiele, AG; Abt, D; Kojzar, H; Mader, JK; Slegtenhorst, S; Ashcroft, N; Wilinska, ME; Sibayan, J; Cohen, N; Kollman, C; Hofer, SE; Fröhlich-Reiterer, E; Kapellen, TM; Acerini, CL; de Beaufort, C; Campbell, F; Rami-Merhar, B; Hovorka, R; Kidsap Consortium Reduced burden of diabetes and improved quality of life: Experiences from unrestricted day-and-night hybrid closed-loop use in very young children with type 1 diabetes.
Pediatr Diabetes. 2019; 20(6):794-799 Doi: 10.1111/pedi.12872 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Regittnig, W; Urschitz, M; Lehki, B; Wolf, M; Kojzar, H; Mader, JK; Ellmerer, M; Pieber, TR Insulin Bolus Administration in Insulin Pump Therapy: Effect of Bolus Delivery Speed on Insulin Absorption from Subcutaneous Tissue.
Diabetes Technol Ther. 2019; 21(1): 44-50. Doi: 10.1089/dia.2018.0295
Web of Science PubMed FullText FullText_MUG

 

** Schierloh, U; Wilinska, ME; Pit-Ten Cate, IM; Baumann, P; Hovorka, R; De Beaufort, C; Spidiman Study Group: Single Port Insulin Infusion for Improved Diabetes Management Lower plasma insulin levels during overnight closed-loop in school children with type 1 diabetes: Potential advantage? A randomized cross-over trial.
PLoS One. 2019; 14(3):e0212013-e0212013 Doi: 10.1371/journal.pone.0212013 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Tauschmann, M; Allen, JM; Nagl, K; Fritsch, M; Yong, J; Metcalfe, E; Schaeffer, D; Fichelle, M; Schierloh, U; Thiele, AG; Abt, D; Kojzar, H; Mader, JK; Slegtenhorst, S; Barber, N; Wilinska, ME; Boughton, C; Musolino, G; Sibayan, J; Cohen, N; Kollman, C; Hofer, SE; Fröhlich-Reiterer, E; Kapellen, TM; Acerini, CL; de Beaufort, C; Campbell, F; Rami-Merhar, B; Hovorka, R; KidsAP Consortium Home Use of Day-and-Night Hybrid Closed-Loop Insulin Delivery in Very Young Children: A Multicenter, 3-Week, Randomized Trial.
Diabetes Care. 2019; 42(4):594-600 Doi: 10.2337/dc18-1881 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Short report/Letter

** Kalscheuer, H; Seufert, J; Lanzinger, S; Rosenbauer, J; Karges, W; Bergis, D; Mader, JK; Zimny, S; Schmid, SM; Hummel, M; Kerner, W; Holl, RW; DPV Initiative Event Rates and Risk Factors for the Development of Diabetic Ketoacidosis in Adult Patients With Type 1 Diabetes: Analysis From the DPV Registry Based on 46,966 Patients.
Diabetes Care. 2019; 42(3):e34-e36-e34-e36 Doi: 10.2337/dc18-1160 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Review

** Clodi, M; Abrahamian, H; Brath, H; Brix, J; Drexel, H; Fasching, P; Föger, B; Francesconi, C; Fröhlich-Reiterer, E; Harreiter, J; Hofer, SE; Hoppichler, F; Huber, J; Kaser, S; Kautzky-Willer, A; Lechleitner, M; Ludvik, B; Luger, A; Mader, JK; Paulweber, B; Pieber, T; Prager, R; Rami-Merhar, B; Resl, M; Riedl, M; Roden, M; Saely, CH; Schelkshorn, C; Schernthaner, G; Sourij, H; Stechemesser, L; Stingl, H; Toplak, H; Wascher, TC; Weitgasser, R; Winhofer-Stöckl, Y; Zlamal-Fortunat, S [Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2019)].
Wien Klin Wochenschr. 2019; 131(Suppl 1):27-38 Doi: 10.1007/s00508-019-1471-z [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Lechleitner, M; Clodi, M; Abrahamian, H; Brath, H; Brix, J; Drexel, H; Fasching, P; Föger, B; Francesconi, C; Fröhlich-Reiterer, E; Harreiter, J; Hofer, SE; Hoppichler, F; Huber, J; Kaser, S; Kautzky-Willer, A; Ludvik, B; Luger, A; Mader, JK; Paulweber, B; Pieber, T; Prager, R; Rami-Merhar, B; Resl, M; Riedl, M; Roden, M; Saely, CH; Schelkshorn, C; Schernthaner, G; Sourij, H; Stechemesser, L; Stingl, H; Toplak, H; Wascher, TC; Weitgasser, R; Winhofer-Stöckl, Y; Zlamal-Fortunat, S [Insulin therapy of type 2 diabetes mellitus (Update 2019)].
Wien Klin Wochenschr. 2019; 131(Suppl 1):39-46 Doi: 10.1007/s00508-019-1492-7
Web of Science PubMed FullText FullText_MUG

 

** Schütz-Fuhrmann, I; Rami-Merhar, B; Hofer, SE; Fröhlich-Reiterer, E; Mader, J; Stadler, M; Bischof, M; Zlamal-Fortunat, S; Laimer, M; Weitgasser, R [CGM-Continuous Glucose Monitoring-Statement of the Austrian Diabetes Association (Update 2019)].
Wien Klin Wochenschr. 2019; 131(Suppl 1):119-123 Doi: 10.1007/s00508-019-1465-x
Web of Science PubMed FullText FullText_MUG

 

** Schütz-Fuhrmann, I; Stadler, M; Zlamal-Fortunat, S; Rami-Merhar, B; Fröhlich-Reiterer, E; Hofer, SE; Mader, J; Resl, M; Bischof, M; Kautzky-Willer, A; Weitgasser, R [Insulin pump therapy in children, adolescents and adults, guidelines (Update 2019)].
Wien Klin Wochenschr. 2019; 131(Suppl 1):47-53 Doi: 10.1007/s00508-019-1485-6
Web of Science PubMed FullText FullText_MUG

 

Case Report

** Aberer, F; Sourij, H; Mader, JK A typical clinical presentation of a woman with Köbberling Syndrome.
Pol Arch Intern Med. 2019; Doi: 10.20452/pamw.4458 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Elsayed, H; Bytyqi, K; Simic, A; Cigler, M; Hochfellner, D; Ziko, H; Knoll, L; Pottler, T; Aberer, F; Mader, J Influence of C-Peptide Status on Frequency and Mean Duration of Hypoglycemia, Time in Blood Sugar Target Range and HbA1c in Type 1 Diabetics using Flash Glucose Monitoring in clinical Routine
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S471-S471. [Oral Communication]
Web of Science

 

** Hochfellner, D; Ziko, H; Ajsic, A; Pandis, M; Beck, P; Mader, JK HOW DOES INPATIENT DIABETES MANAGEMENT AFFECT DISCHARGE SUGGESTIONS?
DIABETES TECHNOL THE. 2019; 21: A67-A68. [Poster]
Web of Science FullText

 

** Hochfellner, DA; Ziko, H; Beck, P; Sendlhofer, G; Mader, J Benefits of a Diabetes-Management-System in inpatient Care.
WIEN KLIN WOCHENSCHR. 2019; 131: S441-S441. [Poster]
Web of Science

 

** Hochfellner, DA; Ziko, H; Elsayed, H; Simic, A; Cigler, M; Knoll, L; Pottler, T; Aberer, F; Mader, J Flash Glucose Monitoring in Routine Clinical Use in Patients with Type 1 Diabetes
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S470-S470. [Poster]
Web of Science

 

** Kopanz, J; Libiseller, A; Lichtenegger, KM; Donsa, K; Truskaller, T; Augustin, T; Aberer, F; Pandis, M; Reinisch-Gratzer, J; Ambrosch, GC; Pieber, TR; Mader, JK GLUCOTAB@MOBILECARE: ACCEPTANCE, USABILITY, SAFETY AND EFFICACY OF THE TABLET-BASED BASAL-INSULIN ALGORITHM FOR GLYCEMIC MANAGEMENT IN PATIENTS WITH TYPE-2-DIABETES RECEIVING HOME NURSING CARE - STUDY PROTOCOL
DIABETES TECHNOL THE. 2019; 21: A72-A72. [Poster]
Web of Science

 

** Kopanz, J; Libiseller, A; Lichtenegger, KM; Donsa, K; Truskaller, T; Lackner, B; Aberer, F; Pandis, M; Reinisch-Gratzer, J; Ambrosch, GC; Sinner, F; Pieber, TR; Mader, JK GlucoTab@MobileCare - Clinical Endpoints of a Proof-of-Concept Study of a Digital Workflow and Decision Support System for Diabetes Management in Mobile Home Health Care
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S466-S467. [Oral Communication]
Web of Science

 

** Kopanz, J; Lichtenegger, KM; Konig, C; Feichtner, F; Libiseller, A; Mader, JK; Donsa, K; Sendlhofer, G; Sinner, F; Pieber, TR Does the implementation of an electronic workflow support system improve quality of routine diabetes care in inpatients with type 2 diabetes?.
DIABETOLOGIA. 2019; 62: S395-S395.-55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 16-20, 2019; Barcelona, SPAIN. [Poster]
Web of Science

 

** Kopanz, J; Lichtenegger, KM; Konig, C; Libiseller, A; Mader, JK; Donsa, K; Truskaller, T; Bauer, N; Hahn, B; Sendlhofer, G; Beck, P; Sinner, F; Feichtner, F; Pieber, TR The GlucoTab® System in Routine Use to Support Diabetes Management for Patients with Diabetes Mellitus Type 2 in a regional Hospital.
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S467-S467. [Poster]
Web of Science

 

** Libiseller, A; Kopanz, J; Lichtenegger, KM; Donsa, K; Truskaller, T; Lackner, B; Aberer, F; Pandis, M; Reinisch-Gratzer, J; Ambrosch, GC; Sinner, F; Pieber, TR; Mader, JK GlucoTab@MobileCare - The Potential of Decision Support to Reduce Hospital Admissions and inpatient Admissions
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S469-S469. [Poster]
Web of Science

 

** Lichtenegger, KM; Aberer, F; Tuca, AC; Donsa, K; Holl, B; Schaupp, L; Beck, P; Fruhwald, F; Plank, J; Pieber, TR; Mader, JK A clinical Decision Support System for Basal Bolus Insulin Therapy in Routine Inpatient Care: Proven Efficacy, Safety, and User Adherence
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S466-S466. [Oral Communication]
Web of Science

 

** Simic, A; Elsayed, H; Ziko, H; Hochfellner, D; Cigler, M; Knoll, L; Pottler, T; Aberer, F; Mader, JK The effect of glucose scanning frequency on HbA1c in individuals with type 1 diabetes using FGM
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S482-S482. [Keynote lecture]
Web of Science

 

** Ziko, H; Hochfellner, D; Elsayed, H; Simic, A; Cigler, M; Knoll, L; Pottler, T; Aberer, F; Mader, JK Influence of Flash Glucose Monitoring on Glycemic Target Achievement
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S487-S487. [Poster]
Web of Science

 

2018

Full paper/article (Journal)

** Bally, L; Thabit, H; Ruan, Y; Mader, JK; Kojzar, H; Dellweg, S; Benesch, C; Hartnell, S; Leelarathna, L; Wilinska, ME; Evans, ML; Arnolds, S; Pieber, TR; Hovorka, R Bolusing frequency and amount impacts glucose control during hybrid closed-loop.
Diabet Med. 2018; 35(3):347-351 Doi: 10.1111/dme.13436 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Mader, JK; Lilly, LC; Aberer, F; Poettler, T; Johns, D; Trautmann, M; Warner, JL; Pieber, TR Improved glycaemic control and treatment satisfaction with a simple wearable 3-day insulin delivery device among people with Type 2 diabetes.
Diabet Med. 2018; 35(10):1448-1456 Doi: 10.1111/dme.13708 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Melmer, A; Kempf, P; Lunger, L; Pieber, TR; Mader, JK; Stettler, C; Tilg, H; Ebenbichler, CF; Laimer, M Short-term effects of dapagliflozin on insulin sensitivity, postprandial glucose excursion and ketogenesis in type 1 diabetes mellitus: A randomized, placebo-controlled, double blind, cross-over pilot study.
Diabetes Obes Metab. 2018; 20(11):2685-2689 Doi: 10.1111/dom.13439
Web of Science PubMed FullText FullText_MUG

 

** Moser, O; Münzker, J; Korsatko, S; Pachler, C; Smolle, K; Toller, W; Augustin, T; Plank, J; Pieber, TR; Mader, JK; Ellmerer, M A prolonged run-in period of standard subcutaneous microdialysis ameliorates quality of interstitial glucose signal in patients after major cardiac surgery.
Sci Rep. 2018; 8(1):1262-1262 Doi: 10.1038/s41598-018-19768-2 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Ruan, Y; Bally, L; Thabit, H; Leelarathna, L; Hartnell, S; Tauschmann, M; Wilinska, ME; Evans, ML; Mader, JK; Kojzar, H; Dellweg, S; Benesch, C; Arnolds, S; Pieber, TR; Hovorka, R Hypoglycaemia incidence and recovery during home use of hybrid closed-loop insulin delivery in adults with type 1 diabetes.
Diabetes Obes Metab. 2018; 20(8):2004-2008 Doi: 10.1111/dom.13304 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Schwetz, V; Trummer, C; Friedl, C; Beham-Schmid, C; Kulnik, R; Wölfler, A; Horvath, K; Wunsch, S; Prattes, J; Zollner-Schwetz, I; Pieber, TR; Mader, JK; Krause, R Visceral leishmaniasis in a patient with diabetes mellitus type 2 and discrete bicytopenia.
CLIN CASE REP. 2018; 6(1): 78-81. Doi: 10.1002/ccr3.1259 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Zenz, S; Mader, JK; Regittnig, W; Brunner, M; Korsatko, S; Boulgaropoulos, B; Magnes, C; Raml, R; Narath, SH; Eller, P; Augustin, T; Pieber, TR Impact of C-Peptide Status on the Response of Glucagon and Endogenous Glucose Production to Induced Hypoglycemia in T1DM.
J Clin Endocrinol Metab. 2018; 103(4):1408-1417 Doi: 10.1210/jc.2017-01836 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Ajsic, A; Krasser, MC; Juliussen, R; Schondorff, PK; Heschel, M; Pottler, T; Schwarzenbacher, D; Augustin, T; Pieber, TR; Treiber; Mader, JK Examination of a prolonged Wearing Period of the newly developed Insulin Infusion Lantern Catheter in Patients with Type 1 Diabetes mellitus
WIEN KLIN WOCHENSCHR. 2018; 130: 360-360. [Poster]
Web of Science

 

** Cigler, M; Pandis, M; Juliussen, R; Schondorff, PK; Heschel, M; Pottler, T; Augustin, T; Schwarzenbacher, D; Pieber, RT; Treiber, G; Mader, JK ASSESSMENT OF INFUSION SET SURVIVAL OF THE NEWLY DEVELOPED LANTERN CATHETER IN TYPE 1 DIABETES BY GLUCOSE CLAMP TECHNIQUE (A PILOT STUDY)
DIABETES TECHNOL THE. 2018; 20: A126-A127. [Poster]
Web of Science

 

** Drechsler, K; Pottler, T; Elsayed, H; Kiesling, L; Aberer, F; Mader, J A Questionnaire Survey on treatment-associated Errors from the Perspective of Patients with Type 2 Diabetes in an internistic Normal Ward
WIEN KLIN WOCHENSCHR. 2018; 130: 365-365. [Poster]
Web of Science

 

** Kojzar, H; Frohlich-Reiterer, E; Mader, JK; Pottler, T; Elsayed, H; Jasser-Nitsche, H; Rami-Merhar, B; Fritsch, M; Nagl, K; Hofer, S; Abt, D; Binder, E; Streichen, E; Acerini, CL; de Beaufort, C; Campbell, F; Kapellen, T; Lawton, J; Roze, S; Sibayan, J; Sonesson, A; Allen, J; Tauschmann, M; Musolino, G; Barber, N; Wilinska, ME; Hovorka, R Use of the artificial Pancreas in Infants with Diabetes mellitus Type 1 KidsAP01
WIEN KLIN WOCHENSCHR. 2018; 130: 347-348. [Oral Communication]
Web of Science

 

** Mader, JK; Ajsic, A; Krasser, MC; Juliussen, R; Schondorff, PK; Heschel, M; Pottler, T; Schwarzenbacher, D; Augustin, T; Pieber, TR; Treiber, G Assessment of infusion set survival of the newly developed coated Lantern catheter in type 1 diabetes by glucose clamp technique
DIABETOLOGIA. 2018; 61: S395-S395.-54th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); OCT 01-05, 2018; Berlin, GERMANY. [Poster]
Web of Science

 

** Rainer, R; Elsayed, H; Aberer, F; Beck, P; Pieber, TR; Donsa, K; Plank, J; Mader, JK Blood Glucose Management in hospitalized Patients with Type 2 Diabetes mellitus during Nursing Phases - A retrospective Study
WIEN KLIN WOCHENSCHR. 2018; 130: 348-348. [Oral Communication]
Web of Science

 

** Ruan, Y; Bally, L; Thabit, H; Mader, J; Kojzar, H; Dellweg, S; Benesch, C; Hartnell, S; Leelarathna, L; Wilinska, M; Evans, M; Arnolds, S; Pieber, T; Hovorka, R HYPOGLYCAEMIA OCCURENCE AND RECOVERY DURING HOME USE OF CLOSED-LOOP INSULIN DELIVERY AND SENSOR-AUGMENTED PUMP THERAPY IN ADULTS WITH TYPE 1 DIABETES
DIABETES TECHNOL THE. 2018; 20: A59-A60.-ATTD; Vienna, Austria. [Poster]
Web of Science

 

** Ruan, Y; Bally, L; Thabit, H; Mader, JK; Kojzar, H; Dellweg, S; Benesch, C; Hartnell, S; Leelarathna, L; Wilinska, ME; Evans, ML; Arnolds, S; Pieber, TR; Hovorka, R OVERTREATMENT OF HYPOGLYCAEMIA IN ADULTS WITH TYPE 1 DIABETES DOES NOT APPEAR TO DETERIORATE GLYCAEMIC CONTROL DURING CLOSED-LOOP INSULIN DELIVERY
DIABETES TECHNOL THE. 2018; 20: A62-A63. [Poster]
Web of Science

 

2017

Full paper/article (Journal)

** Aberer, F; Hajnsek, M; Rumpler, M; Zenz, S; Baumann, PM; Elsayed, H; Puffing, A; Treiber, G; Pieber, TR; Sourij, H; Mader, JK Evaluation of subcutaneous glucose monitoring systems under routine environmental conditions in patients with type 1 diabetes.
Diabetes Obes Metab. 2017; 19(7):1051-1055 Doi: 10.1111/dom.12907 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Bally, L; Thabit, H; Kojzar, H; Mader, JK; Qerimi-Hyseni, J; Hartnell, S; Tauschmann, M; Allen, JM; Wilinska, ME; Pieber, TR; Evans, ML; Hovorka, R Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: an open-label, randomised, crossover study.
Lancet Diabetes Endocrinol. 2017; 5(4):261-270 Doi: 10.1016/S2213-8587(17)30001-3 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Barnard, KD; Wysocki, T; Ully, V; Mader, JK; Pieber, TR; Thabit, H; Tauschmann, M; Leelarathna, L; Hartnell, S; Acerini, CL; Wilinska, ME; Dellweg, S; Benesch, C; Arnolds, S; Holzer, M; Kojzar, H; Campbell, F; Yong, J; Pichierri, J; Hindmarsh, P; Heinemann, L; Evans, ML; Hovorka, R Closing the Loop in Adults, Children and Adolescents With Suboptimally Controlled Type 1 Diabetes Under Free Living Conditions: A Psychosocial Substudy.
J Diabetes Sci Technol. 2017; 11(6):1080-1088 Doi: 10.1177/1932296817702656 [OPEN ACCESS]
PubMed FullText FullText_MUG

 

** Emami, A; Willinska, ME; Thabit, H; Leelarathna, L; Hartnell, S; Dellweg, S; Benesch, C; Mader, JK; Holzer, M; Kojzar, H; Pieber, TR; Arnolds, S; Evans, ML; Hovorka, R Behavioral Patterns and Associations with Glucose Control During 12-Week Randomized Free-Living Clinical Trial of Day and Night Hybrid Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes.
Diabetes Technol Ther. 2017; 19(7):433-437 Doi: 10.1089/dia.2016.0307 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Leitgeb, S; Mader, JK Analysis of "Comparison an Electronic Glycemic Management System Versus Provider Managed Subcutaneous Basal Bolus Insulin Therapy in the Hospital Setting".
J Diabetes Sci Technol. 2017; 11(1):17-19 Doi: 10.1177/1932296816677296 [OPEN ACCESS]
PubMed FullText FullText_MUG

 

** Ruan, Y; Thabit, H; Leelarathna, L; Hartnell, S; Wilinska, ME; Tauschmann, M; Dellweg, S; Benesch, C; Mader, JK; Holzer, M; Kojzar, H; Evans, ML; Pieber, TR; Arnolds, S; Hovorka, R; AP@home consortium Faster insulin action is associated with improved glycaemic outcomes during closed-loop insulin delivery and sensor-augmented pump therapy in adults with type 1 diabetes.
Diabetes Obes Metab. 2017; 19(10):1485-1489 Doi: 10.1111/dom.12956 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Rumpler, M; Mader, JK; Fischer, JP; Thar, R; Granger, JM; Deliane, F; Klimant, I; Aberer, F; Sinner, F; Pieber, TR; Hajnsek, M First application of a transcutaneous optical single-port glucose monitoring device in patients with type 1 diabetes mellitus.
Biosens Bioelectron. 2017; 88:240-248 Doi: 10.1016/j.bios.2016.08.039
Web of Science PubMed FullText FullText_MUG

 

** Spat, S; Donsa, K; Beck, P; Höll, B; Mader, JK; Schaupp, L; Augustin, T; Chiarugi, F; Lichtenegger, KM; Plank, J; Pieber, TR A Mobile Computerized Decision Support System to Prevent Hypoglycemia in Hospitalized Patients With Type 2 Diabetes Mellitus.
J Diabetes Sci Technol. 2017; 11(1):20-28 Doi: 10.1177/1932296816676501 [OPEN ACCESS]
PubMed FullText FullText_MUG

 

** Stauber, MN; Aberer, F; Oulhaj, A; Mader, JK; Zebisch, A; Pieber, TR; Neumeister, P; Greinix, HT; Sill, H; Sourij, H; Wölfler, A Early Hyperglycemia after Initiation of Glucocorticoid Therapy Predicts Adverse Outcome in Patients with Acute Graft-versus-Host Disease.
Biol Blood Marrow Transplant. 2017; 23(7):1186-1192 Doi: 10.1016/j.bbmt.2017.03.010 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Short report/Letter

** Aberer, F; Kremser, S; Mader, JK; Zinke-Cerwenka, W; Greinix, H; Tripolt, NJ; Pieber, TR; Zebisch, A; Sill, H; Oulhaj, A; Sourij, H; Wölfler, A Hyperglycaemia within the first month after allogeneic haematopoietic stem-cell transplantation is an independent risk factor for overall survival in patients with acute myeloid leukaemia.
Diabetes Metab. 2017; 43(6):560-562 Doi: 10.1016/j.diabet.2017.02.001
Web of Science PubMed FullText FullText_MUG

 

** Leelarathna, L; Thabit, H; Hartnell, S; Willinska, ME; Dellweg, S; Benesch, C; Mader, JK; Holzer, M; Kojzar, H; Evans, ML; Arnolds, S; Pieber, TR; Hovorka, R; AP@home Consortium Rapid Benefits of Structured Optimization and Sensor-Augmented Insulin Pump Therapy in Adults With Type 1 Diabetes.
J Diabetes Sci Technol. 2017; 11(1):180-181 Doi: 10.1177/1932296816654715 [OPEN ACCESS]
PubMed FullText FullText_MUG

 

Case Report

** Schwetz, V; Eisner, F; Schilcher, G; Eller, K; Plank, J; Lind, A; Pieber, TR; Mader, JK; Eller, P Combined metformin-associated lactic acidosis and euglycemic ketoacidosis.
Wien Klin Wochenschr. 2017; 129(17-18):646-649 Doi: 10.1007/s00508-017-1251-6 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Aberer, F; Holzgruber, J; Tripolt, NJ; Zebisch, A; Greinix, H; Sill, H; Mader, JK; Pieber, TR; Wölfler, A; Sourij, H Efficacy and safety of an insulin decision support system in the treatment of steroid hyperglycaemia in patients with graft-versus- host-disease: a randomised pilot trial.
Diabetologia. 2017; 60(S1):S323-S324.-53rd Annual Meeting of the European Association for the Study of Diabetes (EASD); SEP 11-15, 2017; Lisbon, PORTUGAL. [Poster]
Web of Science

 

** Drechsler, K; Aberer, F; Trummer, C; Schwetz, V; Pandis, M; Glantschnig, K; Kiesling, L; Lanz, C; Pilz, S; Sourij, H; Mader, JK Therapy-associated Errors in an internal Normal Ward from the Diabetics Point of View - A Questionnaire Survey
WIEN KLIN WOCHENSCHR. 2017; 129: 180-180. [Poster]
Web of Science

 

** Holzgruber, J; Aberer, F; Mader, J; Horvath, K; Tripolt, N; Pieber, T; Sourij, H Retrospective Data Collection on Treatment Regimens in Patients with steroid-induced Hyperglycemia
WIEN KLIN WOCHENSCHR. 2017; 129: 170-170. [Poster]
Web of Science

 

** Kojzar, H; Frohlich-Reiterer, E; Mader, J; Hofer, S; Rami-Merhar, B; de Beaufort, C; Acerini, CL; Campell, F; Kapellen, T; Hovorka, R KidsAP - The artificial pancreas in children aged 1 to 7 years with type 1 diabetes
WIEN KLIN WOCHENSCHR. 2017; 129: 162-162.-45. Jahrestagung der Österreichischen Diabetesgesellschaft; Nov 16-18; Salzburg. [Oral Communication]
Web of Science

 

** Leelarathna, L; Thabit, H; Willinska, ME; Dellweg, S; Mader, JK; Hartnell, S; Benesch, C; Holzer, M; Kojzar, H; Evans, ML; Arnolds, S; Pieber, TR; Hovorka, R; On behalf of AP@home consortium Determining duration of closed-loop studies: evidence from a randomised day-and-night three month trial.
Diabetologia. 2017; 60(S1):S324-S325.-53rd Annual Meeting of the European Association for the Study of Diabetes; SEP 11-15, 2017; Lisbon, PORTUGAL. [Poster]
Web of Science

 

** Mader, JK; Donsa, K; Aberer, F; Smajic, E; Lichtenegger, KM; Lanz, C; Holl, B; Beck, P; Pieber, TR; Plank, J GlucoTab((R))-based Basic Bolus Insulin Therapy with Insulin glargin U300 increases the Time in the Target Area in hospitalized Female Patients with Type 2 Diabetes mellitus
WIEN KLIN WOCHENSCHR. 2017; 129: 171-171. [Poster]
Web of Science

 

** Muenzker, J; Zenz, S; Moser, O; Motschnig, M; Puffing, A; Elsayed, H; Baumann, P; Schadler, HP; Pieber, TR; Sourij, H; Mader, JK Glucagon response in patients with type 1 diabetes during meal- related hypoglycaemia and hyperinsulinaemic, hypoglycaemic clamp conditions.
Diabetologia. 2017; 60(S1):S234-S234.-53rd Annual Meeting of the European Association for the Study of Diabetes (EASD); SEP 11-15, 2017; Lisbon, PORTUGAL. [Poster]
Web of Science

 

** Pandis, M; Elsayed, H; Munzker, J; Puffing, A; Motschning, M; Kojzar, H; Schadler, HP; Pieber, TR; Sourij, H; Treiber, G; Mader, JK Standardized Evaluation of a retrospective versus prospectively calibrated continuous Glucose System at the Research Center and at Home
WIEN KLIN WOCHENSCHR. 2017; 129: 173-173. [Poster]
Web of Science

 

** Pottler, T; Lilly, LC; Aberer, F; Trautmann, M; Warner, J; Pieber, TR; Mader, JK Results of three Months of Insulin Therapy with PAQ((R)) in Female Patients with Type 2 Diabetes
WIEN KLIN WOCHENSCHR. 2017; 129: 173-173. [Poster]
Web of Science

 

** Schmid, SM; Lanzinger, S; Karges, W; Bergis, D; Seufert, J; Kerner, W; Mader, JK; Zimny, S; Hummel, M; Rosenbauer, J; Holl, RW Event rates and risk factors for diabetic ketoacidosis in adult type 1 diabetes: analysis from the German/Austrian DPV registry based on 48,067 patients.
Diabetologia. 2017; 60(S1):S154-S154.-53rd Annual Meeting of the European Association for the Study of Diabetes (EASD); SEP 11-15, 2017; Lisbon, PORTUGAL. [Poster]
Web of Science

 

** Stauber, M; Aberer, F; Oulhaj, A; Mader, JK; Zebisch, A; Pieber, TR; Neumeister, P; Greinix, HT; Sill, H; Sourij, H; Wolfler, A Early hyperglycaemia after initiation of glucocorticoid therapy predicts adverse outcome in patients with acute graft-versus-host disease
BONE MARROW TRANSPL. 2017; 52: S285-S285.
Web of Science

 

2016

Full paper/article (Journal)

** Donsa, K; Beck, P; Höll, B; Mader, JK; Schaupp, L; Plank, J; Neubauer, KM; Baumgartner, C; Pieber, TR Impact of errors in paper-based and computerized diabetes management with decision support for hospitalized patients with type 2 diabetes. A post-hoc analysis of a before and after study.
Int J Med Inform. 2016; 90(2):58-67 Doi: 10.1016/j.ijmedinf.2016.03.007
Web of Science PubMed FullText FullText_MUG

 

** Laimer, M; Melmer, A; Mader, JK; Schütz-Fuhrmann, I; Engels, HR; Götz, G; Pfeifer, M; Hermann, JM; Stettler, C; Holl, RW Variability of Basal Rate Profiles in Insulin Pump Therapy and Association with Complications in Type 1 Diabetes Mellitus.
PLoS One. 2016; 11(3):e0150604-e0150604 Doi: 10.1371/journal.pone.0150604 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Mader, JK; Jensen, L; Ingwersen, SH; Christiansen, E; Heller, S; Pieber, TR Pharmacokinetic Properties of Liraglutide as Adjunct to Insulin in Subjects with Type 1 Diabetes Mellitus.
Clin Pharmacokinet. 2016; 55(11):1457-1463 Doi: 10.1007/s40262-016-0413-4 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Moser, O; Mader, JK; Tschakert, G; Mueller, A; Groeschl, W; Pieber, TR; Koehler, G; Messerschmidt, J; Hofmann, P Accuracy of Continuous Glucose Monitoring (CGM) during Continuous and High-Intensity Interval Exercise in Patients with Type 1 Diabetes Mellitus.
Nutrients. 2016; 8(8): Doi: 10.3390/nu8080489 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Ruan, Y; Thabit, H; Leelarathna, L; Hartnell, S; Willinska, ME; Dellweg, S; Benesch, C; Mader, JK; Holzer, M; Kojzar, H; Evans, ML; Pieber, TR; Arnolds, S; Hovorka, R; AP@home Consortium Variability of Insulin Requirements Over 12 Weeks of Closed-Loop Insulin Delivery in Adults With Type 1 Diabetes.
Diabetes Care. 2016; 39(5):830-832 Doi: 10.2337/dc15-2623 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Schwetz, V; Horvath, K; Kump, P; Lackner, C; Perren, A; Forrer, F; Pieber, TR; Treiber, G; Sourij, H; Mader, JK Successful Medical Treatment of Adult Nesidioblastosis With Pasireotide over 3 Years: A Case Report.
Medicine (Baltimore). 2016; 95(14):e3272-e3272 Doi: 10.1097/MD.0000000000003272 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Short report/Letter

** Dragatin, C; Polus, F; Bodenlenz, M; Calonder, C; Aigner, B; Tiffner, KI; Mader, JK; Ratzer, M; Woessner, R; Pieber, TR; Cheng, Y; Loesche, C; Sinner, F; Bruin, G Secukinumab distributes into dermal interstitial fluid of psoriasis patients as demonstrated by open flow microperfusion.
Exp Dermatol. 2016; 25(2):157-159 Doi: 10.1111/exd.12863 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Review

** Stadler, M; Zlamal-Fortunat, S; Schütz-Fuhrmann, I; Rami-Merhar, B; Fröhlich-Reiterer, E; Hofer, S; Mader, J; Resl, M; Kautzky-Willer, A; Weitgasser, R; Prager, R; Bischof, M [Insulin pump therapy in children, adolescents and adults].
Wien Klin Wochenschr. 2016; 128 Suppl 2(4):S188-S195 Doi: 10.1007/s00508-016-0966-0 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Aberer, F; Hajnsek, M; Rumpler, M; Zenz, S; Puffing, A; Augustin, T; Baumann, P; Sinner, F; Sourijl, H; Pieber, TR; Mader, JK Standardised evaluation of three continuous glucose monitoring systems mimicking real-life conditions.
DIABETOLOGIA. 2016; 59: S411-S412.-52nd Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 12-16, 2016; Munich, GERMANY. [Oral Communication]
Web of Science

 

** Aberer, F; Mader, JK; Wolfler, A; Greinix, H; Tripolt, N; Pieber, TR; Sourij, H Pilot Study for Verifying the Feasibility and Efficiency of a standard Blood Glucose Control using an automated Decision Support Algorithm in the Insulin Therapy of Patients with Graft-versus-host Disease
WIEN KLIN WOCHENSCHR. 2016; 128: S407-S407.-44. Jahrestagung der Österreichischen Diabetesgesellschaft (ÖDG); NOV 17-19, 2016; Salzburg, AUSTRIA. [Poster]
Web of Science

 

** Cigler, M; Schwetz, V; Aberer, F; Zenz, S; Lueger, A; Eller, P; Pieber, TR; Sourij, H; Mader, JK Retrospective Analysis of glycemic Derailments in Diabetes in the internal Emergency Department at the LKH University Hospital in Graz
WIEN KLIN WOCHENSCHR. 2016; 128: S410-S410. [Oral Communication]
Web of Science

 

** Kojzar, H; Ruan, Y; Thabit, H; Leelarathna, L; Hartnell, S; Willinska, ME; Dellweg, S; Benesch, C; Mader, JK; Holzer, M; Evans, ML; Pieber, TR; Arnolds, S; Hovorka, R Time to peak Insulin Action Duration influences the glycemic Outcome in Type 1 Diabetes during the Home Phase with Closed Loop Insulin Delivery
WIEN KLIN WOCHENSCHR. 2016; 128: S423-S423. [Poster]
Web of Science

 

** Mader, JK; Donsa, K; Neubauer, KM; Aberer, F; Schaupp, L; Sourij, H; Spat, S; Holl, B; Beck, P; Pieber, TR; Plank, J What are the main Factors Influencing the Decision to continue Insulin Therapy during Discharge of the Patients with Type 2 Diabetes mellitus from the Hospital?
WIEN KLIN WOCHENSCHR. 2016; 128: S400-S401. [Poster]
Web of Science

 

** Mader, JK; Donsa, K; Neubauer, KM; Pieber, TR; Plank, J Welche Faktoren beeinflussen die Entscheidung über die Fortsetzung der Insulintherapie bei Entlassung aus dem Krankenhaus bei Typ 2 Diabetes?
Wien Klin Wochenschr.. 2016; 128(S05):S381-S281.-47. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin (OEGIM); SEP 22-24, 2016; Salzburg, AUSTRIA. [Poster]
Web of Science

 

** Mader, JK; Hajnsek, M; Aberer, F; Rumpler, M; Zenz, S; Puffing, A; Elsayed, H; Baumann, P; Sinner, F; Pieber, TR Standardized Assessment of three continuous Glucose Monitoring Systems under realistic Conditions
WIEN KLIN WOCHENSCHR. 2016; 128: S400-S400. [Poster]
Web of Science

 

** Mader, JK; Lilly, LC; Aberer, F; Poettler, T; Becvar, S; Lanz, C; Trautmann, M; Pieber, TR PAQ®, A Simple 3-Day Basal/Bolus Insulin Delivery Device for People with Type 2 Diabetes.
DIABETES TECHNOL THE. 2016; 18: A109-A109.-9th International Conference of Advanced Technologies and Treatments for Diabetes (ATTD) ; FEB 3-6, 2016; Milan, ITALY. [Poster]
Web of Science

 

** Mader, JK; Lilly, LC; Aberer, F; Pottler, T; Becvar, S; Lanz, C; Trautmann, M; Pieber, TR Application of PAQ®, an Insulin Dosage Device for Patients with Type 2 Diabetes mellitus, for 3 Months
WIEN KLIN WOCHENSCHR. Wiener Klinische Wochenschrift. 2016; 128(Supp 6):S399-S400.-44. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 17-19, 2016; Salzburg, AUSTRIA. [Oral Communication]
Web of Science

 

** Mader, JK; Zenz, S; Baumann, P; Sourij, H; Pieber, TR Vergleichbare Glukagonantwort bei Patienten mit langer vs. kurzer Typ 1 Diabetes Laufdauer.
Wien Klin Wochenschr. 2016; 128(S05):S381-S382.-47. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin (OEGIM); SEP 22-24, 2016; Salzburg, AUSTRIA. [Poster]
Web of Science

 

** Rumpler, M; Hajnsek, M; Mader, JK; Sinner, F; Pieber, TR SPIDIMAN: Clinical Trial of a Single-Port Glucose Sensor on a Commercial Insulin Infusion Set.
DIABETES TECHNOL THE. 2016; 18: A28-A28.-9th International Conference of Advanced Technologies and Treatments for Diabetes (ATTD); FEB 3-6, 2016; Milan, ITALY. [Oral Communication]
Web of Science

 

** Tuca, AC; Neubauer, KM; Mader, JK; Aberer, F; Lumenta, DB; Bauer, B; Donsa, K; Augustin, T; Holl, B; Schaupp, L; Beck, P; Plank, J; Pieber, TR; Kamolz, LP Treatment of Patients with Type 2 Diabetes mellitus using a clinical Decision Support System at a plastic surgical Ward
WIEN KLIN WOCHENSCHR. Wiener Klinische Wochenschrift. 2016; 128(Supp 6):S412-S413.-44. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 17-19, 2016; Salzburg, AUSTRIA. [Poster]
Web of Science

 

** Zenz, S; Baumann, P; Brunner, M; Puffing, A; Rumpler, M; Wolf, M; Hajnsek, M; Sourij, H; Pieber, TR; Mader, JK Glucagon response in C-peptide positive vs C-peptide negative patients with type 1 diabetes under hypoglycaemic clamp vs real-life setting.
Diabetologia. 2016; 59(Suppl1):S404-S404.-52nd Annual Meeting of the European Association for the Study of Diabetes (EASD); SEP 12-16, 2016; Munich, GERMANY. [Poster]
Web of Science

 

** Zenz, S; Baumann, P; Brunner, M; Puffing, A; Rumpler, M; Wolf, M; Hajnsek, M; Sourij, H; Pieber, TR; Mader, JK Comparison of the Glucagon Response with C-peptide positive vs. C-peptide negative Female Patients with Type 1 Diabetes mellitus in a hypoglycaemic Clamp vs. Real-Life Experiment
WIEN KLIN WOCHENSCHR. 2016; 128: S413-S413. [Oral Communication]
Web of Science

 

2015

Full paper/article (Journal)

** Hermanns, N; Lilly, LC; Mader, JK; Aberer, F; Ribitsch, A; Kojzar, H; Warner, J; Pieber, TR Novel simple insulin delivery device reduces barriers to insulin therapy in type 2 diabetes: results from a pilot study.
J Diabetes Sci Technol. 2015; 9(3):581-587 Doi: 10.1177/1932296815570709 [OPEN ACCESS]
PubMed FullText FullText_MUG

 

** Kropff, J; Bruttomesso, D; Doll, W; Farret, A; Galasso, S; Luijf, YM; Mader, JK; Place, J; Boscari, F; Pieber, TR; Renard, E; DeVries, JH Accuracy of two continuous glucose monitoring systems: a head-to-head comparison under clinical research centre and daily life conditions.
Diabetes Obes Metab. 2015; 17(4):343-349 Doi: 10.1111/dom.12378 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Neubauer, KM; Mader, JK; Höll, B; Aberer, F; Donsa, K; Augustin, T; Schaupp, L; Spat, S; Beck, P; Fruhwald, FM; Schnedl, C; Rosenkranz, AR; Lumenta, DB; Kamolz, LP; Plank, J; Pieber, TR Standardized Glycemic Management with a Computerized Workflow and Decision Support System for Hospitalized Patients with Type 2 Diabetes on Different Wards.
Diabetes Technol Ther. 2015; 17(10):685-692 Doi: 10.1089/dia.2015.0027 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Pilz, S; Gaksch, M; Kienreich, K; Grübler, M; Verheyen, N; Fahrleitner-Pammer, A; Treiber, G; Drechsler, C; Ó, Hartaigh, B; Obermayer-Pietsch, B; Schwetz, V; Aberer, F; Mader, J; Scharnagl, H; Meinitzer, A; Lerchbaum, E; Dekker, JM; Zittermann, A; März, W; Tomaschitz, A Effects of vitamin D on blood pressure and cardiovascular risk factors: a randomized controlled trial.
Hypertension. 2015; 65(6):1195-201 Doi: 10.1161/HYPERTENSIONAHA.115.05319 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Schaupp, L; Donsa, K; Neubauer, KM; Mader, JK; Aberer, F; Höll, B; Spat, S; Augustin, T; Beck, P; Pieber, TR; Plank, J Taking a Closer Look--Continuous Glucose Monitoring in Non-Critically Ill Hospitalized Patients with Type 2 Diabetes Mellitus Under Basal-Bolus Insulin Therapy.
Diabetes Technol Ther. 2015; 17(9):611-618 Doi: 10.1089/dia.2014.0343
Web of Science PubMed FullText FullText_MUG

 

** Thabit, H; Leelarathna, L; Wilinska, ME; Elleri, D; Allen, JM; Lubina-Solomon, A; Walkinshaw, E; Stadler, M; Choudhary, P; Mader, JK; Dellweg, S; Benesch, C; Pieber, TR; Arnolds, S; Heller, SR; Amiel, SA; Dunger, D; Evans, ML; Hovorka, R Accuracy of Continuous Glucose Monitoring During Three Closed-Loop Home Studies Under Free-Living Conditions.
Diabetes Technol Ther. 2015; 17(11):801-807 Doi: 10.1089/dia.2015.0062 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Thabit, H; Tauschmann, M; Allen, JM; Leelarathna, L; Hartnell, S; Wilinska, ME; Acerini, CL; Dellweg, S; Benesch, C; Heinemann, L; Mader, JK; Holzer, M; Kojzar, H; Exall, J; Yong, J; Pichierri, J; Barnard, KD; Kollman, C; Cheng, P; Hindmarsh, PC; Campbell, FM; Arnolds, S; Pieber, TR; Evans, ML; Dunger, DB; Hovorka, R Home Use of an Artificial Beta Cell in Type 1 Diabetes.
N Engl J Med. 2015; 373(22):2129-2140 Doi: 10.1056/NEJMoa1509351 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Aberer, F; Lilly, LC; Pöttler, T; Becvar, S; Lanz, C; Novak, E; Trautmann, M; Pieber, TR; Mader, JK Überprüfung der Effizienz und Sicherheit eines einfachen Insulinabgabegerätes (PaQ) bei Patienten mit Diabetes mellitus Typ 2.
Wiener Klinische Wochenschrift. 2015; 127(Supp 4):S136-S136.-43. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 19-21, 2015; Salzburg, AUSTRIA. [Poster]
Web of Science

 

** Aberer, F; Mader, JK; Kremser, S; Zinke-Cerwenka, W; Greinix, H; Pieber, TR; Zebisch, A; Sill, H; Oulhaj, A; Wölfler, A; Sourij, H Glykämie nach allogener Stammzelltransplantation bei Patienten mit akuter myeloischer Leukämie (AML) ist ein unabhängiger Prädiktor für das Überleben.
Wiener Klinische Wochenschrift. 2015; 127(Suppl 4 ):S135-S135.-43. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 19-21, 2015; Salzburg, AUSTRIA. [Poster]
Web of Science

 

** Aberer, F; Stauber, MN; Mader, JK; Greinix, H; Oulhaj, A; Wölfler, A; Sourij, H Assoziation zwischen Hyperglykämie und ungünstigem Outcome bei Patienten mit akuter oder chronischer Graft-versus-Host Erkrankung (GvHD) nach allogener Stammzelltransplantation.
Wiener Klinische Wochenschrift. 2015; 127(Supp 4):S156-S157.-43. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 19-21, 2015; Salzburg, AUSTRIA. [Oral Communication]
Web of Science

 

** Donsa, K; Neubauer, KM; Mader, JK; Holl, B; Spat, S; Beck, P; Aberer, F; Plank, J; Pieber, TR; Schaupp, L CONTINUOUS GLUCOSE MONITORING ASSESSING THE CLINICAL IMPACT OF AN ALGORITHM DRIVEN BASAL-BOLUS INSULIN REGIMEN IN NON-CRITICALLY ILL INPATIENTS WITH T2DM
DIABETES TECHNOL THE. 2015; 17: A24-A25. [Oral Communication]
Web of Science

 

** Holzer, M; Thabit, H; Leelarathna, L; Dellweg, S; Mader, JK; Hartnell, S; Benesch, C; Kojzar, H; Heinemann, L; Wilinska, M; Pieber, TR; Arnolds, S; Evans, M; Hovorka, R 12-wöchige Tag-und-Nacht Closed-Loop Insulinabgabe bei erwachsenen Typ 1 Diabetikern im Alltag: eine offene multizentrische multinationale prospektive randomisierte Crossover-Studie.
Wiener Klinische Wochenschrift. 2015; 127(Supp 4):S145-S145.-43. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 19-21, 2015; Salzburg, AUSTRIA. [Poster]
Web of Science

 

** Kojzar, H; Thabit, H; Leelarathna, L; Wilinska, ME; Elleri, D; Allen, JM, Lubina-Solomon, A; Walkinshaw, E; Stadler, M; Choudhary, P; Holzer, M; MAder, JK; Dellweg, S; Benesch, C; Pieber, TR; Arnolds, S; Heller, SR; Amiel, SA; Dunger, D; Evans, ML; Hovorka, R Genauigkeit und Performance von kontinuierlichem Glukosemonitoring bei drei Closed-Loop-Studienmit Heimphase unter normalen Lebensbedingungen.
Wiener Klinische Wochenschrift. 2015; 127(Supp 4):S145-S146.-43. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 19-21, 2015; Salzburg, AUSTRIA. [Poster]
Web of Science

 

** Laimer, M; Melmer, A; Mader, J; Schutz-Fuhrmann, I; Rose-Engels, H; Gotz, G; Pfeiffer, M; Hermann, J; Stettler, C; Holl, R WAVY BASAL RATE PROFILES IN INSULIN PUMP THERAPY ASSOCIATE WITH INCREASED RISK FOR ACUTE COMPLICATIONS IN TYPE 1 DIABETES-CROSS-SECTIONAL ANALYSIS FROM THE DPV REGISTRY
DIABETES TECHNOL THE. 2015; 17: A12-A13. [Oral Communication]
Web of Science

 

** Mader, JK; Haas, W; Ribitsch, A; Samonigg, J; Höller, V; Horvath, K; Köhler, G; Sourij, H; Pieber, TR; Plank, J Langzeit Follow-up diner Kohorte von Patienten mit diabetischem Fußsyndrom in der Steiermark.
Wiener Klinische Wochenschrift. 2015; 127(Supp 4):S134-S134.-43. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 19-21, 2015; Salzburg, AUSTRIA. [Poster]
Web of Science

 

** Mader, JK; Lilly, L; Aberer, F; Poettler, T; Trautmann, M; Pieber, T PAQ, A SIMPLE 3-DAY INSULIN DELIVERY DEVICE, IMPROVES GLYCEMIC CONTROL
DIABETES TECHNOL THE. 2015; 17: A13-A13. [Oral Communication]
Web of Science

 

** Mader, JK; Neubauer, KM; Schaupp, L; Aberer, F; Donsa, K; Augustin, T; Spat, S; Höll, B; Beck, P; Plank, J; Pieber, TR Blutzuckermanagement mittels GlucoTab-System bei insulinnaiven versus insulinvorbehandelten Patienten mit Diabetes mellitus Typ 2.
Wiener Klinische Wochenschrift. 2015; 127(Suppl 4):S134-S134.-43. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 19-21, 2015; Salzburg, AUSTRIA. [Poster]
Web of Science

 

** Mader, JK; Sourij, H; Laimer, M; Debong, F; Schandl, B; Pieber, R INFLUENCE OF FREQUENT USE OF MOBILE HEALTH TECHNOLOGY ON BLOOD GLUCOSE CONTROL IN PATIENTS WITH TYPE 1 DIABETES
DIABETES TECHNOL THE. 2015; 17: A124-A125. [Poster]
Web of Science

 

** Neubauer, KM; Aberer, F; Mader, JM; Holl, B; Schaupp, L; Spat, S; Beck, P; Donsa, K; Plank, J; Pieber, TR SAFETY AND EFFICACY OF STANDARDISED GLYCAEMIC MANAGEMENT BY USING THE GLUCOTAB SYSTEM FOR PATIENTS WITH DIABETES MELLITUS TYPE 2 AT DIFFERENT HOSPITAL WARDS
DIABETES TECHNOL THE. 2015; 17: A26-A26. [Oral Communication]
Web of Science

 

** Neubauer, KM; Mader, JK; Aberer, F; Schaupp, L; Donsa, K; Augustin, T; Beck, P, Pieber; TR, Plank, J Wirksamkeit und Sicherheit von standardisierter Insulintherapie bei hospitalisierten Patienten im Alter von <70 und ≥ 70 Nahen mit Diabetes mellitus Typ 2.
Wiener Klinischen Wochenschrift. 2015; 127(Supp 4):S148-S148.-43. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 19-21, 2015; Salzburg, AUSTRIA. [Poster]
Web of Science

 

** Neubauer, KM; Mader, JK; Aberer, F; Schaupp, L; Donsa, K; Augustin, T; Beck, P; Pieber, TR; Plank, J Efficacy and safety of standardised glycaemic control in adult and geriatric hospitalised patients with type 2 diabetes mellitus.
Diabetologia. 2015; 58(Suppl 1):S445-S445.-51st Annual Meeting of the European Association for the Study of Diabetes (EASD); SEP 14-18, 2015; Stockholm, SWEDEN. [Poster]
Web of Science

 

** Ribitsch, A; Haas, W; Mader, JK; Samonigg, J; Horvath, K; Köhler, G; Sourij, H; Pieber, TR; Plank, J Long-term follow-up of a cohort with a history of diabetic foot ulcer in Austria.
Diabetologia. 2015; 58(Suppl 1):S512-S512.-51st Annual Meeting of the European Association for the Study of Diabetes (EASD); SEP 14-18, 2015; Stockholm, SWEDEN. [Poster]
Web of Science

 

** Schwetz, V; Eisner, F; Schilcher, G; Pieber, TR; Mader, JK; Eller, P Metformin-assoziierte Laktat- und Ketoazidose in zwei kritisch kranken Patientinnen.
Wiener Klinische Wochenschrift. 2015; 127(Suppl 4 ):S135-S136.-43. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 19-21, 2015; Salzburg, AUSTRIA. [Poster]
Web of Science

 

** Thabit, H; Leelarathna, L; Dellweg, S; Mader, JK; Hartnell, S; Benesch, C; Kojzar, H; Holzer, M; Heinemann, L; Wilinska, ME; Pieber, TR; Arnolds, S; Evans, ML; Hovorka, R; AP@Home consortium Twelve-week unsupervised day-and-night closed loop insulin delivery during free daily living in adults with type 1 diabetes: a multicentre randomised cross-over study
DIABETOLOGIA. 2015; 58: S478-S478.-51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 14-18, 2015; Stockholm, SWEDEN. [Poster]
Web of Science

 

** Zlamal-Fortunat, S; Schütz-Fuhrmann, I; Stadler, M; Laimer, M; Hofer, S; Rami-Merhar, B; Weitgasser, R; Mader, JK; Fröhlich-Reiterer, E; Holl, RW Auswertung des österreichischen Insulinpumpenregisters März 2015.
Wiener Klinische Wochenschrift. 2015; 127(Supp 4):S154-S154.-43. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 19-21, 2015; Salzburg, AUSTRIA. [Oral Communication]
Web of Science

 

2014

Full paper/article (Journal)

** Donsa, K; Beck, P; Plank, J; Schaupp, L; Mader, JK; Truskaller, T; Tschapeller, B; Höll, B; Spat, S; Pieber, TR A toolbox to improve algorithms for insulin-dosing decision support.
Appl Clin Inform. 2014; 5(2):548-556 Doi: 10.4338/ACI-2014-04-RA-0033 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Koehler, G; Treiber, G; Wutte, A; Korsatko, S; Mader, JK; Semlitsch, B; Pieber, TR Pharmacodynamics of the long-acting insulin analogues detemir and glargine following single-doses and under steady-state conditions in patients with type 1 diabetes.
Diabetes Obes Metab. 2014; 16(1):57-62 Doi: 10.1111/dom.12178
Web of Science PubMed FullText FullText_MUG

 

** Korsatko, S; Deller, S; Mader, JK; Glettler, K; Koehler, G; Treiber, G; Urschitz, M; Wolf, M; Hastrup, H; Søndergaard, F; Haahr, H; Pieber, TR Ultra-long pharmacokinetic properties of insulin degludec are comparable in elderly subjects and younger adults with type 1 diabetes mellitus.
Drugs Aging. 2014; 31(1):47-53 Doi: 10.1007/s40266-013-0138-0 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Leelarathna, L; Dellweg, S; Mader, JK; Allen, JM; Benesch, C; Doll, W; Ellmerer, M; Hartnell, S; Heinemann, L; Kojzar, H; Michalewski, L; Nodale, M; Thabit, H; Wilinska, ME; Pieber, TR; Arnolds, S; Evans, ML; Hovorka, R; AP@home Consortium Day and night home closed-loop insulin delivery in adults with type 1 diabetes: three-center randomized crossover study.
Diabetes Care. 2014; 37(7):1931-1937 Doi: 10.2337/dc13-2911 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Leelarathna, L; Dellweg, S; Mader, JK; Barnard, K; Benesch, C; Ellmerer, M; Heinemann, L; Kojzar, H; Thabit, H; Wilinska, ME; Wysocki, T; Pieber, TR; Arnolds, S; Evans, ML; Hovorka, R; AP@home consortium Assessing the effectiveness of 3 months day and night home closed-loop insulin delivery in adults with suboptimally controlled type 1 diabetes: a randomised crossover study protocol.
BMJ Open. 2014; 4(9):e006075-e006075 Doi: 10.1136/bmjopen-2014-006075 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Mader, JK; Lilly, LC; Aberer, F; Korsatko, S; Strock, E; Mazze, RS; Damsbo, P; Pieber, TR A feasibility study of a 3-day basal-bolus insulin delivery device in individuals with type 2 diabetes.
Diabetes Care. 2014; 37(5):1476-1479 Doi: 10.2337/dc13-2238 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Mader, JK; Neubauer, KM; Schaupp, L; Augustin, T; Beck, P; Spat, S; Höll, B; Treiber, GM; Fruhwald, FM; Pieber, TR; Plank, J Efficacy, usability and sequence of operations of a workflow-integrated algorithm for basal-bolus insulin therapy in hospitalized type 2 diabetes patients.
Diabetes Obes Metab. 2014; 16(2):137-146 Doi: 10.1111/dom.12186 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Prietl, B; Treiber, G; Mader, JK; Hoeller, E; Wolf, M; Pilz, S; Graninger, WB; Obermayer-Pietsch, BM; Pieber, TR High-dose cholecalciferol supplementation significantly increases peripheral CD4⁺ Tregs in healthy adults without negatively affecting the frequency of other immune cells.
Eur J Nutr. 2014; 53(3):751-759 Doi: 10.1007/s00394-013-0579-6
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Bruin, G; Dragatin, C; Aigner, B; Polus, F; Calonder, C; Froeliger, C; Tiffner, K; Bodenlenz, M; Mader, J; Korsatko, S; Ratzer, M; Pieber, T; Loesche, C; Sinner, F The anti IL-17A IgG1 antibody distributes in dermal interstitial fluid as demonstrated by using dermal open flow microperfusion after a single 300 mg subcutaneous administration; assessment in healthy volunteers and patients with moderate-to-severe plaque psoriasis
J INVEST DERMATOL. 2014; 134: S18-S18.-Annual Meeting of the Society-for-Investigative-Dermatology (SID); MAY 07-10, 2014; Albuquerque, NM. [Poster]
Web of Science

 

** Donsa, K; Neubauer, KM; Mader, JK; Höll, B; Spat, S; Tschapeller, B; Beck, P; Plank, J; Pieber, TR; Schaupp, L Are we missing something? Continuous glucose monitoring compared with POCT among hospitalised type 2 diabetes patients on basal-bolus insulin therapy
DIABETES TECHNOLOGY & THERAPEUTICS. 2014; 16(S1):A7-A7.-7th International Conference on Advanced Technologies and Treatments for Diabetes; FEB 5-8, 2014; Vienna, AUSTRIA. [Oral Communication]
Web of Science

 

** Hermanns, N; Lilly, LC; Mader, JK; Aberer, F; Pachatz, J; Korsatko, S; Warner, J; Pieber, TR Use of PaQ (R), a simple 3-day basal/bolus insulin delivering device, reduces barriers to insulin therapy in patients withy type 2 diabetes
DIABETES TECHNOLOGY & THERAPEUTICS. 2014; 16(S1):A19-A19.-7th International Conference of Advanced Technologies and Treatments for Diabetes; FEB 5-8, 2014; Vienna, AUSTRIA. [Oral Communication]
Web of Science

 

** Höll, B; Spat, S; Beck, P; Neubauer, KM; Mader, JK; Schaupp, L; Chiarugi, F; Pieber,TR GlucoTab (R) Automatic decision support for treatment of patients with diabetes type 2 in hospital.
DIABETES TECHNOLOGY & THERAPEUTICS. 2014; 16(S1):A114-A114.-7th International Conference of Advanced Technologies and Treatments for Diabetes; FEB 5-8, 2014; Vienna, AUSTRIA. [Poster]
Web of Science

 

** Horvath, K; Pürstl, M; Mader, J; Augustin, T; Pieber, T Evaluation des ambulante Insulinisierungsprozesses von Patienten mit Typ 2 Diabetes mellitus an einem tertiären Zentrum
Wiener Klinische Wochenschrift. 2014; 126(S04):S182-S182.-42. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 20-22, 2014; Salzburg, AUSTRIA. [Poster]
Web of Science

 

** Kardas, P; Beck, P; Bromuri, S; Chiarugi, F; Enzmann, M; Höll, B; Keller, O; Lane, S; Mader, J; Marchesini, O; Mougiakakou, S; Neubauer, K; Pieber, TR; Plößnig, M; Puricel, SG; Schaupp, L; Spat, S 7th Framework program Funded eHealth systems for diabetes
DIABETES TECHNOLOGY & THERAPEUTICS. 2014; 16(S1):A1-A1.-7th International Conference on Advanced Technologies and Treatments for Diabetes; FEB 5-8, 2014; Vienna, AUSTRIA. [Oral Communication]
Web of Science

 

** Kropff, J; Bruttomesso, D; Doll, W; Farret, A; Galasso, S; Luijf, YM; Mader, JK; Place, J; Boscari, F; Pieber, TR; Renard, E; DeVries, JH Standardised procedure for the assessment of new-to-market continuous glucose monitoring (CGM) systems (Space2).
Diabetologia. 2014; 57(Supp.1):S419-S419.-50th Annual Meeting of the European Diabetes Association (EASD) Vienna; SEP 15-19, 2014; Vienna, AUSTRIA. [Poster]
Web of Science

 

** Kropff, J; Doll, W; Mader, JK; Pieber, T; Farret, A; Place, J; Renard, E; Boscari, F; Bruttomesso, D; Galasso, S; DeVries, JH Standardized procedure for the assessment of new-to-market continuous glucose monitoring (CGM) systems (SPACE2).
DIABETES TECHNOLOGY & THERAPEUTICS. 2014; 16(S1):A34-A35.-7th International Conference of Advanced Technologies and Treatments for Diabetes; FEB 5-8, 2014; Vienna, AUSTRIA. [Poster]
Web of Science

 

** Leelarathna, L; Thabit, H; Elleri, D; Allen, JM; Lubina-Solomon, A; Mader, JK; Benesch, C; Stadler, M; Pieber, TR; Arnolds, S; Heller, SR; Amiel, SA; Dunger, DB; Evans, ML; Hovorka, R Accuracy of Continuous Glucose Monitoring (CGM) under free-living conditions during three home closed loop studies.
Diabetologia. 2014; 57(Supp.1):S406-S407.-50th Annual Meeting of the European Diabetes Association (EASD) ; SEP 15-19, 2014; Vienna, AUSTRIA. [Poster]
Web of Science

 

** Mader, JK; Kropff, J; Doll, W; Kojzar, H; Pieber, TR; Farret, A; Place, J; Renard, E; Boscari, F; Bruttomesso, D; Galasso, S; DeVries, JH Verwendung eines standardisierten Protokolls zur Bewertung der Genauigkeit und Zuverlässigkeit der zwei am häufigsten verwendeten kontinuierlichen Glukosemonitoringsysteme
Wiener Klinische Wochenschrift. 2014; 126(S04):S190-S190.-42. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 20-22, 2014; Salzburg, AUSTRIA. [Poster]
Web of Science

 

** Mader, JK; Leelarathna, L; Dellweg, S; Allen, JM; Benesch, C; Doll, W; Ellmerer, M; Hartnell, S; Heinemann, L; Kojzar, H; Holzer, M; Michalewski, L; Nodale, M; Thabit, H; Wilinska, ME; Pieber, TR; Arnolds, S; Evans, ML; Hovorka, R Tag und Nacht automatisierte Closed-Loop Insulintherapie bei Erwachsenen mit Typ 1 Diabetes: eine randomisierte Crossover-Studie in 3 europäischen Zentren
Wiener Klinische Wochenschrift. 2014; 126(S04):S180-S180.-42. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 20-22, 2014; Salzburg, AUSTRIA. [Oral Communication]
Web of Science

 

** Mader, JK; Neubauer, KM; Schaupp, L; Aberer, F; Augustin, T; Spat, S; Hoell, B; Beck, P; Plank, J; Pieber, TR Evaluation of glycemic control using an algorithm for basal bolus insulin therapy in hospitalised patients with diabetes mellitus type 2
DIABETES TECHNOLOGY & THERAPEUTICS. 2014; 16(S1):A8-A81.-7th International Conference of Advanced Technologies and Treatments for Diabetes; FEB 5-8, 2014; Vienna, AUSTRIA. [Oral Communication]
Web of Science

 

** Mader, JK; Neubauer, KM; Schaupp, L; Aberer, F; Donsa, K; Augustin, T; Spat, S; Hoell, B; Beck, P; Plank, J; Pieber, TR Assessment of glycaemic control and risk of hypoglycaemia for two basal-bolus algorithms in hospitalised patients with diabetes mellitus type 2.
Diabetologia. 2014; 57(Supp.1):S402-S402.-50th Annual Meeting of the European Diabetes Association (EASD); SEP 15-19, 2014; Vienna, AUSTRIA. [Poster]
Web of Science

 

** Mader, JK; Neubauer, KM; Schaupp, L; Aberer, F; Donsa, K; Augustin, T; Spat, S; Höll, B; Beck, P; Plank, J; Pieber, TR Bewertung der Blutzuckereinstellung und des Hypoglykämierisikos unter Verwendung von zwei Algorithmen zur Basis-Bolus-Insulintherapie bei hospitalisierten Patienten mit Diabetes mellitus Typ 2.
Wiener Klinische Wochenschrift. 2014; 126(S04):S181-S181.-42. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 20-22, 2014; Salzburg, AUSTRIA. [Poster]
Web of Science

 

** Mader, JK; Ribitsch, A; Horvath, K; Kump, P; Lipp, RW; Pieber, TR; Treiber, G Medical treatment of adult nesidioblastosis - a case report.
Wiener Klinische Wochenschrift. 2014; 126(Suppl3):S155-S156.-14th International workshop on multiple endocrine neoplasia and other rare endocrine tumors (World MEN); SEP 25-27, 2014; Vienna, AUSTRIA. [Poster]
Web of Science

 

** Mader, JK; Ribitsch, A; Sourij, H; Horvath, K; Pieber, TR; Treiber, G Pasireotide as Treatment option for recurrent Hypoglycemia in adult Nesidioblastosis
WIEN KLIN WOCHENSCHR. 2014; 126(17-18):565-566.-ÖGIM; SEP 25-27, 2014; Salzburg. [Poster]
Web of Science

 

** Neubauer, KM; Mader, JK; Höll, B; Schaupp, L; Beck, P; Spat, S; Aberer, F; Schwagerle, G; Plank, J; Buttinger, M; Pieber, TR GlucoTab - Software basierte Arbeitsprozess- und Entscheidungsunterstützung für sichere gylkämische Kontrolle durch Basal-Bolus Insulintherapie bei hospitalisierten PatientInnen mit Typ-2-Diabetes
Wiener Klinische Wochenschrift. 2014; 126(S04):S182-S182.-42. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 20-22, 2014; Salzburg, AUSTRIA. [Oral Communication]
Web of Science

 

** Neubauer, KM; Mader, JK; Schaupp, L, Höll, B; Spat, S; Augustin, T; Beck, P; Buttinger, M; Plank, J; Pieber, TR Tablet-based workflow and decision support of in-hospital glycaemic management - perceptions of nurses and physicians.
DIABETES TECHNOLOGY & THERAPEUTICS. 2014; 16(S1):A140-A140.-7th International Conference of Advanced Technologies and Treatments for Diabetes; FEB 5-8, 2014; Vienna, AUSTRIA. [Poster]
Web of Science

 

** Ribitsch, A; Kienreich, T; Mader, JK; Horvath, K; Pieber, TR; Treiber, G Applications of Insulin Pumping Treatment and clinical Characteristics of Adult-Patients with Type 1 Diabetes
WIEN KLIN WOCHENSCHR. 2014; 126: S178-S179.-42. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV ; Salzburg, AUSTRIA. [Poster]
Web of Science

 

** Ribitsch, A; Mader, JK; Köhler, G; von Lewinski, D; Pieber, TR; Treiber, G Gute Genesung nach Diabetes Typ 1 Manifestation mit schwerer Ketoazidose, Insult, Rhabdomyolyse, akutem Nierenversagen und septischem Schock.
Wiener Klinische Wochenschrift. 2014; 126(S04):S178-S178.-42. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 20-22, 2014; Salzburg, AUSTRIA. [Poster]
Web of Science

 

** Svehlikova, E; Tuca, A; Höller, V; Mader, J; Obermayer-Pietsch, B; Freisinger, O; Tadler, F; Ernst, B; Wilms, B; Thurnheer, M; Schultes, B; Pieber, TR Die Verbesserung der Betazellfunktion bei morbid adipösen Patienten mit Typ 2 Diabetes nach Magenbypassoperationen ist mit einer verbesserten Insulinverarbeitung in der Betazelle verbunden.
Wiener Klinische Wochenschrift. 2014; 126(S04):S185-S185.-42. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 20-22, 2014; Salzburg, AUSTRIA. [Oral Communication]
Web of Science

 

** Tuca, A; Schober, MM; Korsatko, S; Mader, J; Bauer, G; Smolle, KH; Wurzer, P; Ellmerer, M; Pieber TR Evaluation of three point of care glucose-meters in critically ill patients at a medical intensive care unit.
Wiener Klinische Wochenschrift. 2014; 126(S04):S193-S193.-42. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 20-22, 2014; Salzburg, AUSTRIA. [Poster]
Web of Science

 

2013

Full paper/article (Journal)

** Facchinetti, A; Sparacino, G; Guerra, S; Luijf, YM; Devries, JH; Mader, JK; Ellmerer, M; Benesch, C; Heinemann, L; Bruttomesso, D; Avogaro, A; Cobelli, C; on behalf of the AP@home Consortium Real-Time Improvement of Continuous Glucose-Monitoring Accuracy: The smart sensor concept.
Diabetes Care. 2013; 36(4):793-800 Doi: 10.2337/dc12-0736 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Friedl, C; Hemetsberger, M; Mader, J; Fahrleitner-Pammer, A; Pieber, TR; Rosenkranz, AR Awareness of chronic kidney disease in Austria: a frequently under-recognized clinical picture.
Wien Klin Wochenschr. 2013; 125(13-14):362-367 Doi: 10.1007/s00508-013-0374-7
Web of Science PubMed FullText FullText_MUG

 

** Korsatko, S; Deller, S; Koehler, G; Mader, JK; Neubauer, K; Adrian, CL; Thomsen, H; Haahr, H; Pieber, TR A comparison of the steady-state pharmacokinetic and pharmacodynamic profiles of 100 and 200 U/mL formulations of ultra-long-acting insulin degludec.
Clin Drug Investig. 2013; 33(7):515-521 Doi: 10.1007/s40261-013-0096-7
Web of Science PubMed FullText FullText_MUG

 

** Korsatko, S; Glettler, K; Olsen, KJ; Wutte, A; Bock, G; Koehler, G; Mader, JK; Semlitsch, B; Pieber, TR A direct comparison of the pharmacodynamic properties of insulin detemir and neutral protamine lispro (NPL) insulin in patients with type 1 diabetes.
Diabetes Obes Metab. 2013; 15(3):241-245 Doi: 10.1111/dom.12016
Web of Science PubMed FullText FullText_MUG

 

** Luijf, YM; DeVries, JH; Zwinderman, K; Leelarathna, L; Nodale, M; Caldwell, K; Kumareswaran, K; Elleri, D; Allen, JM; Wilinska, ME; Evans, ML; Hovorka, R; Doll, W; Ellmerer, M; Mader, JK; Renard, E; Place, J; Farret, A; Cobelli, C; Del Favero, S; Dalla Man, C; Avogaro, A; Bruttomesso, D; Filippi, A; Scotton, R; Magni, L; Lanzola, G; Di Palma, F; Soru, P; Toffanin, C; De Nicolao, G; Arnolds, S; Benesch, C; Heinemann, L; AP@home Consortium Day and night closed-loop control in adults with type 1 diabetes: a comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-management.
Diabetes Care. 2013; 36(12):3882-3887 Doi: 10.2337/dc12-1956 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Luijf, YM; Mader, JK; Doll, W; Pieber, T; Farret, A; Place, J; Renard, E; Bruttomesso, D; Filippi, A; Avogaro, A; Arnolds, S; Benesch, C; Heinemann, L; DeVries, JH; AP@home consortium Accuracy and reliability of continuous glucose monitoring systems: a head-to-head comparison.
Diabetes Technol Ther. 2013; 15(8):722-727 Doi: 10.1089/dia.2013.0049 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Mader, JK; Birngruber, T; Korsatko, S; Deller, S; Köhler, G; Boysen, S; Augustin, T; Mautner, SI; Sinner, F; Pieber, TR; AP@home Consortium Enhanced absorption of insulin aspart as the result of a dispersed injection strategy tested in a randomized trial in type 1 diabetic patients.
Diabetes Care. 2013; 36(4):780-785 Doi: 10.2337/dc12-1319 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Mader, JK; Lilly, LC; Aberer, F; Pachatz, J; Korsatko, S; Damsbo, P; Pieber, TR PaQ®, a simple 3-day basal/bolus insulin delivery device, in people with type 2 diabetes.
Biomed Tech (Berl). 2013; 58 Suppl 1(1): Doi: 10.1515/bmt-2013-4038
Web of Science PubMed FullText FullText_MUG

 

** Mader, JK; Lucarelli, F; Scuffi, C; Aberer, F; Korsatko, S; Valgimigli, F; Pieber, TR Optimising the glucose sampling performance of an intravascular microdialysisbased continuous glucose monitoring device for use in hospital settings.
Biomed Tech (Berl). 2013; 58 Suppl 1(1): Doi: 10.1515/bmt-2013-4142
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Bruin, G; Dragatin, C; Aigner, B; Polus, F; Calonder, C; Froeliger, C; Tiffner, K; Bodenlenz, M; Mader, J; Korsatko, S; Ratzer, M; Pieber, TR; Loesche, C; Sinner, F; Absolute levels of the novel anti-IL-17A antibody, secukinumab, in skin can be quantified by dermal open flow microperfusion (dOFM).
J INVEST DERMATOL. 2013; 133: S52-S52.-International Investigative Dermatology Meeting; MAY 08-11, 2013; Edinburgh, SCOTLAND. [Poster]
Web of Science

 

** Doll, WK; Mader, JK; Ellmerer, M; Pieber, TR; CLOSING THE LOOP IN DIABETES: SAFETY CONSIDERATIONS FOR MOVING FROM THE CLINICAL RESEARCH CENTER TO THE HOME ENVIRONMENT.
DIABETES TECHNOL THER. DIABETES TECHNOLOGY AND THERAPEUTICS15: A78-A78. NEW ROCHELLE: MARY ANN LIEBERT INC; [Poster]
Web of Science

 

** Klim, S; Ingwersen, SH; Jensen, L; Kiyomi, F; Mader, J; Heller, S; Pieber, TR Liraglutide demonstrates similar pharmacokinetic properties in patients with type 1 and type 2 diabetes.
Diabetologia 2013. 2013; 56(S1):S404-S404.-49th Annual Meeting of the European Association for the Study of Diabetes (EASD); SEP 23-27, 2013; Barcelona, SPAIN. [Poster]
Web of Science

 

** Lucarelli, F; Scuffi, C; Mader, JK; Aberer, F; Korsatko, S; Pieber, TR; Valgimigli, F; OPTIMISING THE GLUCOSE SAMPLING PERFORMANCE OF AN INTRAVASCULAR MICRODIALYSIS-BASED CONTINUOUS GLUCOSE MONITORING DEVICE FOR USE IN HOSPITAL SETTINGS.
DIABETES TECHNOL THER. DIABETES TECHNOLOGY AND THERAPEUTICS15: A13-A13. NEW ROCHELLE: MARY ANN LIEBERT INC; [Oral Communication]
Web of Science

 

** Luijf, YM; DeVries, JH; Mader, JK; Doll, W; Place, J; Renard, E; Bruttomesso, D; Avogaro, A; Benesch, C; Heinemann, L; ACCURACY AND RELIABILITY OF CURRENT CGM SYSTEMS: A DIRECT COMPARISON.
DIABETES TECHNOL THER. DIABETES TECHNOLOGY AND THERAPEUTICS15: A13-A14. NEW ROCHELLE: MARY ANN LIEBERT INC; [Oral Communication]
Web of Science

 

** Mader, JK; Lilly, LC; Aberer, F; Kojzar, H; Korsatko, S; Strock, E; Mazze, R; Damsbo, P; Pieber, TR A Feasibility Assessment of PaQ®, a Simple 3-Day Basal/Bolus Insulin Delivery Device, in Patients with Type 2 Diabetes.
Diabetologia 2013. 2013; 56(S1):S445-S445.-49th Annual Meeting of the European Association for the Study of Diabetes (EASD); SeP 23-27, 2013; Barcelona, SPAIN. [Poster]
Web of Science

 

** Mader, JK; Lilly, LC; Aberer, F; Pachatz, J; Korsatko, S; Damsbo, P; Pieber, TR; PAQ, A SIMPLE 3-DAY BASAL/BOLUS INSULIN DELIVERY DEVICE, IN PATIENTS WITH TYPE 2 DIABETES.
DIABETES TECHNOL THER. DIABETES TECHNOLOGY AND THERAPEUTICS15: A14-A14. NEW ROCHELLE: MARY ANN LIEBERT INC; [Oral Communication]
Web of Science

 

** Mader, JK; Lilly, LC; Warner, JL; Pieber, TR; GLYCEMIC MANAGEMENT USING SIMPLE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IN PATIENTS WITH TYPE 2 DIABETES.
DIABETES TECHNOL THER. DIABETES TECHNOLOGY AND THERAPEUTICS15: A138-A138. NEW ROCHELLE: MARY ANN LIEBERT INC; [Oral Communication]
Web of Science

 

** Mader, JK; Neubauer, K; Schaupp, L; Augustin, T; Spat, S; Holl, B; Beck, P; Pieber, TR; Plank, J; USER ADHERENCE TO DOSING ADVICE OF AN ALGORITHM FOR BASAL BOLUS INSULIN THERAPY IN HOSPITALISED PATIENTS WITH DIABETES MELLITUS TYPE 2.
DIABETES TECHNOL THER. DIABETES TECHNOLOGY AND THERAPEUTICS15: A14-A15. NEW ROCHELLE: MARY ANN LIEBERT INC; [Oral Communication]
Web of Science

 

** Neubauer, KM; Mader, JK; Plank, J; Schaupp, L; Buttinger, M; Holl, B; Spat, S; Tschapeller, B; Beck, P; Pieber, TR; NURSES' EXPERIENCES ON IMPLEMENTING THE REACTION ALGORITHM FOR GLYCAEMIC MANAGEMENT AT A GENERAL WARD.
DIABETES TECHNOL THER. DIABETES TECHNOLOGY AND THERAPEUTICS15: A132-A132. NEW ROCHELLE: MARY ANN LIEBERT INC; [Poster]
Web of Science

 

** Pieber, TR; Schaupp, L; Neubauer, KM; Mader, JK; Augustin, T; Spat, S; Hoell, B; Beck, P; Plank, J; REACTION ALGORITHM AS AN IMPROVED PROTOCOL FOR IN-HOSPITAL MANAGEMENT OF TYPE 2 DIABETES.
DIABETES TECHNOL THER. DIABETES TECHNOLOGY AND THERAPEUTICS15: A18-A18. NEW ROCHELLE: MARY ANN LIEBERT INC; [Oral Communication]
Web of Science

 

** Schaupp, L; Neubauer, KM; Mader, JK; Augustin, T; Spat, S; Hoell, B; Beck, P; Plank, J; Pieber, TR; CONTINUOUS GLUCOSE MONITORING IN HOSPITALISED PATIENTS AT THE GENERAL WARD.
DIABETES TECHNOL THER. DIABETES TECHNOLOGY AND THERAPEUTICS15: A134-A134. NEW ROCHELLE: MARY ANN LIEBERT INC; [Poster]
Web of Science

 

2012

Full paper/article (Journal)

** Luijf, YM; Avogaro, A; Benesch, C; Bruttomesso, D; Cobelli, C; Ellmerer, M; Heinemann, L; Mader, JK; DeVries, JH; AP@home consortium Continuous glucose monitoring accuracy results vary between assessment at home and assessment at the clinical research center.
J Diabetes Sci Technol. 2012; 6(5):1103-1106 Doi: 10.1177/193229681200600514 [OPEN ACCESS]
PubMed FullText FullText_MUG

 

** Mader, JK; Feichtner, F; Bock, G; Köhler, G; Schaller, R; Plank, J; Pieber, TR; Ellmerer, M Microdialysis-A versatile technology to perform metabolic monitoring in diabetes and critically ill patients.
Diabetes Res Clin Pract. 2012; 97(1):112-118 Doi: 10.1016/j.diabres.2012.02.010
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Ribitsch, A; Tauschmann, M; Horki, V; Mader, J; Semlitsch, B; Horvath, K; Pieber, T; Bock, G Possible effects of Immunoglobulin A Deficiency in the management of Type 1 Diabetes Mellitus in Pregnancy-2 Case Reports
WIEN KLIN WOCHENSCHR. 2012; 124(15-16):569-569. [Poster]
Web of Science

 

2011

Full paper/article (Journal)

** Amrein, K; Sourij, H; Mader, J; Amrein, S; Robl, T Occult Pneumothorax on Chest X-ray.
Am J Emerg Med. 2011; 29(8):959.e3-959.e4 Doi: 10.1016/j.ajem.2010.07.025
Web of Science PubMed FullText FullText_MUG

 

** Bock, G; Prietl, B; Mader, JK; Höller, E; Wolf, M; Pilz, S; Graninger, WB; Obermayer-Pietsch, BM; Pieber, TR The effect of vitamin D supplementation on peripheral regulatory T cells and β cell function in healthy humans: a randomized controlled trial.
Diabetes Metab Res Rev. 2011; 27(8):942-945 Doi: 10.1002/dmrr.1276
Web of Science PubMed FullText FullText_MUG

 

** Feichtner, F; Mader, JK; Schaller, R; Schaupp, L; Ellmerer, M; Korsatko, S; Kondepati, VR; Heise, HM; Wilinska, ME; Hovorka, R; Pieber, TR A stepwise approach toward closed-loop blood glucose control for intensive care unit patients: results from a feasibility study in type 1 diabetic subjects using vascular microdialysis with infrared spectrometry and a model predictive control algorithm.
J Diabetes Sci Technol. 2011; 5(4): 901-905. Doi: 10.1177/193229681100500412 [OPEN ACCESS]
PubMed FullText FullText_MUG

 

** Ikeoka, DT; Pachler, C; Mader, JK; Bock, G; Neves, AL; Svehlikova, E; Feichtner, F; Koehler, G; Wrighton, CJ; Pieber, TR; Ellmerer, M Lipid-heparin infusion suppresses the IL-10 response to trauma in subcutaneous adipose tissue in humans.
Obesity (Silver Spring). 2011; 19(4):715-721 Doi: 10.1038/oby.2010.227 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Bock, G; Froehlich-Reiterer, E; Tauschmann, M; Prietl, B; Mader, J; Neuper, C; Borkenstein, M; Pieber, TR Characterization of beta cell function in patients with newly manifested Type 1 diabetes mellitus and Patients with positive autoantibodies at even low glucose abnormalities
WIEN KLIN WOCHENSCHR. 2011; 123: S15-S16.-ÖDG; NOV 17-19, 2011; Salzburg, Austria. [Poster]
Web of Science

 

** Bock, G; Prietl, B; Mader, JK; Kohler, G; Pilz, S; Obermayer-Pietsch, B; Pieber, TR No Sex-Specific Effect of Vitamin D Supplementation on Peripheral Regulatory T Cells and Other Immune Cells and Glucose Metabolism in Healthy Humans
J WOMENS HEALTH. 2011; 20(3):483-484.-Women's Health 2011, 19th Annual Congress; APR 1-3, 2011; Washington DC, USA. [Poster]
Web of Science

 

** Deller, S; Neubauer, K; Korsatko, S; Wolf, M; Urschitz, M; Zahiragic, S; Mader, J; Adrian, C; Thomsen, H; Haahr, H; Pieber, T Ultra-Long-acting insulin Degludec: Two different concentrations (U100 and U200) showing bioequivalence and comparable pharmacodynamics
WIEN KLIN WOCHENSCHR. . 2011; 123: S10-S11.-39. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 17-19, 2011; Salzburg, AUSTRIA. [Oral Communication]
Web of Science

 

** Kohler, G; Korsatko, S; Deller, S; Neubauer, K; Bock, G; Mader, J; Roepstorff, C; Rasmussen, S; Haahr, H; Pieber, T; Heller, S Induced hypoglycemia in type 1 diabetes with insulin Degludev and Insulin Glargine
WIEN KLIN WOCHENSCHR. 2011; 123: S9-S9.-ÖDG; NOV 17-19, 2011; Salzburg, Austria. [Oral Communication]
Web of Science

 

** Mader, J; Lucarelli, F; Scuffi, C; Friedrich, S; Korsatko, S; Urschitz, M; Wolf, M; Ellmerer, M; Valgimigli, F; Pieber, T Evaluate the safety and accuracy of GlucoMen (R) Day system for continuous subcutaneous glucose monitoring in patients with Type 1 diabetes
WIEN KLIN WOCHENSCHR. . 2011; 123: S5-S5.-39. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 17-19, 2011; Salzburg, AUSTRIA. [Oral Communication]
Web of Science

 

** Prietl, B; Bock, G; Mader, J; Holler, E; Wolf, M; Graninger, WB; Tauschmann, M; Obermayer-Pietsch, BM; Frohlich-Reiterer, E; Pieber, TR Differences in the frequency of memory T-cells and of plasmacytoid dendritic cells in the blood of patients with type 1 diabetes mellitus and healthy subjects
WIEN KLIN WOCHENSCHR. 2011; 123: S14-S14.-ÖDG; NOV 17-19, 2011; Salzburg, Austria. [Oral Communication]
Web of Science

 

** Ribitsch, A; Haas, W; Kohler, G; Valentin, T; Mader, J; Horvath, K; Pieber, TR; Bock, G Spectrum of germs in infected wounds in neuropathic diabetic foot performance in the outpatient clinic of a tertiary center
WIEN KLIN WOCHENSCHR. 2011; 123: S13-S13.-ÖDG; NOV 17-19, 2011; Salzburg, Austria. [Poster]
Web of Science

 

2010

Full paper/article (Journal)

** Ikeoka, D; Mader, JK; Pieber, TR Adipose tissue, inflammation and cardiovascular disease.
Rev Assoc Med Bras. 2010; 56(1): 116-121. Doi: 10.1590/S0104-42302010000100026 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Ikeoka, D; Pachler, C; Korsatko, S; Mader, JK; Weinhandl, H; Bodenlenz, M; Plank, J; Smolle, KH; Ellmerer, M; Pieber, TR Interleukin-6 produced in subcutaneous adipose tissue is linked to blood pressure control in septic patients.
Cytokine. 2010; 50(3): 284-291. Doi: 10.1016/j.cyto.2010.02.015
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Mader, JK; Weinhandl, H; Köhler, G; Plank, J; Bock, G; Korsatko, S; Ratzer, M; Ikeoka, D; Köhler, H; Pieber, TR; Ellmerer, M Assessment of different techniques for subcutaneous glucose monitoring in Type 1 diabetic patients during 'real-life' glucose excursions.
Diabet Med. 2010; 27(3): 332-338. Doi: 10.1111/j.1464-5491.2009.02924.x
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Bock, G; Mader, J; Prietl, B; Fruhmann, J; Urschitz, M; Hueter, N; Obermayer-Pietsch, B; Pieber, T Placebo-controlled trial to investigate dan effects of vitamin D substitution on the glucose metabolism in healthy subjects.
WIEN KLIN WOCHENSCHR. 2010; 122: S5-S5.-ÖDG; [Oral Communication]
Web of Science

 

** Bock, G; Mader, JK; Kohler, G; Svehlikova, E; Horvath, K; Pieber, TR Pseudo-hypoglycemia - a diagnostosche challenge in the investigation.
WIEN KLIN WOCHENSCHR. 2010; 122: S5-S5. [Poster]
Web of Science

 

** Bock, G; Prietl, B; Mader, JK; Fruhmann, J; Pilz, S; Hueter, N; Obermayer-Pietsch, BM; Pieber, TR The effect of vitamin D supplementation on beta cell function and insulin sensitivity during a mixed meal tolerance test in healthy humans
DIABETOLOGIA. 2010; 53: 889 [Poster]
Web of Science

 

** Mader, JK; Bock, G; Wagner, M; Forrer, F; Lackner, C; Portugaller, RH; Fickert, P; Krejs, GJ; Pieber, TR Recurrent hypoglycemia in adults - a diagnostic challenge (case report).
WIEN KLIN WOCHENSCHR. 2010; 122(17-18):A7-A7.-ÖGIM; Sep 29-Oct. 1; Salzburg, Austria. [Poster]
Web of Science

 

** Mader, JK; Korsatko, S; Bock, G; Kohler, G; Plank, J; Pieber, TR; Ellmerer, M Comparison of continuous subcutaneous glucose monitoring in different populations of critically ill patients.
WIEN KLIN WOCHENSCHR. 2010; 122: S14-S14.-Jahrestagung der Österreichischen Diabetesgesellschaft; NOV, 2010; Salzburg, AUSTRIA. [Poster]
Web of Science

 

** Prietl, B; Bock, G; Mader, JK; Holler, E; Wolf, M; Pilz, S; Graninger, WB; Obermayer-Pietsch, BM; Pieber, TR The effect of Vitamin D supplementation on peripheral regulatory T cells in healthy humans, a randomised controlled trial
DIABETOLOGIA. 2010; 53: 441 [Poster]
Web of Science

 

** Prietl, B; Bock, G; Mader, JK; Wulz, C; Fruhmann, J; Pilz, S; Graninger, W; Obermayer-Pietsch, B; Pieber, TR Significant increase of peripheral regulatory T cells in healthy subjects after vitamin D intake - a randomized placebo-controlled study
WIEN KLIN WOCHENSCHR. 2010; 122: S15-S15. [Oral Communication]
Web of Science

 

2009

Full paper/article (Journal)

** Korsatko, S; Ellmerer, M; Schaupp, L; Mader, JK; Smolle, KH; Tiran, B; Plank, J Hypoglycaemic coma due to falsely high point-of-care glucose measurements in an ICU-patient with peritoneal dialysis: a critical incidence report.
Intensive Care Med. 2009; 35(3): 571-572. Doi: 10.1007/s00134-008-1362-7
Web of Science PubMed FullText FullText_MUG

 

** Schaller, R; Feichtner, F; Köhler, H; Bodenlenz, M; Plank, J; Wutte, A; Mader, JK; Ellmerer, M; Hainisch, R; Pieber, TR; Schaupp, L An automated discontinuous venous blood sampling system for ex vivo glucose determination in humans.
J Diabetes Sci Technol. 2009; 3(1): 110-116. Doi: 10.1177/193229680900300112 [OPEN ACCESS]
PubMed FullText FullText_MUG Google Scholar

 

** Schaller, R; Feichtner, F; Köhler, H; Bodenlenz, M; Plank, J; Wutte, A; Mader, JK; Ellmerer, M; Hellmich, R; Wedig, H; Hainisch, R; Pieber, TR; Schaupp, L A novel automated discontinuous venous blood monitoring system for ex vivo glucose determination in humans.
Biosens Bioelectron. 2009; 24(7): 2239-2245. Doi: 10.1016/j.bios.2008.11.029
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Journal)

** Ikeoka, D; Korsatko, S; Pachler, C; Mader, JK; Bodenlenz, M; Plank, J; Ellmerer, M; Pieber, TR Clinical impact of inflammatory cytokines produced in adipose tissue of septic patients
DIABETOLOGIA. 2009; 52: 643--45th Annual Meeting of the EASD (European Association for the Study of Diabetes); SEP 29 - OCT 2, 2009; Vienna, AUSTRIA. [Poster]
Web of Science

 

** Ikeoka, D; Korsatko, S; Pachler, C; Mader, JK; Smolle, KH; Bodenlenz, M; Plank, J; Ellmerer, M; Pieber, TR INTERLEUKIN-6 PRODUCED IN ADIPOSE TISSUE IS STRONGLY LINKED TO DIASTOLIC BLOOD PRESSURE DURING SEVERE SEPSIS
INTENS CARE MED. 2009; 35: 0959--22nd Congress of the European Society of Intensive Care Medicine; OCT 11-14, 2009; Vienna, AUSTRIA. [Poster]
Web of Science

 

** Korsatko, S; Gettler, K; Olsen, KJ; Wutte, A; Bock, G; Kohler, G; Mader, J; Semlitsch, B; Pieber, T Comparison of pharmacodynamic and pharmacokinetic properties of insulin detemir and neutral protamine lispro (NPL) insulin in patients with Type 1 Diabetes.
WIEN KLIN WOCHENSCHR. 2009; 121: S17-S17.-37. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 19-21, 2009; Salzburg, Österreich. [Oral Communication]
Web of Science

 

** Korsatko, S; Glettler, K; Olsen, KJ; Wutte, A; Bock, G; Koehler, G; Mader, JK; Semlitsch, B; Pieber, TR A direct comparison of pharmacodynamics and pharmacokinetics of insulin detemir and neutral protamine lispro (NPL) insulin in subjects with type 1 diabetes
DIABETOLOGIA. 2009; 52: 499--c; SEP 29 - OCT 2, 2009; Vienna, AUSTRIA. [Poster]
Web of Science

 

** Lipp, RW; Schnedl, WJ; Bock, G; Kohler, G; Horvath, K; Mader, JK; Pieber, TR; Piswanger-Soelkner, J Gastric emptying as prognostic factor for life expectancy in patients with type 1 diabetes
DIABETOLOGIA. 2009; 52: 977--45th Annual Meeting of the EASD (European Association for the Study of Diabetes); SEP 29 - OCT 2, 2009; Vienna, AUSTRIA. [Poster]
Web of Science

 

** Mader, J; Feichtner, F; Bock, G; Kohler, G; Schaller, R; Plank, J; Pieber, T; Ellmerer, M Evaluation of Microdialysis-based glucose monitoring in blood and subcutaneous adipose tissue in patients with Type 1 Diabetes.
WIEN KLIN WOCHENSCHR. 2009; 121: S20-S20. [Poster]
Web of Science

 

** Mader, JK; Feichtner, F; Ikeoka, D; Korsatko, G; Köhler, G; Schaller, R; Plank, J; Pieber, TR; Ellmerer, M Evaluation of Microdialysis-based Glucose monitoring in Blood and Subcutaneous adipose tissue in Patients with Type 1 Diabetes
WIEN KLIN WOCHENSCHR. 2009; 121(15-16):A19-A19.-40. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin (ÖGIM); SEP 17-19, 2009; Vienna, AUSTRIA. [Poster]
Web of Science

 

** Mader, JK; Kohler, G; Plank, J; Suppan, M; Ikeoka, D; Kohler, H; Pieber, TR; Ellmerer, M Comparison of three different techniques for subcutaneous glucose monitoring in type 1 diabetic patients
DIABETOLOGIA. 2009; 52: 924--EASD - European Association for the Study of Diabetes; SEP 28-OCT 2, 2009; Vienna, AUSTRIA. [Poster]
Web of Science

 

** Pichler, EM; Ikeoka, D; Pachler, C; Mader, JK; Bock, G; Krusinova, E; Feichtner, F; Koehler, G; Pieber, T; Ellmerer, M Serum and adipose tissue adipokine concentrations are affected by non-esterified fatty-acids in healthy individuals
DIABETOLOGIA. 2009; 52: 61--45th Meeting of the EASD (European Society for the Study of Diabetes); SEP 29 - OCT 2, 2009; Vienna, AUSTRIA. [Oral Communication]
Web of Science

 

** Piswanger-Soelkner, J; Schnedl, WJ; Bock, G; Kohler, G; Horvath, K; Mader, JK; Pieber, TR; Lipp, RW The influence of gastric emptying patterns on blood glucose in type 1 diabetes
DIABETOLOGIA. 2009; 52: 978--45th Annual Meeting of the EASD (European Association for the Study of Diabetes); SEP 29 - OCT 2, 2009; Vienna, AUSTRIA. [Poster]
Web of Science

 

2008

Abstract (Journal)

** Mader, JK; Feichtner, F; Korsatko, S; Kohler, G; Schaller, R; Plank, J; Pieber, TR; Ellmerer, M Evaluation of microdialysis-based glucose monitoring in blood and subcutaneous adipose tissue in type 1 diabetic patients
DIABETOLOGIA. 2008; 51: S435-S435.-EASD Annual Meeting; SEP 7-11, 2008; Rome, ITALY. [Poster]
Web of Science

 

2007

Full paper/article (Journal)

** Pachler, C; Ikeoka, D; Plank, J; Weinhandl, H; Suppan, M; Mader, JK; Bodenlenz, M; Regittnig, W; Mangge, H; Pieber, TR; Ellmerer, M Subcutaneous adipose tissue exerts proinflammatory cytokines after minimal trauma in humans.
Am J Physiol Endocrinol Metab. 2007; 293(3):E690-E696 Doi: 10.1152/ajpendo.00034.2007 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Weinhandl, H; Pachler, C; Mader, JK; Ikeoka, D; Mautner, A; Falk, A; Suppan, M; Pieber, TR; Ellmerer, M Physiological hyperinsulinemia has no detectable effect on access of macromolecules to insulin-sensitive tissues in healthy humans.
Diabetes. 2007; 56(9): 2213-2217. Doi: 10.2337/db07-0238 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Short report/Letter

** Vlasselaers, D; Schaupp, L; van den Heuvel, I; Mader, J; Bodenlenz, M; Suppan, M; Wouters, P; Ellmerer, M; Van den Berghe, G Monitoring blood glucose with microdialysis of interstitial fluid in critically ill children.
CLIN CHEM. 2007; 53(3): 536-537. Doi: 10.1373/clinchem.2006.078089 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Pachler, C; Ikeoka, D; Plank, J; Weinhandl, H; Suppan, M; Mader, JK; Bodenlenz, M; Regittnig, W; Mangge, H; Pieber, TR; Ellmerer, M Inflammatory cytokine response of subcutaneous adipose tissue after minimal trauma in humans
DIABETES. 2007; 56: A354-A355. [Poster]
Web of Science

 

Abstract (Proceedings)

** Ikeoka, D; Pachler, C; Korsatko, S; Bodenlenz, M; Mader, J; Weinhandl, H; Plasnik, A; Suppan, M; Smolle, KH; Plank, J; Pieber, T; Ellmerer; M Local Stimulated Secretion of Inflammatory Cytokines from Adipose Tissue is Reduced in Septic Patients in Comparison to Healthy Controls.
. 2007; 39(1): 17-17. Doi: 10.1016/j.cyto.2007.07.065 [Poster]
Web of Science FullText FullText_MUG

 

2006

Full paper/article (Journal)

** Ellmerer, M; Haluzik, M; Blaha, J; Kremen, J; Svacina, S; Toller, W; Mader, J; Schaupp, L; Plank, J; Pieber, T Clinical evaluation of alternative-site glucose measurements in patients after major cardiac surgery.
Diabetes Care. 2006; 29(6):1275-1281 Doi: 10.2337/dc05-2377 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

↑ Top of page / Navigation

© Med Uni Graz • Imprint